Barclays PLC
Results Announcement
31 December 2020
Table of Contents
Results Announcement | Page | |
Notes | 1 | |
Performance Highlights | 2-4 | |
Group Chief Executive Officer's Review | 5 | |
Group Finance Director's Review | 6-7 | |
Results by Business | | |
· | Barclays UK | 8-10 |
· | Barclays International | 11-14 |
· | Head Office | 15 |
Quarterly Results Summary | 16 | |
Quarterly Results by Business | 17-22 | |
Performance Management | | |
· | Margins and Balances | 23 |
· | Remuneration | 24-25 |
Risk Management | | |
· | Risk Management and Principal Risks | 26 |
· | Credit Risk | 27-40 |
· | Market Risk | 41 |
· | Treasury and Capital Risk | 42-52 |
Statement of Directors' Responsibilities | 53 | |
Condensed Consolidated Financial Statements | 54-58 | |
Financial Statement Notes | 59-64 | |
Appendix: Non-IFRS Performance Measures | 65-74 | |
Shareholder Information | 75 |
BARCLAYS PLC, 1 CHURCHILL PLACE, LONDON, E14 5HP, UNITED KINGDOM. TELEPHONE: +44 (0) 20 7116 1000. COMPANY NO. 48839
Notes
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014 (as it forms part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018).
The terms Barclays or Group refer to Barclays PLC together with its subsidiaries. Unless otherwise stated, the income statement analysis compares the year ended 31 December 2020 to the corresponding 12 months of 2019 and balance sheet analysis as at 31 December 2020 with comparatives relating to 31 December 2019. The abbreviations '£m' and '£bn' represent millions and thousands of millions of Pounds Sterling respectively; the abbreviations '$m' and '$bn' represent millions and thousands of millions of US Dollars respectively; and the abbreviations '€m' and '€bn' represent millions and thousands of millions of Euros respectively.
There are a number of key judgement areas, for example impairment calculations, which are based on models and which are subject to ongoing adjustment and modifications. Reported numbers reflect best estimates and judgements at the given point in time.
Relevant terms that are used in this document but are not defined under applicable regulatory guidance or International Financial Reporting Standards (IFRS) are explained in the results glossary that can be accessed at home.barclays/investor-relations/reports-and-events/latest-financial-results.
The information in this announcement, which was approved by the Board of Directors on 17 February 2021, does not comprise statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2020, which contain an unmodified audit report under Section 495 of the Companies Act 2006 (which did not make any statements under Section 498 of the Companies Act 2006) will be delivered to the Registrar of Companies in accordance with Section 441 of the Companies Act 2006.
These results will be furnished on Form 6-K with the US Securities and Exchange Commission (SEC) as soon as practicable following their publication. Once furnished with the SEC, a copy of the Form 6-K will be available from the SEC's website at www.sec.gov.
Barclays is a frequent issuer in the debt capital markets and regularly meets with investors via formal road-shows and other ad hoc meetings. Consistent with its usual practice, Barclays expects that from time to time over the coming quarter it will meet with investors globally to discuss these results and other matters relating to the Group.
Non-IFRS performance measures
Barclays management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses' performance between financial periods and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by Barclays management. However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well. Refer to the appendix on pages 65 to 74 for further information and calculations of non-IFRS performance measures included throughout this document, and the most directly comparable IFRS measures.
Forward-looking statements
This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the Group. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ materially from those contained in the forward-looking statements. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as 'may', 'will', 'seek', 'continue', 'aim', 'anticipate', 'target', 'projected', 'expect', 'estimate', 'intend', 'plan', 'goal', 'believe', 'achieve' or other words of similar meaning. Forward-looking statements can be made in writing but also may be made verbally by members of the management of the Group (including, without limitation, during management presentations to financial analysts) in connection with this document. Examples of forward-looking statements include, among others, statements or guidance regarding or relating to the Group's future financial position, income growth, assets, impairment charges, provisions, business strategy, capital, leverage and other regulatory ratios, capital distributions (including dividend payout ratios and expected payment strategies), projected levels of growth in the banking and financial markets, projected costs or savings, any commitments and targets, estimates of capital expenditures, plans and objectives for future operations, projected employee numbers, IFRS impacts and other statements that are not historical fact. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. The forward-looking statements speak only as at the date on which they are made. Forward-looking statements may be affected by: changes in legislation; the development of standards and interpretations under IFRS, including evolving practices with regard to the interpretation and application of accounting and regulatory standards; the outcome of current and future legal proceedings and regulatory investigations; future levels of conduct provisions; the policies and actions of governmental and regulatory authorities; the Group's ability along with government and other stakeholders to manage and mitigate the impacts of climate change effectively; geopolitical risks; and the impact of competition. In addition, factors including (but not limited to) the following may have an effect: capital, leverage and other regulatory rules applicable to past, current and future periods; UK, US, Eurozone and global macroeconomic and business conditions; the effects of any volatility in credit markets; market related risks such as changes in interest rates and foreign exchange rates; effects of changes in valuation of credit market exposures; changes in valuation of issued securities; volatility in capital markets; changes in credit ratings of any entity within the Group or any securities issued by such entities; direct and indirect impacts of the coronavirus (COVID-19) pandemic; instability as a result of the UK's exit from the European Union (EU), the effects of the EU-UK Trade and Cooperation Agreement and the disruption that may subsequently result in the UK and globally; the risk of cyber-attacks, information or security breaches or technology failures on the Group's business or operations; and the success of future acquisitions, disposals and other strategic transactions. A number of these influences and factors are beyond the Group's control. As a result, the Group's actual financial position, future results, capital distributions, capital, leverage or other regulatory ratios or other financial and non-financial metrics or performance measures may differ materially from the statements or guidance set forth in the Group's forward-looking statements. Additional risks and factors which may impact the Group's future financial condition and performance are identified in our filings with the SEC (including, without limitation, our Annual Report on Form 20-F for the fiscal year ended 31 December 2020), which are available on the SEC's website at www.sec.gov.
Subject to our obligations under the applicable laws and regulations of any relevant jurisdiction, (including, without limitation, the UK and the US), in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Performance Highlights
Helping support the economy during the COVID-19 pandemic
COVID-19 support
Continuing to support our customers, clients, communities and colleagues | · | In 2020, provided over 680k payment holidays to customers, c.£27bn of COVID-19 support to UK businesses1 and helped businesses and institutions access global capital markets including underwriting c.£1.5tn of new issuance2. Also waived c.£100m of interest and fees to customers, and committed £100m to a COVID-19 Community Aid Package |
Barclays' diversified business model delivered a resilient operating performance, allowing capital distributions to shareholders equivalent to 5.0p per share
Despite the pandemic, Barclays remained profitable every quarter during 2020 and delivered a full year Group profit before tax of £3.1bn (2019: £4.4bn, including a Payment Protection Insurance (PPI) provision of £1.4bn), attributable profit of £1.5bn (2019: £2.5bn), a return on tangible equity (RoTE) of 3.2% (2019: 5.3%) and earnings per share (EPS) of 8.8p (2019: 14.3p)
Income
Diversified income streams with strong CIB income offsetting challenges in Barclays UK and CC&P | Group income of £21.8bn up 1% versus prior year | ||
· | Barclays International income of £15.9bn, up 8% versus prior year | ||
| - | Corporate and Investment Bank (CIB) income of £12.5bn, up 22% due to strong Markets income reflecting market share gains3 in a buoyant trading environment, as well as strong Banking income, resulting in the best ever year on a comparable basis for both businesses4 | |
| - | Consumer, Cards and Payments (CC&P) income of £3.4bn, down 22% driven by lower credit card balances, margin compression and reduced payments activity | |
· | Barclays UK income of £6.3bn, down 14% versus prior year reflecting lower unsecured lending balances and interest rates, and COVID-19 customer support actions, partially offset by mortgages growth | ||
Credit impairment charges
Increased impairment provisioning driving higher coverage ratios across portfolios | Group credit impairment charges increased to £4.8bn (2019: £1.9bn) due to the deterioration in economic outlook driven by the COVID-19 pandemic | ||
· | Current year charge includes £2.3bn of non-default provision for expected future customer and client stress | ||
· | Total balance sheet impairment allowance of £9.4bn (2019: £6.6bn), resulting in higher coverage ratios for unsecured consumer lending and wholesale portfolios of 12.3% (2019: 8.1%) and 1.5% (2019: 0.8%) respectively | ||
Costs5 Stable cost: income ratio including structural cost actions | Group operating expenses of £13.7bn up 1% versus prior year | ||
· | 2020 operating expenses reflect £0.4bn of structural cost actions mainly taken in Q420 and additional COVID-19 related costs resulting in a cost: income ratio of 63% (2019: 63%) | ||
Capital
Strong capital position | Common equity tier 1 (CET1) ratio of 15.1% up 130bps versus prior year | ||
· | The increase reflects profits, regulatory measures and cancellation of the full year 2019 dividend payment, partially offset by the announced 1.0p full year 2020 dividend and an increase in Risk Weighted Assets (RWAs) | ||
Capital distributions Return of capital through dividends and share buybacks | Capital distributions announced of 5.0p per share in aggregate: | ||
· | 1.0p 2020 full year dividend declared | ||
· | Intend to initiate a share buyback of up to £700m, which would have an effect of 23bps on the CET1 ratio | ||
Q420 performance
| |||
Remained profitable in Q420 despite the continuing impact of the pandemic
| Q420 Group profit before tax of £0.6bn (Q419: £1.1bn) and attributable profit of £0.2bn (Q419: £0.7bn), resulting in a RoTE of 1.8% (Q419: 5.9%) and EPS of 1.3p (Q419: 3.9p) | ||
· | Q420 Group income of £4.9bn, down 7% versus prior year | ||
· | Q420 Barclays International income of £3.5bn, up 1% versus prior year | ||
| - | Q420 CIB income of £2.6bn, up 14% versus prior year driven by a 19% increase in Markets income and 30% increase in Banking fees, partially offset by a 12% decrease in Corporate income | |
| - | Q420 CC&P income of £0.8bn, down 25% versus prior year and down 3% versus prior quarter, as the impacts of the pandemic continued to result in lower balances, margin compression and reduced payments activity | |
· | Q420 Barclays UK income of £1.6bn, down 17% versus prior year but up 5% versus prior quarter, reflecting lower unsecured lending balances and interest rates, partially offset by mortgages growth | ||
· | Q420 Group credit impairment charge of £0.5bn, down 6% versus prior year and down 19% versus prior quarter | ||
· | Q420 Group operating expenses of £3.8bn5, up 7% versus prior year and up 11% versus prior quarter, including the UK bank levy of £0.3bn (Q419: £0.2bn) and structural cost actions of £0.3bn | ||
· | CET1 ratio of 15.1%6, an increase of 50bps in Q420 mainly due to a 30bps benefit from regulatory changes to software assets |
1 | Total payment holidays granted as at 31 December 2020, business lending and commercial paper issuance data as at 12 and 15 February 2021 respectively. |
2 | Across Equity and Debt Capital Markets in Q220-Q420. |
3 | Data source: Coalition Greenwich, Preliminary FY20 Competitor Analysis. Market share represents Barclays share of the Global Industry Revenue Pool. Analysis is based on Barclays internal business structure and internal revenues. |
4 | Period covering Q114-Q420. Pre 2014 financials were not restated following re-segmentation in Q116. |
5 | Excluding litigation and conduct. |
6 | On 12 February 2021 the Prudential Regulation Authority (PRA) launched a consultation on certain items within the Basel standards that remain to be implemented in the UK as well as setting out proposed new PRA CRR rules. The proposals include reverting to the previous treatment of 100% CET1 capital deduction for qualifying software assets by the end of 2021, meaning the benefit in the CET1 ratio is likely to be reversed in future periods. |
Group outlook and targets
Outlook Remains uncertain and subject to change depending on the evolution and persistence of the COVID-19 pandemic | Returns | ||
· | Barclays expects to deliver meaningful year-on-year RoTE improvement in 2021 | ||
| |||
Income | |||
· | Headwinds to income in Barclays UK are expected to persist in 2021 and the medium-term, including the subdued demand for unsecured lending and the low interest rate environment | ||
· | Within Barclays International, CC&P income outlook remains uncertain and contingent on the evolution of US and UK spending and cards balances; after a strong 2020 CIB performance, driven by Markets and Banking income, the franchise is well positioned for the future | ||
| |||
Impairment | |||
· | Provided macroeconomic assumptions remain consistent with expectations, the Group expects that the full year 2021 impairment charge will be materially below that of 2020 | ||
| |||
Costs | |||
· | COVID-19 related expenses are likely to remain elevated in 2021. However, the Group will continue to drive efficiencies while investing in its franchise where appropriate | ||
| |||
Capital | |||
· | Barclays remains in a strong capital position with a year end CET1 ratio of 15.1% | ||
· | Certain headwinds to capital are likely in 2021, including procyclical effects on RWAs, reversal of regulatory forbearance applied through 2020 and increased pension contributions | ||
| |||
Capital distributions | |||
· | Barclays understands the importance of delivering attractive total cash returns to shareholders | ||
· | Announced a total payout equivalent to 5.0p per share, consistent with the temporary guardrails announced by the PRA in December 2020, comprising: | ||
| - | 1.0p 2020 full year dividend; and the | |
| - | Intention to initiate a share buyback of up to £700m, which is expected to commence in Q121 |
Targets | Barclays remains committed to its medium term targets: | |
· | Returns: RoTE of greater than 10% over time | |
· | Cost efficiency: Cost: income ratio below 60% over time | |
· | Capital adequacy: CET1 ratio in the range of 13-14% |
Barclays Group results | | ||
for the year ended | 31.12.20 | 31.12.19 | |
| £m | £m | % Change |
Net interest income | 8,122 | 9,407 | (14) |
Net fee, commission and other income | 13,644 | 12,225 | 12 |
Total income | 21,766 | 21,632 | 1 |
Credit impairment charges | (4,838) | (1,912) | |
Net operating income | 16,928 | 19,720 | (14) |
Operating costs | (13,434) | (13,359) | (1) |
UK bank levy | (299) | (226) | (32) |
Operating expenses | (13,733) | (13,585) | (1) |
Litigation and conduct | (153) | (1,849) | 92 |
Total operating expenses | (13,886) | (15,434) | 10 |
Other net income | 23 | 71 | (68) |
Profit before tax | 3,065 | 4,357 | (30) |
Tax charge | (604) | (1,003) | 40 |
Profit after tax | 2,461 | 3,354 | (27) |
Non-controlling interests | (78) | (80) | 3 |
Other equity instrument holders | (857) | (813) | (5) |
Attributable profit | 1,526 | 2,461 | (38) |
| | | |
Performance measures | | | |
Return on average tangible shareholders' equity | 3.2% | 5.3% | |
Average tangible shareholders' equity (£bn) | 48.3 | 46.6 | |
Cost: income ratio | 64% | 71% | |
Loan loss rate (bps) | 138 | 55 | |
Basic earnings per share | 8.8p | 14.3p | (38) |
Dividend per share1 | 1.0p | 3.0p | |
Share buyback announced2 | 700 | - | |
Total payout equivalent per share | 5.0p | 3.0p | 67 |
| | | |
Performance measures excluding litigation and conduct3 | | | |
Profit before tax | 3,218 | 6,206 | (48) |
Attributable profit | 1,638 | 4,194 | (61) |
Return on average tangible shareholders' equity | 3.4% | 9.0% | |
Cost: income ratio | 63% | 63% | |
Basic earnings per share | 9.5p | 24.4p | (61) |
| | | |
Balance sheet and capital management4 | £bn | £bn | |
Loans and advances at amortised cost | 342.6 | 339.1 | 1 |
Deposits at amortised cost | 481.0 | 415.8 | 16 |
Tangible net asset value per share | 269p | 262p | 3 |
Common equity tier 1 ratio | 15.1% | 13.8% | |
Common equity tier 1 capital | 46.3 | 40.8 | |
Risk weighted assets | 306.2 | 295.1 | |
Average UK leverage ratio | 5.0% | 4.5% | |
UK leverage ratio | 5.3% | 5.1% | |
| | | |
Funding and liquidity | | | |
Group liquidity pool (£bn) | 266 | 211 | 26 |
Liquidity coverage ratio | 162% | 160% | |
Loan: deposit ratio | 71% | 82% | |
1 | In response to a request from the PRA, and to preserve additional capital for use in serving Barclays customers and clients through the extraordinary challenges presented by the COVID-19 pandemic, the Board agreed to cancel the 6.0p per ordinary share full year 2019 dividend. |
2 | Barclays intends to initiate a share buyback of up to £700m, which is expected to commence in Q121. |
3 | Refer to pages 65 to 74 for further information and calculations of performance measures excluding litigation and conduct. |
4 | Refer to pages 45 to 51 for further information on how capital, RWAs and leverage are calculated. |
Group Chief Executive Officer's Review
"In a year in which the COVID-19 pandemic affected people across the globe, 2020 demonstrated our strengths, our values, and our resilience.
Throughout the pandemic we have focussed on preserving the financial and operational integrity of the firm so that we can maximise our support for clients and customers, for colleagues, and for the communities in which we live and work.
In the past year, we have helped companies to raise around £1.5tn through the global capital markets1, extended around £27bn to businesses through UK government lending schemes, provided over 680k payment holidays to customers2, waived around £100m of interest and fees, and committed £100m to charities through our COVID-19 Community Aid Package.
2020 demonstrated the value of our diversified banking model, delivering resilient Group results even in a difficult macroeconomic period, driven by the performance of our CIB.
Total income increased to £21.8bn. Within Barclays International, CIB income was up 22%, while CC&P income was down 22%. In Barclays UK, income was down 14%.
Pre-provision profits3 were broadly stable at £8.1bn. However, impairment charges, maintaining our cautious view of the impact of the pandemic, totalled £4.8bn. The fourth quarter impairment charge of c.£500m was however down 19% from the previous quarter.
Group profit before tax was £3.1bn for the year, and we remained profitable in every quarter, including generating profit before tax of £646m in the fourth quarter.
CIB income was £12.5bn, with both Markets and Banking achieving their best ever income performance4, up 45% and 8% respectively. Corporate income was down 13%, including the impact of lower interest rates. Overall, profit before tax in the CIB increased 35% to £4bn.
Our CC&P business made a loss before tax of £388m for the full year due to impairment charges, despite returning to profit in the third and fourth quarters.
Barclays UK profit before tax, excluding litigation and conduct, decreased 78% to £578m, including £278m in the fourth quarter, reflecting the impact of the COVID-19 pandemic driving higher impairment.
Group costs, excluding litigation and conduct, rose 1% to £13.7bn which included structural cost actions, leading to a cost to income ratio of 63%.
Group RoTE was 3.2%, including 9.5% for the CIB, (7.5%) for CC&P, and 3.2% for Barclays UK. Earnings per share were 8.8p.
Our CET1 capital ratio increased 50bps in the quarter, and 130bps in the year to 15.1%, significantly ahead of our minimum requirement.
Given the strength of our business, we have decided the time is right to resume capital distributions. We have today announced a total payout equivalent to 5p per share, comprising a 1p 2020 full year dividend and the intention to initiate a share buyback of up to £700m. We expect to comment further on capital distributions when appropriate.
Barclays remains well capitalised, well provisioned for impairments, highly liquid, with a strong balance sheet, and competitive market positions across the Group. We expect that our resilient and diversified business model will deliver a meaningful improvement in returns in 2021."
James E Staley, Group Chief Executive Officer
1 | Across Equity and Debt Capital Markets in Q220-Q420. |
2 | Total payment holidays granted as at 31 December 2020, business lending and commercial paper issuance data as at 12 and 15 February 2021 respectively. |
3 | Excluding litigation and conduct. |
4 | Period covering Q114 - Q420. Pre 2014 financials were not restated following re-segmentation in Q116. |
Group Finance Director's Review
Group performance
· | Statutory RoTE was 3.2% (2019: 5.3%) and statutory EPS was 8.8p (2019: 14.3p) |
· | Profit before tax was £3,065m (2019: £4,357m). Excluding litigation and conduct, profit before tax was £3,218m (2019: £6,206m) |
· | Pre-provision profits1 were broadly stable at £8,056m despite the pandemic, benefitting from the Group's diversified business model, which included a strong performance in CIB offset by headwinds in Barclays UK and CC&P |
· | Total income increased to £21,766m (2019: £21,632m). Barclays UK income decreased 14%. Barclays International income increased 8%, with CIB income up 22% and CC&P income down 22% |
· | Credit impairment charges increased to £4,838m (2019: £1,912m) due to the deterioration in economic outlook driven by the COVID-19 pandemic. The current year charge is broadly driven by £2,323m of non-default provision for expected future customer and client stress and £800m of single name wholesale loan charges. The expected credit loss (ECL) provision remains highly uncertain as the economic impact of the global pandemic continues to evolve |
· | Operating expenses increased 1% to £13,733m, including structural cost actions and additional COVID-19 related costs, resulting in a cost: income ratio, excluding litigation and conduct, of 63% (2019: 63%). Excluding structural cost actions of £368m (2019: £150m) and £95m spend to date of Barclays' COVID-19 Community Aid Package, operating expenses would have been £13,270m (2019: £13,435m), reflecting disciplined cost management and efficiencies, resulting in a cost: income ratio of 61% (2019: 62%) |
· | Attributable profit was £1,526m (2019: £2,461m). Excluding litigation and conduct, attributable profit was £1,638m (2019: £4,194m), generating a RoTE of 3.4% (2019: 9.0%) and EPS of 9.5p (2019: 24.4p) |
· | Total assets increased to £1,350bn (December 2019: £1,140bn) primarily due to a £73bn increase in derivative assets driven by a decrease in major interest rate curves and increased client activity, a £42bn increase in financial assets at fair value due to an increase in reverse repurchase agreements and similar secured lending and £41bn increase in cash and balances at central banks |
· | Loans and advances at amortised cost increased by £4bn to £343bn, which reflected £12bn of lending under the government backed loan schemes and £5bn of mortgage growth, partially offset by lower unsecured lending balances |
· | Deposits at amortised cost increased by £65bn to £481bn primarily due to CIB clients increasing liquidity, and lower consumer spending levels |
· | Tangible net asset value (TNAV) per share increased to 269p (December 2019: 262p) primarily reflecting 8.8p of statutory EPS |
Group capital and leverage
· | The CET1 ratio increased to 15.1% (December 2019: 13.8%), reflecting headroom of 3.9% above the Maximum Distributable Amount (MDA) hurdle of 11.2% | |
| - | CET1 capital increased by £5.5bn to £46.3bn reflecting resilient capital generation through £7.9bn of profit before tax, excluding credit impairment charges of £4.8bn, and a £1.0bn increase due to the cancellation of the full year 2019 dividend. These increases were partially offset by £0.9bn of AT1 coupons paid and the announced 1.0p full year 2020 dividend. The CET1 capital increase also reflects regulatory measures for IFRS 9 transitional relief, prudent valuation and qualifying software assets |
| - | RWAs increased by £11.1bn to £306.2bn primarily due to higher market volatility, increased client activity and a reduction in credit quality within CIB, partially offset by lower consumer lending |
· | The average UK leverage ratio increased to 5.0% (December 2019: 4.5%) primarily driven by the increase in Tier 1 (T1) capital. The average leverage exposure increased to £1,147bn (December 2019: £1,143bn) primarily driven by an increase in securities financing transactions (SFTs) and trading portfolio assets (TPAs) largely driven by an increase in secured lending and client activity within CIB, partially offset by the PRA's early adoption of CRR II settlement netting |
1 | Excluding litigation and conduct. |
Group funding and liquidity
· | The liquidity pool was £266bn (December 2019: £211bn) and the liquidity coverage ratio (LCR) remained significantly above the 100% regulatory requirement at 162% (December 2019: 160%), equivalent to a surplus of £99bn (December 2019: £78bn). The increase in the liquidity pool, LCR and surplus over the year was driven by a 16% growth in deposits, which was largely a consequence of government and central bank policy response to the COVID-19 pandemic. The reduction in Q420 reflects actions taken to manage down surplus liquidity proactively as the prevailing uncertainty from earlier in the year abated |
· | Wholesale funding outstanding, excluding repurchase agreements, was £145.0bn (December 2019: £147.1bn). The Group issued £7.9bn equivalent of minimum requirement for own funds and eligible liabilities (MREL) instruments from Barclays PLC (the Parent company) during the year. The Group is well advanced in its MREL issuance plans relative to the estimated 1 January 2022 requirement |
Other matters
· | As at 31 December 2020, the Group held a residual provision of £129m relating to PPI, following a provision release of £55m in Q420 on resolution of the items received up to and including Q319. Observations from resolved complaints support the residual provision level, which is expected to be utilised in 2021 |
· | Following the UK's exit from the EU on 31 December 2020, Barclays remains well positioned to continue providing services in the EU through Barclays Europe (operating through Barclays Bank Ireland PLC) which was expanded post the EU referendum vote to ensure continuity of services to Barclays International clients in Europe |
· | The High Court has indicated that judgment in relation to the civil action brought against Barclays Bank PLC by PCP Capital Partners LLP and PCP International Finance Limited, under which PCP is seeking damages of up to approximately £819m, is imminent. The outcome of the judgement, and any financial impact on the Group, is unknown. Barclays is defending the claim. See Note 26 to the audited financial statements for the year ended 31 December 2020 contained in the Barclays PLC Annual Report 2020 for further details |
Capital distributions
· | Barclays understands the importance of delivering attractive total cash returns to shareholders. Barclays is therefore committed to maintaining an appropriate balance between total cash returns to shareholders, investment in the business and maintaining a strong capital position. Going forward, Barclays intends to pay a progressive ordinary dividend, taking into account these objectives and the earnings outlook of the Group. It is also the Board's intention to continue to supplement the ordinary dividends with additional cash returns, including share buybacks, to shareholders as and when appropriate | |
· | Announced a total payout equivalent to 5.0p per share, consistent with the temporary guardrails announced by the PRA in December 2020, comprising: | |
| - | 1.0p 2020 full year dividend; and the |
| - | Intention to initiate a share buyback of up to £700m which is expected to commence in Q121 |
Tushar Morzaria, Group Finance Director
Results by Business
Barclays UK | Year ended | Year ended | |
31.12.20 | 31.12.19 | | |
Income statement information | £m | £m | % Change |
Net interest income | 5,234 | 5,888 | (11) |
Net fee, commission and other income | 1,113 | 1,465 | (24) |
Total income | 6,347 | 7,353 | (14) |
Credit impairment charges | (1,467) | (712) | |
Net operating income | 4,880 | 6,641 | (27) |
Operating costs | (4,270) | (3,996) | (7) |
UK bank levy | (50) | (41) | (22) |
Operating expenses | (4,320) | (4,037) | (7) |
Litigation and conduct | (32) | (1,582) | 98 |
Total operating expenses | (4,352) | (5,619) | 23 |
Other net income | 18 | - | |
Profit before tax | 546 | 1,022 | (47) |
Attributable profit | 325 | 281 | 16 |
| | | |
Balance sheet information | £bn | £bn | |
Loans and advances to customers at amortised cost | 205.4 | 193.7 | |
Total assets | 289.1 | 257.8 | |
Customer deposits at amortised cost | 240.5 | 205.5 | |
Loan: deposit ratio | 89% | 96% | |
Risk weighted assets | 73.7 | 74.9 | |
Period end allocated tangible equity | 9.7 | 10.3 | |
| | | |
Key facts | | | |
Average loan to value of mortgage portfolio1 | 51% | 51% | |
Average loan to value of new mortgage lending1 | 68% | 68% | |
Number of branches | 859 | 963 | |
Mobile banking active customers | 9.2m | 8.4m | |
30 day arrears rate - Barclaycard Consumer UK | 1.7% | 1.7% | |
| | | |
Performance measures | | | |
Return on average allocated tangible equity | 3.2% | 2.7% | |
Average allocated tangible equity (£bn) | 10.1 | 10.3 | |
Cost: income ratio | 69% | 76% | |
Loan loss rate (bps) | 68 | 36 | |
Net interest margin | 2.61% | 3.09% | |
| | | |
Performance measures excluding litigation and conduct2 | £m | £m | |
Profit before tax | 578 | 2,604 | (78) |
Attributable profit | 343 | 1,813 | (81) |
Return on average allocated tangible equity | 3.4% | 17.5% | |
Cost: income ratio | 68% | 55% |
1 | Average loan to value of mortgages is balance weighted and reflects both residential and buy-to-let (BTL) mortgage portfolios within the Home Loans portfolio. |
2 | Refer to pages 65 to 74 for further information and calculations of performance measures excluding litigation and conduct. |
Analysis of Barclays UK | Year ended | Year ended | |
31.12.20 | 31.12.19 | | |
Analysis of total income | £m | £m | % Change |
Personal Banking | 3,522 | 4,009 | (12) |
Barclaycard Consumer UK | 1,519 | 1,992 | (24) |
Business Banking | 1,306 | 1,352 | (3) |
Total income | 6,347 | 7,353 | (14) |
| | | |
Analysis of credit impairment charges | | | |
Personal Banking | (380) | (195) | (95) |
Barclaycard Consumer UK | (881) | (472) | (87) |
Business Banking | (206) | (45) | |
Total credit impairment charges | (1,467) | (712) | |
| | | |
Analysis of loans and advances to customers at amortised cost | £bn | £bn | |
Personal Banking | 157.3 | 151.9 | |
Barclaycard Consumer UK | 9.9 | 14.7 | |
Business Banking | 38.2 | 27.1 | |
Total loans and advances to customers at amortised cost | 205.4 | 193.7 | |
| | | |
Analysis of customer deposits at amortised cost | | | |
Personal Banking | 179.7 | 159.2 | |
Barclaycard Consumer UK | 0.1 | - | |
Business Banking | 60.7 | 46.3 | |
Total customer deposits at amortised cost | 240.5 | 205.5 | |
Barclays UK continued to support customers throughout the challenging operating environment, increasing lending by £11.7bn predominantly through Bounce Back Loan Scheme (BBLS) and Coronavirus Business Interruption Loan Scheme (CBILS) loans to small and medium-sized enterprises (SMEs), as well as delivering strong mortgage growth. Customer deposit growth of £35bn added to a strong liquidity position reflected in the full year loan: deposit ratio of 89%, 7% lower than prior year. Full year RoTE of 3.4%, excluding litigation and conduct, was materially below historical performance, reflecting the impact of the COVID-19 pandemic as well as ongoing investment spend, including structural cost actions to continue to transform the business over time.
2020 compared to 2019
Income statement
· | Profit before tax, excluding litigation and conduct, decreased 78% to £578m. RoTE was 3.4% (2019: 17.5%) reflecting a challenging operating environment and materially higher credit impairment charges | |
· | Total income decreased 14% to £6,347m. Net interest income reduced 11% to £5,234m with a net interest margin (NIM) of 2.61% (2019: 3.09%). Net fee, commission and other income decreased 24% to £1,113m | |
| - | Personal Banking income decreased 12% to £3,522m, reflecting deposit margin compression from lower interest rates, lower unsecured lending balances, and COVID-19 customer support actions, partially offset by balance growth in deposits and mortgages, as well as the transfer of Barclays Partner Finance (BPF) from Barclays International in Q220 |
| - | Barclaycard Consumer UK income decreased 24% to £1,519m as reduced borrowing and spend levels by customers resulted in a lower level of interest earning lending (IEL) balances, as well as lower debt sales |
| - | Business Banking income decreased 3% to £1,306m due to deposit margin compression from lower interest rates, lower transactional fee volumes as a result of COVID-19 and related customer support actions, partially offset by lending and deposit balance growth from continued support for SMEs through £11.0bn of BBLS and CBILS loans |
· | Credit impairment charges increased to £1,467m (2019: £712m) due to the deterioration in economic outlook driven by the COVID-19 pandemic. The current year charge is broadly driven by £847m of non-default provision for expected future customer and client stress. As at 31 December 2020, 30 and 90 day arrears rates in UK cards were 1.7% (Q419: 1.7%) and 0.8% (Q419: 0.8%) respectively | |
· | Operating expenses increased 7% to £4,320m reflecting investment spend including structural cost actions, higher servicing and financial assistance costs, and the transfer of BPF, partially offset by efficiency savings |
Balance sheet
· | Loans and advances to customers at amortised cost increased 6% to £205.4bn predominantly from continued support for SMEs through £11.0bn of BBLS and CBILS lending, £5.1bn of mortgage growth following a strong flow of new applications as well as strong customer retention and the £2.4bn transfer of BPF, partially offset by £6.6bn lower unsecured lending balances |
· | Customer deposits at amortised cost increased 17% to £240.5bn reflecting an increase of £20.5bn and £14.4bn in Personal Banking and Business Banking respectively, further strengthening the liquidity position and contributing to a loan: deposit ratio of 89% (2019: 96%) |
· | RWAs decreased to £73.7bn (December 2019: £74.9bn) driven by lower unsecured lending balances, partially offset by growth in mortgages and the transfer of BPF |
Barclays International | Year ended | Year ended | |
31.12.20 | 31.12.19 | | |
Income statement information | £m | £m | % Change |
Net interest income | 3,282 | 3,941 | (17) |
Net trading income | 6,920 | 4,199 | 65 |
Net fee, commission and other income | 5,719 | 6,535 | (12) |
Total income | 15,921 | 14,675 | 8 |
Credit impairment charges | (3,280) | (1,173) | |
Net operating income | 12,641 | 13,502 | (6) |
Operating costs | (8,765) | (9,163) | 4 |
UK bank levy | (240) | (174) | (38) |
Operating expenses | (9,005) | (9,337) | 4 |
Litigation and conduct | (48) | (116) | 59 |
Total operating expenses | (9,053) | (9,453) | 4 |
Other net income | 28 | 69 | (59) |
Profit before tax | 3,616 | 4,118 | (12) |
Attributable profit | 2,220 | 2,816 | (21) |
| | | |
Balance sheet information | £bn | £bn | |
Loans and advances at amortised cost | 122.7 | 132.8 | |
Trading portfolio assets | 127.7 | 113.3 | |
Derivative financial instrument assets | 301.8 | 228.9 | |
Financial assets at fair value through the income statement | 170.7 | 128.4 | |
Cash collateral and settlement balances | 97.5 | 79.4 | |
Other assets | 221.4 | 178.6 | |
Total assets | 1,041.8 | 861.4 | |
Deposits at amortised cost | 240.5 | 210.0 | |
Derivative financial instrument liabilities | 300.4 | 228.9 | |
Loan: deposit ratio | 51% | 63% | |
Risk weighted assets | 222.3 | 209.2 | |
Period end allocated tangible equity | 30.2 | 29.6 | |
| | | |
Performance measures | | | |
Return on average allocated tangible equity | 7.1% | 9.0% | |
Average allocated tangible equity (£bn) | 31.5 | 31.2 | |
Cost: income ratio | 57% | 64% | |
Loan loss rate (bps) | 257 | 86 | |
Net interest margin | 3.64% | 4.07% | |
| | | |
Performance measures excluding litigation and conduct1 | £m | £m | |
Profit before tax | 3,664 | 4,234 | (13) |
Attributable profit | 2,258 | 2,906 | (22) |
Return on average allocated tangible equity | 7.2% | 9.3% | |
Cost: income ratio | 57% | 64% |
1 | Refer to pages 65 to 74 for further information and calculations of performance measures excluding litigation and conduct. |
Analysis of Barclays International | | | |
Corporate and Investment Bank | Year ended | Year ended | |
31.12.20 | 31.12.19 | | |
Income statement information | £m | £m | % Change |
FICC | 5,138 | 3,364 | 53 |
Equities | 2,471 | 1,887 | 31 |
Markets | 7,609 | 5,251 | 45 |
Advisory | 561 | 776 | (28) |
Equity capital markets | 473 | 329 | 44 |
Debt capital markets | 1,697 | 1,430 | 19 |
Banking fees | 2,731 | 2,535 | 8 |
Corporate lending | 590 | 765 | (23) |
Transaction banking | 1,546 | 1,680 | (8) |
Corporate | 2,136 | 2,445 | (13) |
Total income | 12,476 | 10,231 | 22 |
Credit impairment charges | (1,559) | (157) | |
Net operating income | 10,917 | 10,074 | 8 |
Operating costs | (6,689) | (6,882) | 3 |
UK bank levy | (226) | (156) | (45) |
Operating expenses | (6,915) | (7,038) | 2 |
Litigation and conduct | (4) | (109) | 96 |
Total operating expenses | (6,919) | (7,147) | 3 |
Other net income | 6 | 28 | (79) |
Profit before tax | 4,004 | 2,955 | 35 |
Attributable profit | 2,554 | 1,980 | 29 |
| | | |
Balance sheet information | £bn | £bn | |
Loans and advances at amortised cost | 92.4 | 92.0 | |
Trading portfolio assets | 127.5 | 113.3 | |
Derivative financial instrument assets | 301.7 | 228.8 | |
Financial assets at fair value through the income statement | 170.4 | 127.7 | |
Cash collateral and settlement balances | 96.7 | 78.5 | |
Other assets | 194.9 | 155.3 | |
Total assets | 983.6 | 795.6 | |
Deposits at amortised cost | 175.2 | 146.2 | |
Derivative financial instrument liabilities | 300.3 | 228.9 | |
Risk weighted assets | 192.2 | 171.5 | |
| | | |
Performance measures | | | |
Return on average allocated tangible equity | 9.5% | 7.6% | |
Average allocated tangible equity (£bn) | 27.0 | 25.9 | |
Cost: income ratio | 55% | 70% | |
| | | |
Performance measures excluding litigation and conduct1 | £m | £m | |
Profit before tax | 4,008 | 3,064 | 31 |
Attributable profit | 2,556 | 2,064 | 24 |
Return on average allocated tangible equity | 9.5% | 8.0% | |
Cost: income ratio | 55% | 69% |
1 | Refer to pages 65 to 74 for further information and calculations of performance measures excluding litigation and conduct. |
Analysis of Barclays International | | | |
Consumer, Cards and Payments | Year ended | Year ended | |
31.12.20 | 31.12.19 | | |
Income statement information | £m | £m | % Change |
Net interest income | 2,198 | 2,822 | (22) |
Net fee, commission, trading and other income | 1,247 | 1,622 | (23) |
Total income | 3,445 | 4,444 | (22) |
Credit impairment charges | (1,721) | (1,016) | (69) |
Net operating income | 1,724 | 3,428 | (50) |
Operating costs | (2,076) | (2,281) | 9 |
UK bank levy | (14) | (18) | 22 |
Operating expenses | (2,090) | (2,299) | 9 |
Litigation and conduct | (44) | (7) | |
Total operating expenses | (2,134) | (2,306) | 7 |
Other net income | 22 | 41 | (46) |
(Loss)/profit before tax | (388) | 1,163 | |
Attributable (loss)/profit | (334) | 836 | |
| | | |
Balance sheet information | £bn | £bn | |
Loans and advances at amortised cost | 30.3 | 40.8 | |
Total assets | 58.2 | 65.8 | |
Deposits at amortised cost | 65.3 | 63.8 | |
Risk weighted assets | 30.1 | 37.7 | |
| | | |
Key facts | | | |
30 day arrears rate - Barclaycard US | 2.5% | 2.7% | |
US cards customer FICO score distribution | | | |
<660 | 13% | 14% | |
>660 | 87% | 86% | |
Total number of Barclaycard payments clients | c.365,000 | c.376,000 | |
Value of payments processed (£bn)1 | 274 | 354 | |
| | | |
Performance measures | | | |
Return on average allocated tangible equity | (7.5%) | 15.8% | |
Average allocated tangible equity (£bn) | 4.5 | 5.3 | |
Cost: income ratio | 62% | 52% | |
Loan loss rate (bps) | 517 | 234 | |
| | | |
Performance measures excluding litigation and conduct2 | £m | £m | |
(Loss)/profit before tax | (344) | 1,170 | |
Attributable (loss)/profit | (298) | 842 | |
Return on average allocated tangible equity | (6.7%) | 15.9% | |
Cost: income ratio | 61% | 52% | |
1 | Includes £268bn (2019: £272bn) of merchant acquiring payments. |
2 | Refer to pages 65 to 74 for further information and calculations of performance measures excluding litigation and conduct. |
Barclays International continued to support its customers and clients through the COVID-19 pandemic by providing or facilitating lending, through the range of support programmes which have been introduced, as well as enabling the raising of debt and equity financing in the capital markets. Support actions, including payment holidays, were introduced to help customers and clients. Despite the challenging operating environment, Barclays International delivered a RoTE, excluding litigation and conduct, of 7.2%, reflecting the benefits of a diversified business model.
2020 compared to 2019
Income statement
· | Profit before tax, excluding litigation and conduct, decreased 13% to £3,664m with a RoTE of 7.2% (2019: 9.3%), reflecting a RoTE of 9.5% (2019: 8.0%) in CIB and (6.7)% (2019: 15.9%) in CC&P | ||
· | Total income increased to £15,921m (2019: £14,675m) | ||
| - | CIB income increased 22% to £12,476m driven by Markets and Banking which both had their best ever year on a comparable basis1 | |
| | - | Markets income increased 45% to £7,609m reflecting gains in market share as well as an increase in market size2. FICC income increased 53% to £5,138m driven by strong performances in macro and credit, mainly reflecting wider spreads. Equities income increased 31% to £2,471m driven by derivatives and cash due to higher levels of client activity and volatility |
| | - | Banking fees income increased 8% to £2,731m as a strong performance in equity and debt capital markets, driven by market size, was offset by lower fee income in advisory, which was impacted by a reduced fee pool3 |
| | - | Within Corporate, Transaction banking income decreased 8% to £1,546m as deposit balance growth was more than offset by margin compression. Corporate lending income decreased by 23% to £590m reflecting c.£210m of losses on the mark to market of lending and related hedge positions, and the carry costs of those hedges |
| - | CC&P income decreased 22% to £3,445m reflecting lower cards balances, margin compression and reduced payments activity, which were impacted by the COVID-19 pandemic, and the transfer of BPF to Barclays UK in Q220. Q220 included a c.£100m valuation loss on Barclays' preference shares in Visa Inc. resulting from the impact of the Supreme Court ruling concerning charges paid by merchants | |
· | Credit impairment charges increased to £3,280m (2019: £1,173m) | ||
| - | CIB credit impairment charges increased to £1,559m (2019: £157m) due to the deterioration in economic outlook driven by the COVID-19 pandemic. The current year charge is broadly driven by £711m of non-default provision for future expected customer and client stress and c.£800m of single name wholesale loan charges | |
| - | CC&P credit impairment charges increased to £1,721m (2019: £1,016m) due to the deterioration in economic outlook driven by the COVID-19 pandemic. The current year charge is broadly driven by £752m of non-default provisions for future expected customer and client stress. As at 31 December 2020, 30 and 90 day arrears in US cards were 2.5% (Q419: 2.7%) and 1.4% (Q419: 1.4%) respectively | |
· | Operating expenses decreased 4% to £9,005m | ||
| - | CIB operating expenses decreased 2% to £6,915m due to cost efficiencies and discipline in the current environment partially offset by a higher bank levy charge mainly due to the non-recurrence of prior year adjustments | |
| - | CC&P operating expenses decreased 9% to £2,090m reflecting cost efficiencies, lower marketing spend due to the impacts of the COVID-19 pandemic and transfer of BPF |
Balance sheet
· | Loans and advances at amortised cost decreased £10.1bn to £122.7bn due to lower unsecured lending balances in CC&P |
· | Trading portfolio assets increased £14.4bn to £127.7bn due to increased client activity |
· | Derivative financial instruments assets increased £72.9bn and liabilities increased £71.5bn to £301.8bn and £300.4bn respectively driven by a decrease in major interest rate curves and increased client activity |
· | Financial assets at fair value through the income statement increased £42.3bn to £170.7bn driven by reverse repurchase agreements and similar secured lending |
· | Cash collateral and settlements increased £18.1bn to £97.5bn predominantly due to increased activity |
· | Other assets increased £42.8bn to £221.4bn due to an increase in cash at central banks and securities within the liquidity pool |
· | Deposits at amortised cost increased £30.5bn to £240.5bn due to CIB clients increasing liquidity |
· | RWAs increased to £222.3bn (December 2019: £209.2bn) primarily due to increased market volatility, client activity and a reduction in credit quality within CIB, partially offset by lower CC&P balances |
1 | Period covering Q114 - Q420. Pre 2014 financials were not restated following re-segmentation in Q116. |
2 | Data source: Coalition Greenwich, Preliminary FY20 Competitor Analysis. Market share represents Barclays share of the Global Industry Revenue Pool. Analysis is based on Barclays internal business structure and internal revenues. |
3 | Data source: Dealogic for the period covering 1 January to 31 December 2020. |
Head Office | Year ended | Year ended | |
31.12.20 | 31.12.19 | | |
Income statement information | £m | £m | % Change |
Net interest income | (393) | (422) | 7 |
Net fee, commission and other income | (109) | 26 | |
Total income | (502) | (396) | (27) |
Credit impairment charges | (91) | (27) | |
Net operating income | (593) | (423) | (40) |
Operating costs | (399) | (200) | (100) |
UK bank levy | (9) | (11) | 18 |
Operating expenses | (408) | (211) | (93) |
Litigation and conduct | (73) | (151) | 52 |
Total operating expenses | (481) | (362) | (33) |
Other net (expenses)/income | (23) | 2 | |
Loss before tax | (1,097) | (783) | (40) |
Attributable loss | (1,019) | (636) | (60) |
| | | |
Balance sheet information | £bn | £bn | |
Total assets | 18.6 | 21.0 | |
Risk weighted assets | 10.2 | 11.0 | |
Period end allocated tangible equity | 6.8 | 5.6 | |
| | | |
Performance measures | | | |
Average allocated tangible equity (£bn) | 6.7 | 5.1 | |
| | | |
Performance measures excluding litigation and conduct1 | £m | £m | |
Loss before tax | (1,024) | (632) | (62) |
Attributable loss | (963) | (525) | (83) |
1 | Refer to pages 65 to 74 for further information and calculations of performance measures excluding litigation and conduct. |
2020 compared to 2019
Income statement
· | Loss before tax, excluding litigation and conduct, was £1,024m (2019: £632m) |
· | Total income was an expense of £502m (2019: £396m), which reflected treasury items and hedge accounting, mark-to-market losses on legacy investments and funding costs on legacy capital instruments, including £85m from repurchases of some of the Barclays Bank PLC 7.625% Contingent Capital Notes. This was partially offset by the recognition of dividends on Barclays' stake in Absa Group Limited |
· | Credit impairment increased to £91m (2019: £27m) due to the deterioration in economic outlook driven by the COVID-19 pandemic. The current year charge is broadly driven by provision for future expected customer stress in the Italian home loan portfolio |
· | Operating expenses were £408m (2019: £211m), which included c.£150m of cost actions, principally related to the discontinued use of certain software assets and £95m of charitable donations from Barclays' COVID-19 Community Aid Package |
· | Other net expenses were £23m (2019: income of £2m), which included a fair value loss on an investment in an associate |
Balance sheet
· | RWAs decreased to £10.2bn (December 2019: £11.0bn) driven by the reduction in value of Barclays' stake in Absa Group Limited |
Quarterly Results Summary
Barclays Group | ||||||||||
| Q420 | Q320 | Q220 | Q120 | | Q419 | Q319 | Q219 | Q119 |
|
Income statement information | £m | £m | £m | £m | | £m | £m | £m | £m |
|
Net interest income | 1,845 | 2,055 | 1,892 | 2,331 | | 2,344 | 2,445 | 2,360 | 2,258 |
|
Net fee, commission and other income | 3,096 | 3,149 | 3,446 | 3,952 | | 2,957 | 3,096 | 3,178 | 2,994 |
|
Total income | 4,941 | 5,204 | 5,338 | 6,283 | | 5,301 | 5,541 | 5,538 | 5,252 |
|
Credit impairment charges | (492) | (608) | (1,623) | (2,115) | | (523) | (461) | (480) | (448) |
|
Net operating income | 4,449 | 4,596 | 3,715 | 4,168 | | 4,778 | 5,080 | 5,058 | 4,804 |
|
Operating costs | (3,480) | (3,391) | (3,310) | (3,253) | | (3,308) | (3,293) | (3,501) | (3,257) |
|
UK bank levy | (299) | - | - | - | | (226) | - | - | - |
|
Operating expenses | (3,779) | (3,391) | (3,310) | (3,253) | | (3,534) | (3,293) | (3,501) | (3,257) |
|
Litigation and conduct | (47) | (76) | (20) | (10) | | (167) | (1,568) | (53) | (61) |
|
Total operating expenses | (3,826) | (3,467) | (3,330) | (3,263) | | (3,701) | (4,861) | (3,554) | (3,318) |
|
Other net income/(expenses) | 23 | 18 | (26) | 8 | | 20 | 27 | 27 | (3) |
|
Profit before tax | 646 | 1,147 | 359 | 913 | | 1,097 | 246 | 1,531 | 1,483 |
|
Tax charge | (163) | (328) | (42) | (71) | | (189) | (269) | (297) | (248) |
|
Profit/(loss) after tax | 483 | 819 | 317 | 842 | | 908 | (23) | 1,234 | 1,235 |
|
Non-controlling interests | (37) | (4) | (21) | (16) | | (42) | (4) | (17) | (17) |
|
Other equity instrument holders | (226) | (204) | (206) | (221) | | (185) | (265) | (183) | (180) |
|
Attributable profit/(loss) | 220 | 611 | 90 | 605 | | 681 | (292) | 1,034 | 1,038 |
|
| | | | | | | | | |
|
Performance measures | | | | | | | | | |
|
Return on average tangible shareholders' equity | 1.8% | 5.1% | 0.7% | 5.1% | | 5.9% | (2.4%) | 9.0% | 9.2% |
|
Average tangible shareholders' equity (£bn) | 47.6 | 48.3 | 50.2 | 47.0 | | 46.4 | 48.4 | 46.2 | 45.2 |
|
Cost: income ratio | 77% | 67% | 62% | 52% | | 70% | 88% | 64% | 63% |
|
Loan loss rate (bps) | 56 | 69 | 179 | 223 | | 60 | 52 | 56 | 54 |
|
Basic earnings/(loss) per share | 1.3p | 3.5p | 0.5p | 3.5p | | 3.9p | (1.7p) | 6.0p | 6.1p |
|
| | | | | | | | | |
|
Performance measures excluding litigation and conduct1 | £m | £m | £m | £m | | £m | £m | £m | £m |
|
Profit before tax | 693 | 1,223 | 379 | 923 | | 1,264 | 1,814 | 1,584 | 1,544 |
|
Attributable profit | 260 | 668 | 106 | 604 | | 803 | 1,233 | 1,074 | 1,084 |
|
Return on average tangible shareholders' equity | 2.2% | 5.5% | 0.8% | 5.1% | | 6.9% | 10.2% | 9.3% | 9.6% |
|
Cost: income ratio | 76% | 65% | 62% | 52% | | 67% | 59% | 63% | 62% |
|
Basic earnings per share | 1.5p | 3.9p | 0.6p | 3.5p | | 4.7p | 7.2p | 6.3p | 6.3p |
|
| | | | | | | | | |
|
Balance sheet and capital management2 | £bn | £bn | £bn | £bn | | £bn | £bn | £bn | £bn |
|
Loans and advances at amortised cost | 342.6 | 344.4 | 354.9 | 374.1 | | 339.1 | 345.1 | 339.3 | 330.7 |
|
Total assets | 1,349.5 | 1,421.7 | 1,385.1 | 1,444.3 | | 1,140.2 | 1,290.4 | 1,232.8 | 1,193.5 |
|
Deposits at amortised cost | 481.0 | 494.6 | 466.9 | 470.7 | | 415.8 | 420.6 | 413.6 | 412.7 |
|
Tangible net asset value per share | 269p | 275p | 284p | 284p | | 262p | 274p | 275p | 266p |
|
Common equity tier 1 ratio | 15.1% | 14.6% | 14.2% | 13.1% | | 13.8% | 13.4% | 13.4% | 13.0% |
|
Common equity tier 1 capital | 46.3 | 45.5 | 45.4 | 42.5 | | 40.8 | 41.9 | 42.9 | 41.4 |
|
Risk weighted assets | 306.2 | 310.7 | 319.0 | 325.6 | | 295.1 | 313.3 | 319.1 | 319.7 |
|
Average UK leverage ratio | 5.0% | 5.1% | 4.7% | 4.5% | | 4.5% | 4.6% | 4.7% | 4.6% |
|
Average UK leverage exposure | 1,146.9 | 1,111.1 | 1,148.7 | 1,176.2 | | 1,142.8 | 1,171.2 | 1,134.6 | 1,105.5 |
|
UK leverage ratio | 5.3% | 5.2% | 5.2% | 4.5% | | 5.1% | 4.8% | 5.1% | 4.9% |
|
UK leverage exposure | 1,090.9 | 1,095.1 | 1,071.1 | 1,178.7 | | 1,007.7 | 1,099.8 | 1,079.4 | 1,065.0 |
|
| | | | | | | | | |
|
Funding and liquidity | | | | | | | | | |
|
Group liquidity pool (£bn) | 266 | 327 | 298 | 237 | | 211 | 226 | 238 | 232 |
|
Liquidity coverage ratio | 162% | 181% | 186% | 155% | | 160% | 151% | 156% | 160% |
|
Loan: deposit ratio | 71% | 70% | 76% | 79% | | 82% | 82% | 82% | 80% |
|
1 | Refer to pages 65 to 74 for further information and calculations of performance measures excluding litigation and conduct. |
2 | Refer to pages 45 to 51 for further information on how capital, RWAs and leverage are calculated. |
Quarterly Results by Business
Barclays UK | | | | | | | | | |
| Q420 | Q320 | Q220 | Q120 | | Q419 | Q319 | Q219 | Q119 |
Income statement information | £m | £m | £m | £m | | £m | £m | £m | £m |
Net interest income | 1,317 | 1,280 | 1,225 | 1,412 | | 1,478 | 1,503 | 1,438 | 1,469 |
Net fee, commission and other income | 309 | 270 | 242 | 292 | | 481 | 343 | 333 | 308 |
Total income | 1,626 | 1,550 | 1,467 | 1,704 | | 1,959 | 1,846 | 1,771 | 1,777 |
Credit impairment charges | (170) | (233) | (583) | (481) | | (190) | (101) | (230) | (191) |
Net operating income | 1,456 | 1,317 | 884 | 1,223 | | 1,769 | 1,745 | 1,541 | 1,586 |
Operating costs | (1,134) | (1,095) | (1,018) | (1,023) | | (1,023) | (952) | (1,022) | (999) |
UK bank levy | (50) | - | - | - | | (41) | - | - | - |
Operating expenses | (1,184) | (1,095) | (1,018) | (1,023) | | (1,064) | (952) | (1,022) | (999) |
Litigation and conduct | 4 | (25) | (6) | (5) | | (58) | (1,480) | (41) | (3) |
Total operating expenses | (1,180) | (1,120) | (1,024) | (1,028) | | (1,122) | (2,432) | (1,063) | (1,002) |
Other net income/(expenses) | 6 | (1) | 13 | - | | - | - | (1) | 1 |
Profit/(loss) before tax | 282 | 196 | (127) | 195 | | 647 | (687) | 477 | 585 |
Attributable profit/(loss) | 160 | 113 | (123) | 175 | | 438 | (907) | 328 | 422 |
| | | | | | | | | |
Balance sheet information | £bn | £bn | £bn | £bn | | £bn | £bn | £bn | £bn |
Loans and advances to customers at amortised cost | 205.4 | 203.9 | 202.0 | 195.7 | | 193.7 | 193.2 | 189.1 | 187.5 |
Total assets | 289.1 | 294.5 | 287.6 | 267.5 | | 257.8 | 257.9 | 259.0 | 253.1 |
Customer deposits at amortised cost | 240.5 | 232.0 | 225.7 | 207.5 | | 205.5 | 203.3 | 200.9 | 197.3 |
Loan: deposit ratio | 89% | 91% | 92% | 96% | | 96% | 97% | 97% | 96% |
Risk weighted assets | 73.7 | 76.2 | 77.9 | 77.7 | | 74.9 | 76.8 | 76.2 | 76.6 |
Period end allocated tangible equity | 9.7 | 10.0 | 10.3 | 10.3 | | 10.3 | 10.4 | 10.3 | 10.5 |
| | | | | | | | | |
Performance measures | | | | | | | | | |
Return on average allocated tangible equity | 6.5% | 4.5% | (4.8%) | 6.9% | | 17.0% | (34.9%) | 12.7% | 16.3% |
Average allocated tangible equity (£bn) | 9.8 | 10.1 | 10.3 | 10.1 | | 10.3 | 10.4 | 10.3 | 10.4 |
Cost: income ratio | 73% | 72% | 70% | 60% | | 57% | 132% | 60% | 56% |
Loan loss rate (bps) | 31 | 43 | 111 | 96 | | 38 | 20 | 47 | 40 |
Net interest margin | 2.56% | 2.51% | 2.48% | 2.91% | | 3.03% | 3.10% | 3.05% | 3.18% |
| | | | | | | | | |
Performance measures excluding litigation and conduct1 | £m | £m | £m | £m | | £m | £m | £m | £m |
Profit/(loss) before tax | 278 | 221 | (121) | 200 | | 705 | 793 | 518 | 588 |
Attributable profit/(loss) | 153 | 130 | (118) | 178 | | 481 | 550 | 358 | 424 |
Return on average allocated tangible equity | 6.2% | 5.2% | (4.6%) | 7.0% | | 18.7% | 21.2% | 13.9% | 16.4% |
Cost: income ratio | 73% | 71% | 69% | 60% | | 54% | 52% | 58% | 56% |
1 | Refer to pages 65 to 74 for further information and calculations of performance measures excluding litigation and conduct. |
Analysis of Barclays UK | Q420 | Q320 | Q220 | Q120 | | Q419 | Q319 | Q219 | Q119 |
Analysis of total income | £m | £m | £m | £m | | £m | £m | £m | £m |
Personal Banking | 895 | 833 | 826 | 968 | | 1,064 | 1,035 | 946 | 964 |
Barclaycard Consumer UK | 354 | 362 | 367 | 436 | | 533 | 472 | 497 | 490 |
Business Banking | 377 | 355 | 274 | 300 | | 362 | 339 | 328 | 323 |
Total income | 1,626 | 1,550 | 1,467 | 1,704 | | 1,959 | 1,846 | 1,771 | 1,777 |
| | | | | | | | | |
Analysis of credit impairment (charges)/releases | | | | | | | | | |
Personal Banking | (68) | (48) | (130) | (134) | | (71) | (36) | (36) | (52) |
Barclaycard Consumer UK | (78) | (106) | (396) | (301) | | (108) | (49) | (175) | (140) |
Business Banking | (24) | (79) | (57) | (46) | | (11) | (16) | (19) | 1 |
Total credit impairment charges | (170) | (233) | (583) | (481) | | (190) | (101) | (230) | (191) |
| | | | | | | | | |
Analysis of loans and advances to customers at amortised cost | £bn | £bn | £bn | £bn | | £bn | £bn | £bn | £bn |
Personal Banking | 157.3 | 155.7 | 154.9 | 153.4 | | 151.9 | 150.1 | 147.3 | 145.9 |
Barclaycard Consumer UK | 9.9 | 10.7 | 11.5 | 13.6 | | 14.7 | 14.9 | 15.1 | 15.0 |
Business Banking | 38.2 | 37.5 | 35.6 | 28.7 | | 27.1 | 28.2 | 26.7 | 26.6 |
Total loans and advances to customers at amortised cost | 205.4 | 203.9 | 202.0 | 195.7 | | 193.7 | 193.2 | 189.1 | 187.5 |
| | | | | | | | | |
Analysis of customer deposits at amortised cost | | | | | | | | | |
Personal Banking | 179.7 | 173.2 | 169.6 | 161.4 | | 159.2 | 157.9 | 156.3 | 154.1 |
Barclaycard Consumer UK | 0.1 | 0.1 | 0.1 | - | | - | - | - | - |
Business Banking | 60.7 | 58.7 | 56.0 | 46.1 | | 46.3 | 45.4 | 44.6 | 43.2 |
Total customer deposits at amortised cost | 240.5 | 232.0 | 225.7 | 207.5 | | 205.5 | 203.3 | 200.9 | 197.3 |
Barclays International | | | | | | | | | |
| Q420 | Q320 | Q220 | Q120 | | Q419 | Q319 | Q219 | Q119 |
Income statement information | £m | £m | £m | £m | | £m | £m | £m | £m |
Net interest income | 614 | 823 | 847 | 998 | | 965 | 1,059 | 1,017 | 900 |
Net trading income | 1,372 | 1,528 | 1,660 | 2,360 | | 929 | 1,110 | 1,016 | 1,144 |
Net fee, commission and other income | 1,500 | 1,430 | 1,503 | 1,286 | | 1,558 | 1,581 | 1,870 | 1,526 |
Total income | 3,486 | 3,781 | 4,010 | 4,644 | | 3,452 | 3,750 | 3,903 | 3,570 |
Credit impairment charges | (291) | (370) | (1,010) | (1,609) | | (329) | (352) | (247) | (245) |
Net operating income | 3,195 | 3,411 | 3,000 | 3,035 | | 3,123 | 3,398 | 3,656 | 3,325 |
Operating costs | (2,133) | (2,227) | (2,186) | (2,219) | | (2,240) | (2,282) | (2,435) | (2,206) |
UK bank levy | (240) | - | - | - | | (174) | - | - | - |
Operating expenses | (2,373) | (2,227) | (2,186) | (2,219) | | (2,414) | (2,282) | (2,435) | (2,206) |
Litigation and conduct | (9) | (28) | (11) | - | | (86) | - | (11) | (19) |
Total operating expenses | (2,382) | (2,255) | (2,197) | (2,219) | | (2,500) | (2,282) | (2,446) | (2,225) |
Other net income | 9 | 9 | 4 | 6 | | 17 | 21 | 13 | 18 |
Profit before tax | 822 | 1,165 | 807 | 822 | | 640 | 1,137 | 1,223 | 1,118 |
Attributable profit | 441 | 782 | 468 | 529 | | 397 | 799 | 832 | 788 |
| | | | | | | | | |
Balance sheet information | £bn | £bn | £bn | £bn | | £bn | £bn | £bn | £bn |
Loans and advances at amortised cost | 122.7 | 128.0 | 138.1 | 167.0 | | 132.8 | 138.1 | 134.8 | 130.9 |
Trading portfolio assets | 127.7 | 122.3 | 109.5 | 101.6 | | 113.3 | 119.4 | 120.0 | 117.2 |
Derivative financial instrument assets | 301.8 | 295.9 | 306.8 | 341.5 | | 228.9 | 286.0 | 243.8 | 217.3 |
Financial assets at fair value through the income statement | 170.7 | 178.2 | 154.3 | 188.4 | | 128.4 | 158.0 | 154.7 | 153.5 |
Cash collateral and settlement balances | 97.5 | 121.8 | 130.8 | 153.2 | | 79.4 | 112.5 | 101.3 | 97.8 |
Other assets | 221.4 | 261.7 | 236.3 | 201.5 | | 178.6 | 195.6 | 196.8 | 202.3 |
Total assets | 1,041.8 | 1,107.9 | 1,075.8 | 1,153.2 | | 861.4 | 1,009.6 | 951.4 | 919.0 |
Deposits at amortised cost | 240.5 | 262.4 | 241.2 | 263.3 | | 210.0 | 217.6 | 212.0 | 215.5 |
Derivative financial instrument liabilities | 300.4 | 293.3 | 307.6 | 338.8 | | 228.9 | 283.3 | 243.0 | 213.5 |
Loan: deposit ratio | 51% | 49% | 57% | 63% | | 63% | 63% | 64% | 61% |
Risk weighted assets | 222.3 | 224.7 | 231.2 | 237.9 | | 209.2 | 223.1 | 214.8 | 216.1 |
Period end allocated tangible equity | 30.2 | 30.5 | 31.6 | 33.1 | | 29.6 | 31.4 | 30.2 | 30.6 |
| | | | | | | | | |
Performance measures | | | | | | | | | |
Return on average allocated tangible equity | 5.8% | 10.2% | 5.6% | 6.8% | | 5.1% | 9.9% | 10.7% | 10.4% |
Average allocated tangible equity (£bn) | 30.5 | 30.6 | 33.5 | 31.2 | | 30.9 | 32.2 | 31.1 | 30.5 |
Cost: income ratio | 68% | 60% | 55% | 48% | | 72% | 61% | 63% | 62% |
Loan loss rate (bps) | 90 | 112 | 284 | 377 | | 96 | 99 | 72 | 73 |
Net interest margin | 3.41% | 3.79% | 3.43% | 3.93% | | 4.29% | 4.10% | 3.91% | 3.99% |
| | | | | | | | | |
Performance measures excluding litigation and conduct1 | £m | £m | £m | £m | | £m | £m | £m | £m |
Profit before tax | 831 | 1,193 | 818 | 822 | | 726 | 1,137 | 1,234 | 1,137 |
Attributable profit | 450 | 803 | 476 | 529 | | 461 | 801 | 840 | 804 |
Return on average allocated tangible equity | 5.9% | 10.5% | 5.7% | 6.8% | | 6.0% | 10.0% | 10.8% | 10.6% |
Cost: income ratio | 68% | 59% | 55% | 48% | | 70% | 61% | 62% | 62% |
1 | Refer to pages 65 to 74 for further information and calculations of performance measures excluding litigation and conduct. |
Analysis of Barclays International | | | | | | ||||
| | | | | | | | | |
Corporate and Investment Bank | Q420 | Q320 | Q220 | Q120 | | Q419 | Q319 | Q219 | Q119 |
Income statement information | £m | £m | £m | £m | | £m | £m | £m | £m |
FICC | 812 | 1,000 | 1,468 | 1,858 | | 726 | 816 | 920 | 902 |
Equities | 542 | 691 | 674 | 564 | | 409 | 494 | 517 | 467 |
Markets | 1,354 | 1,691 | 2,142 | 2,422 | | 1,135 | 1,310 | 1,437 | 1,369 |
Advisory | 232 | 90 | 84 | 155 | | 202 | 221 | 221 | 132 |
Equity capital markets | 104 | 122 | 185 | 62 | | 56 | 86 | 104 | 83 |
Debt capital markets | 418 | 398 | 463 | 418 | | 322 | 381 | 373 | 354 |
Banking fees | 754 | 610 | 732 | 635 | | 580 | 688 | 698 | 569 |
Corporate lending | 186 | 232 | 61 | 111 | | 202 | 195 | 216 | 152 |
Transaction banking | 344 | 372 | 381 | 449 | | 397 | 424 | 444 | 415 |
Corporate | 530 | 604 | 442 | 560 | | 599 | 619 | 660 | 567 |
Total income | 2,638 | 2,905 | 3,316 | 3,617 | | 2,314 | 2,617 | 2,795 | 2,505 |
Credit impairment charges | (52) | (187) | (596) | (724) | | (30) | (31) | (44) | (52) |
Net operating income | 2,586 | 2,718 | 2,720 | 2,893 | | 2,284 | 2,586 | 2,751 | 2,453 |
Operating costs | (1,603) | (1,716) | (1,680) | (1,690) | | (1,691) | (1,712) | (1,860) | (1,619) |
UK bank levy | (226) | - | - | - | | (156) | - | - | - |
Operating expenses | (1,829) | (1,716) | (1,680) | (1,690) | | (1,847) | (1,712) | (1,860) | (1,619) |
Litigation and conduct | 2 | (3) | (3) | - | | (79) | (4) | (7) | (19) |
Total operating expenses | (1,827) | (1,719) | (1,683) | (1,690) | | (1,926) | (1,716) | (1,867) | (1,638) |
Other net income | 2 | 1 | 3 | - | | 1 | 12 | 3 | 12 |
Profit before tax | 761 | 1,000 | 1,040 | 1,203 | | 359 | 882 | 887 | 827 |
Attributable profit | 413 | 627 | 694 | 820 | | 193 | 609 | 596 | 582 |
| | | | | | | | | |
Balance sheet information | £bn | £bn | £bn | £bn | | £bn | £bn | £bn | £bn |
Loans and advances at amortised cost | 92.4 | 96.8 | 104.9 | 128.2 | | 92.0 | 95.8 | 92.1 | 90.6 |
Trading portfolio assets | 127.5 | 122.2 | 109.3 | 101.5 | | 113.3 | 119.3 | 119.9 | 117.2 |
Derivative financial instruments assets | 301.7 | 295.9 | 306.7 | 341.4 | | 228.8 | 286.0 | 243.7 | 217.3 |
Financial assets at fair value through the income statement | 170.4 | 177.9 | 153.7 | 187.8 | | 127.7 | 157.3 | 154.1 | 152.9 |
Cash collateral and settlement balances | 96.7 | 121.0 | 129.7 | 152.2 | | 78.5 | 111.6 | 100.4 | 96.9 |
Other assets | 194.9 | 228.9 | 205.5 | 171.4 | | 155.3 | 171.5 | 168.1 | 163.2 |
Total assets | 983.6 | 1,042.7 | 1,009.8 | 1,082.5 | | 795.6 | 941.5 | 878.3 | 838.1 |
Deposits at amortised cost | 175.2 | 195.6 | 173.9 | 198.4 | | 146.2 | 152.1 | 145.4 | 151.4 |
Derivative financial instrument liabilities | 300.3 | 293.2 | 307.6 | 338.7 | | 228.9 | 283.2 | 242.9 | 213.5 |
Risk weighted assets | 192.2 | 193.3 | 198.3 | 201.7 | | 171.5 | 184.9 | 175.9 | 176.6 |
| | | | | | | | | |
Performance measures | | | | | | | | | |
Return on average allocated tangible equity | 6.3% | 9.5% | 9.6% | 12.5% | | 3.0% | 9.1% | 9.2% | 9.3% |
Average allocated tangible equity (£bn) | 26.3 | 26.4 | 29.0 | 26.2 | | 25.8 | 26.9 | 25.8 | 25.1 |
Cost: income ratio | 69% | 59% | 51% | 47% | | 83% | 66% | 67% | 65% |
| | | | | | | | | |
Performance measures excluding litigation and conduct1 | £m | £m | £m | £m | | £m | £m | £m | £m |
Profit before tax | 759 | 1,003 | 1,043 | 1,203 | | 438 | 886 | 894 | 846 |
Attributable profit | 411 | 629 | 696 | 820 | | 251 | 614 | 601 | 598 |
Return on average allocated tangible equity | 6.2% | 9.5% | 9.6% | 12.5% | | 3.9% | 9.2% | 9.3% | 9.5% |
Cost: income ratio | 69% | 59% | 51% | 47% | | 80% | 65% | 67% | 65% |
1 | Refer to pages 65 to 74 for further information and calculations of performance measures excluding litigation and conduct. |
Analysis of Barclays International | | | | | | | | | |
| | | | | | | | | |
Consumer, Cards and Payments | Q420 | Q320 | Q220 | Q120 | | Q419 | Q319 | Q219 | Q119 |
Income statement information | £m | £m | £m | £m | | £m | £m | £m | £m |
Net interest income | 504 | 518 | 513 | 663 | | 717 | 720 | 720 | 665 |
Net fee, commission, trading and other income | 344 | 358 | 181 | 364 | | 421 | 413 | 388 | 400 |
Total income | 848 | 876 | 694 | 1,027 | | 1,138 | 1,133 | 1,108 | 1,065 |
Credit impairment charges | (239) | (183) | (414) | (885) | | (299) | (321) | (203) | (193) |
Net operating income | 609 | 693 | 280 | 142 | | 839 | 812 | 905 | 872 |
Operating costs | (530) | (511) | (506) | (529) | | (549) | (570) | (575) | (587) |
UK bank levy | (14) | - | - | - | | (18) | - | - | - |
Operating expenses | (544) | (511) | (506) | (529) | | (567) | (570) | (575) | (587) |
Litigation and conduct | (11) | (25) | (8) | - | | (7) | 4 | (4) | - |
Total operating expenses | (555) | (536) | (514) | (529) | | (574) | (566) | (579) | (587) |
Other net income | 7 | 8 | 1 | 6 | | 16 | 9 | 10 | 6 |
Profit/(loss) before tax | 61 | 165 | (233) | (381) | | 281 | 255 | 336 | 291 |
Attributable profit/(loss) | 28 | 155 | (226) | (291) | | 204 | 190 | 236 | 206 |
| | | | | | | | | |
Balance sheet information | £bn | £bn | £bn | £bn | | £bn | £bn | £bn | £bn |
Loans and advances at amortised cost | 30.3 | 31.2 | 33.2 | 38.8 | | 40.8 | 42.3 | 42.7 | 40.3 |
Total assets | 58.2 | 65.2 | 66.0 | 70.7 | | 65.8 | 68.1 | 73.1 | 80.9 |
Deposits at amortised cost | 65.3 | 66.8 | 67.3 | 64.9 | | 63.8 | 65.5 | 66.6 | 64.1 |
Risk weighted assets | 30.1 | 31.4 | 32.9 | 36.2 | | 37.7 | 38.2 | 38.9 | 39.5 |
| | | | | | | | | |
Performance measures | | | | | | | | | |
Return on average allocated tangible equity | 2.7% | 14.7% | (20.2%) | (23.5%) | | 15.9% | 14.2% | 17.8% | 15.4% |
Average allocated tangible equity (£bn) | 4.2 | 4.2 | 4.5 | 5.0 | | 5.1 | 5.3 | 5.3 | 5.4 |
Cost: income ratio | 65% | 61% | 74% | 52% | | 50% | 50% | 52% | 55% |
Loan loss rate (bps) | 286 | 211 | 455 | 846 | | 273 | 283 | 180 | 182 |
| | | | | | | | | |
Performance measures excluding litigation and conduct1 | £m | £m | £m | £m | | £m | £m | £m | £m |
Profit/(loss) before tax | 72 | 190 | (225) | (381) | | 288 | 251 | 340 | 291 |
Attributable profit/(loss) | 39 | 174 | (220) | (291) | | 210 | 187 | 239 | 206 |
Return on average allocated tangible equity | 3.8% | 16.5% | (19.6%) | (23.5%) | | 16.3% | 14.0% | 18.0% | 15.4% |
Cost: income ratio | 64% | 58% | 73% | 52% | | 50% | 50% | 52% | 55% |
1 | Refer to pages 65 to 74 for further information and calculations of performance measures excluding litigation and conduct. |
Head Office | | | | | | | | | |
| Q420 | Q320 | Q220 | Q120 | | Q419 | Q319 | Q219 | Q119 |
Income statement information | £m | £m | £m | £m | | £m | £m | £m | £m |
Net interest income | (86) | (48) | (180) | (79) | | (99) | (117) | (95) | (111) |
Net fee, commission and other income | (85) | (79) | 41 | 14 | | (11) | 62 | (41) | 16 |
Total income | (171) | (127) | (139) | (65) | | (110) | (55) | (136) | (95) |
Credit impairment charges | (31) | (5) | (30) | (25) | | (4) | (8) | (3) | (12) |
Net operating expenses | (202) | (132) | (169) | (90) | | (114) | (63) | (139) | (107) |
Operating costs | (213) | (69) | (106) | (11) | | (45) | (59) | (44) | (52) |
UK bank levy | (9) | - | - | - | | (11) | - | - | - |
Operating expenses | (222) | (69) | (106) | (11) | | (56) | (59) | (44) | (52) |
Litigation and conduct | (42) | (23) | (3) | (5) | | (23) | (88) | (1) | (39) |
Total operating expenses | (264) | (92) | (109) | (16) | | (79) | (147) | (45) | (91) |
Other net income/(expenses) | 8 | 10 | (43) | 2 | | 3 | 6 | 15 | (22) |
Loss before tax | (458) | (214) | (321) | (104) | | (190) | (204) | (169) | (220) |
Attributable loss | (381) | (284) | (255) | (99) | | (154) | (184) | (126) | (172) |
| | | | | | | | | |
Balance sheet information | £bn | £bn | £bn | £bn | | £bn | £bn | £bn | £bn |
Total assets | 18.6 | 19.3 | 21.7 | 23.6 | | 21.0 | 22.9 | 22.4 | 21.4 |
Risk weighted assets | 10.2 | 9.8 | 9.9 | 10.0 | | 11.0 | 13.4 | 28.1 | 27.0 |
Period end allocated tangible equity | 6.8 | 7.1 | 7.4 | 6.0 | | 5.6 | 5.5 | 7.0 | 4.5 |
| | | | | | | | | |
Performance measures | | | | | | | | | |
Average allocated tangible equity (£bn) | 7.3 | 7.6 | 6.4 | 5.6 | | 5.2 | 5.8 | 4.8 | 4.3 |
| | | | | | | | | |
Performance measures excluding litigation and conduct1 | £m | £m | £m | £m | | £m | £m | £m | £m |
Loss before tax | (416) | (191) | (318) | (99) | | (167) | (116) | (168) | (181) |
Attributable loss | (343) | (265) | (252) | (103) | | (139) | (118) | (124) | (144) |
1 | Refer to pages 65 to 74 for further information and calculations of performance measures excluding litigation and conduct. |
Performance Management
Margins and balances | | | | | | |
| Year ended 31.12.20 | Year ended 31.12.19 | ||||
| Net interest income | Average customer assets | Net interest margin | Net interest income | Average customer assets | Net interest margin |
| £m | £m | % | £m | £m | % |
Barclays UK | 5,234 | 200,317 | 2.61 | 5,888 | 190,849 | 3.09 |
Barclays International1,2 | 3,382 | 92,909 | 3.64 | 4,021 | 98,824 | 4.07 |
Total Barclays UK and Barclays International | 8,616 | 293,226 | 2.94 | 9,909 | 289,673 | 3.42 |
Other3 | (494) | | | (502) | | |
Total Barclays Group | 8,122 | | | 9,407 | |
1 | Barclays International margins include IEL balances within the investment banking business. |
2 | Barclays has amended the presentation of the premium paid for purchased financial guarantees which are embedded in notes it issues directly to the market. From Q420 onwards, the full note coupon is presented as interest expense within net interest income. The financial guarantee element of the coupon, for these notes, had previously been recognised in net investment income. The reclassification of £99m in Q4 included £74m related to Q320 YTD. This has caused a reduction in the 2020 Barclays International and Total Barclays UK and Barclays International NIMs of 0.11% and 0.03% respectively. Had the equivalent 2019 interest expense been recognised in net interest income, the Barclays International and Total Barclays UK and Barclays International NIMs would have been 4.04% and 3.41% respectively. |
3 | Other includes Head Office and non-lending related investment banking businesses not included in Barclays International margins. |
The Group NIM decreased 48bps to 2.94%. Barclays UK NIM decreased 48bps to 2.61% reflecting the impact of lower UK interest rates, COVID-19 customer support actions, as well as the mix impact of strong mortgage growth and lower unsecured lending balances. Barclays International NIM decreased 43bps to 3.64% mainly reflecting lower cards balances.
The Group's combined product and equity structural hedge notional as at 31 December 2020 was £188bn, with an average duration of 2.5 to 3 years. Group net interest income includes gross structural hedge contributions of £1.7bn (2019: £1.8bn) and net structural hedge contributions of £1.2bn (2019: £0.5bn). Gross structural hedge contributions represent the absolute level of interest earned from the fixed receipts on the basket of swaps in the structural hedge, while the net structural hedge contributions represent the net interest earned on the difference between the structural hedge rate and prevailing floating rates.
Quarterly analysis for Barclays UK and Barclays International | Net interest income | Average customer assets | Net interest margin |
Three months ended 31.12.20 | £m | £m | % |
Barclays UK | 1,317 | 204,315 | 2.56 |
Barclays International1,2 | 696 | 81,312 | 3.41 |
Total Barclays UK and Barclays International | 2,013 | 285,627 | 2.80 |
| | | |
Three months ended 30.09.20 | | | |
Barclays UK | 1,280 | 203,089 | 2.51 |
Barclays International1 | 838 | 88,032 | 3.79 |
Total Barclays UK and Barclays International | 2,118 | 291,121 | 2.89 |
| | | |
Three months ended 30.06.20 | | | |
Barclays UK | 1,225 | 199,039 | 2.48 |
Barclays International1 | 868 | 101,706 | 3.43 |
Total Barclays UK and Barclays International | 2,093 | 300,745 | 2.80 |
| | | |
Three months ended 31.03.20 | | | |
Barclays UK | 1,412 | 195,204 | 2.91 |
Barclays International1 | 980 | 100,171 | 3.93 |
Total Barclays UK and Barclays International | 2,392 | 295,375 | 3.26 |
| | | |
Three months ended 31.12.19 | | | |
Barclays UK | 1,478 | 193,610 | 3.03 |
Barclays International1 | 1,036 | 95,819 | 4.29 |
Total Barclays UK and Barclays International | 2,514 | 289,429 | 3.45 |
1 | Barclays International margins include interest earning lending balances within the investment banking business. |
2 | The aforementioned reclassification of expense from net investment income to net interest income has resulted in 0.48% reduction on the Q420 Barclays International NIM and 0.14% reduction on the Q420 Total Barclays UK and Barclays International NIM. |
Remuneration
Deferred bonuses are payable only once an employee meets certain conditions, including a specified period of service. This creates a timing difference between the communication of the bonus pool and the charges that are recognised in the income statement which are reconciled in the table below to show the charge for performance costs. Refer to the Remuneration Report on pages 108-142 of the Barclays PLC Annual Report 2020 for further detail on remuneration. The table below includes the other elements of compensation and staff costs.
| Year ended | Year ended | |
| 31.12.20 | 31.12.19 | |
| £m | £m | % Change |
Incentive awards granted: | | | |
Current year bonus | 1,090 | 1,058 | (3) |
Deferred bonus | 490 | 432 | (13) |
Total incentive awards granted | 1,580 | 1,490 | (6) |
| | | |
Reconciliation of incentive awards granted to income statement charge: | | | |
Less: deferred bonuses granted but not charged in current year | (335) | (293) | (14) |
Add: current year charges for deferred bonuses from previous years | 293 | 308 | 5 |
Other differences between incentive awards granted and income statement charge | (34) | (48) | 29 |
Income statement charge for performance costs | 1,504 | 1,457 | (3) |
| | | |
Other income statement charges: | | | |
Salaries | 4,322 | 4,332 | - |
Social security costs | 613 | 573 | (7) |
Post-retirement benefits1 | 519 | 501 | (4) |
Other compensation costs | 479 | 480 | - |
Total compensation costs2 | 7,437 | 7,343 | (1) |
| | | |
Other resourcing costs: | | | |
Outsourcing | 342 | 433 | 21 |
Redundancy and restructuring | 102 | 132 | 23 |
Temporary staff costs | 102 | 256 | 60 |
Other | 114 | 151 | 25 |
Total other resourcing costs | 660 | 972 | 32 |
| | | |
Total staff costs | 8,097 | 8,315 | 3 |
| | | |
Group compensation costs as a % of total income | 34.2 | 33.9 | |
Group staff costs as a % of total income | 37.2 | 38.4 | |
1 | Post-retirement benefits charge includes £279m (2019: £270m) in respect of defined contribution schemes and £240m (2019: £231m) in respect of defined benefit schemes. |
2 | £451m (2019: £439m) of Group compensation was capitalised as internally generated software. |
Deferred bonuses have been awarded and are expected to be charged to the income statement in the years outlined in the table that follows:
Year in which income statement charge is expected to be taken for deferred bonuses awarded to date1 | |||||
| Actual | | Expected1,2 | ||
| Year ended | Year ended | | Year ended | 2022 and |
| 31.12.19 | 31.12.20 | | 31.12.21 | beyond |
| £m | £m | | £m | £m |
Deferred bonuses from 2017 and earlier bonus pools | 141 | 49 | | 6 | 1 |
Deferred bonuses from 2018 bonus pool | 169 | 109 | | 48 | 9 |
Deferred bonuses from 2019 bonus pool | 137 | 135 | | 82 | 51 |
Deferred bonuses from 2020 bonus pool | - | 155 | | 148 | 136 |
Income statement charge for deferred bonuses | 447 | 448 | | 284 | 197 |
1 | The actual amount charged depends upon whether conditions have been met and may vary compared with the above expectation. |
2 | Does not include the impact of grants which will be made in 2021 and beyond. |
Charging of deferred bonus profile1 | |||
Grant date | Expected payment date(s)2 | Year | Income statement charge profile of 2020 awards3,4 |
March 2021 | | 2020 | 35% |
| | 2021 | 34% |
| March 2022 (33.3%) | 2022 | 21% |
| March 2023 (33.3%) | 2023 | 9% |
| March 2024 (33.3%) | 2024 | 1% |
1 | Represents a typical vesting schedule for deferred awards. Certain awards may be subject to 5- or 7-year deferral in line with regulatory requirements. |
2 | Share awards may be subject to an additional holding period. |
3 | The income statement charge is based on the period over which conditions are met. |
4 | Income statement charge profile % disclosed as a percentage of the award excluding lapse. |
Risk Management
Risk management and principal risks
The roles and responsibilities of the business groups, Risk and Compliance, in the management of risk in the Group are identified in the Enterprise Risk Management Framework. The purpose of the framework is to identify the principal risks of the Group, the process by which the Group sets its appetite for these risks in its business activities, and the consequent limits which it places on related risk taking. The framework identifies eight principal risks: credit risk; market risk; treasury and capital risk; operational risk; conduct risk; reputation risk; model risk; and legal risk. Further detail on these risks and how they are managed is available in the Barclays PLC Annual Report 2020 or online at home.barclays/annualreport.
The following section gives an overview of credit risk, market risk, and treasury and capital risk for the period.
Credit risk overview
The impact of the COVID-19 pandemic has increased the level of judgement that management has been required to exercise over the course of 2020. Customer and client default rates have remained relatively stable despite the impact of the pandemic and volatile macroeconomic environment. In retail cards, credit profiles improved or were stable versus pre-pandemic levels as a result of government support measures and customer deleveraging. In wholesale, furlough and liquidity funding schemes are supporting businesses through the pandemic, with limited credit deterioration. This lack of deterioration, combined in some cases with improving economics, is leading to large scale credit loss stock releases on a modelled basis in pockets of the portfolio. Given this backdrop, management has applied COVID-19 specific adjustments to modelled outputs to ensure the full potential impacts of stress are provided for. These adjustments address the temporary nature of ongoing government support, the uncertainty in relation to the timing of stress and the degree to which economic consensus has yet captured the range of economic uncertainty, particularly in the UK.
Credit Risk
Loans and advances at amortised cost by stage
The table below presents an analysis of loans and advances at amortised cost by gross exposure, impairment allowance, impairment charge and coverage ratio by stage allocation and business segment as at 31 December 2020. Also included are off-balance sheet loan commitments and financial guarantee contracts by gross exposure, impairment allowance and coverage ratio by stage allocation as at 31 December 2020.
Impairment allowance under IFRS 9 considers both the drawn and the undrawn counterparty exposure. For retail portfolios, the total impairment allowance is allocated to the drawn exposure to the extent that the allowance does not exceed the exposure, as ECL is not reported separately. Any excess is reported on the liability side of the balance sheet as a provision. For wholesale portfolios, the impairment allowance on the undrawn exposure is reported on the liability side of the balance sheet as a provision.
Gross exposure | | Impairment allowance | Net exposure | |||||||
| Stage 1 | Stage 2 | Stage 3 | Total | | Stage 1 | Stage 2 | Stage 3 | Total | |
As at 31.12.20 | £m | £m | £m | £m | | £m | £m | £m | £m | £m |
Barclays UK | 153,250 | 23,896 | 2,732 | 179,878 | | 332 | 1,509 | 1,147 | 2,988 | 176,890 |
Barclays International1 | 21,048 | 5,500 | 1,992 | 28,540 | | 396 | 1,329 | 1,205 | 2,930 | 25,610 |
Head Office | 4,267 | 720 | 844 | 5,831 | | 4 | 51 | 380 | 435 | 5,396 |
Total Barclays Group retail | 178,565 | 30,116 | 5,568 | 214,249 | | 732 | 2,889 | 2,732 | 6,353 | 207,896 |
Barclays UK | 31,918 | 4,325 | 1,126 | 37,369 | | 13 | 129 | 116 | 258 | 37,111 |
Barclays International1 | 79,911 | 16,565 | 2,270 | 98,746 | | 288 | 546 | 859 | 1,693 | 97,053 |
Head Office | 570 | - | 33 | 603 | | - | - | 31 | 31 | 572 |
Total Barclays Group wholesale2 | 112,399 | 20,890 | 3,429 | 136,718 | | 301 | 675 | 1,006 | 1,982 | 134,736 |
Total loans and advances at amortised cost | 290,964 | 51,006 | 8,997 | 350,967 | | 1,033 | 3,564 | 3,738 | 8,335 | 342,632 |
Off-balance sheet loan commitments and financial guarantee contracts3 | 289,939 | 52,891 | 2,330 | 345,160 | | 256 | 758 | 50 | 1,064 | 344,096 |
Total4 | 580,903 | 103,897 | 11,327 | 696,127 | | 1,289 | 4,322 | 3,788 | 9,399 | 686,728 |
| | | | | | | | | | |
| As at 31.12.20 | | Year ended 31.12.20 | | ||||||
| Coverage ratio | | Loan impairment charge and loan loss rate4 | | ||||||
| Stage 1 | Stage 2 | Stage 3 | Total | | Loan impairment charge | Loan loss rate | | ||
| % | % | % | % | | £m | bps | | ||
Barclays UK | 0.2 | 6.3 | 42.0 | 1.7 | | | 1,070 | | 59 | |
Barclays International1 | 1.9 | 24.2 | 60.5 | 10.3 | | | 1,680 | | 589 | |
Head Office | 0.1 | 7.1 | 45.0 | 7.5 | | | 91 | | 156 | |
Total Barclays Group retail | 0.4 | 9.6 | 49.1 | 3.0 | | | 2,841 | | 133 | |
Barclays UK | - | 3.0 | 10.3 | 0.7 | | | 154 | | 41 | |
Barclays International1 | 0.4 | 3.3 | 37.8 | 1.7 | | | 914 | | 93 | |
Head Office | - | - | 93.9 | 5.1 | | | - | | - | |
Total Barclays Group wholesale2 | 0.3 | 3.2 | 29.3 | 1.4 | | | 1,068 | | 78 | |
Total loans and advances at amortised cost | 0.4 | 7.0 | 41.5 | 2.4 | | | 3,909 | | 111 | |
Off-balance sheet loan commitments and financial guarantee contracts3 | 0.1 | 1.4 | 2.1 | 0.3 | | | 776 | | | |
Other financial assets subject to impairment4 | | | | | | | 153 | | | |
Total5 | 0.2 | 4.2 | 33.4 | 1.4 | | | 4,838 | | |
1 | Private Banking have refined the methodology to classify £5bn of their exposure between Wholesale and Retail during the year. |
2 | Includes Wealth and Private Banking exposures measured on an individual customer exposure basis, and excludes Business Banking exposures that are managed on a collective basis. The net impact is a difference in total exposure of £7,551m of balances reported as wholesale loans on page 29 in the Loans and advances at amortised cost by product disclosure. |
3 | Excludes loan commitments and financial guarantees of £9.5bn carried at fair value. |
4 | Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £180.3bn and impairment allowance of £165m. This comprises £11m ECL on £175.7bn stage 1 assets, £9m on £4.4bn stage 2 fair value through other comprehensive income assets, other assets, cash collateral and settlement balances and £145m on £154m stage 3 other assets. |
5 | The loan loss rate is 138bps after applying the total impairment charge of £4,838m. |
| Gross exposure | | Impairment allowance | Net exposure | ||||||
| Stage 1 | Stage 2 | Stage 3 | Total | | Stage 1 | Stage 2 | Stage 3 | Total | |
As at 31.12.19 | £m | £m | £m | £m | | £m | £m | £m | £m | £m |
Barclays UK | 143,097 | 23,198 | 2,446 | 168,741 | | 198 | 1,277 | 974 | 2,449 | 166,292 |
Barclays International | 27,886 | 4,026 | 1,875 | 33,787 | | 352 | 774 | 1,359 | 2,485 | 31,302 |
Head Office | 4,803 | 500 | 826 | 6,129 | | 5 | 36 | 305 | 346 | 5,783 |
Total Barclays Group retail | 175,786 | 27,724 | 5,147 | 208,657 | | 555 | 2,087 | 2,638 | 5,280 | 203,377 |
Barclays UK | 27,891 | 2,397 | 1,124 | 31,412 | | 16 | 38 | 108 | 162 | 31,250 |
Barclays International | 92,615 | 8,113 | 1,615 | 102,343 | | 136 | 248 | 447 | 831 | 101,512 |
Head Office | 2,974 | - | 37 | 3,011 | | - | - | 35 | 35 | 2,976 |
Total Barclays Group wholesale1 | 123,480 | 10,510 | 2,776 | 136,766 | | 152 | 286 | 590 | 1,028 | 135,738 |
Total loans and advances at amortised cost | 299,266 | 38,234 | 7,923 | 345,423 | | 707 | 2,373 | 3,228 | 6,308 | 339,115 |
Off-balance sheet loan commitments and financial guarantee contracts2 | 321,140 | 19,185 | 935 | 341,260 | | 97 | 170 | 55 | 322 | 340,938 |
Total3 | 620,406 | 57,419 | 8,858 | 686,683 | | 804 | 2,543 | 3,283 | 6,630 | 680,053 |
| | | | | | | | | | |
| As at 31.12.19 | | Year ended 31.12.19 | | ||||||
| Coverage ratio | | Loan impairment charge and loan loss rate4 | | ||||||
| Stage 1 | Stage 2 | Stage 3 | Total | | Loan impairment charge | Loan loss rate | | ||
| % | % | % | % | | £m | | bps | | |
Barclays UK | 0.1 | 5.5 | 39.8 | 1.5 | | | 661 | | 39 | |
Barclays International | 1.3 | 19.2 | 72.5 | 7.4 | | | 999 | | 296 | |
Head Office | 0.1 | 7.2 | 36.9 | 5.6 | | | 27 | | 44 | |
Total Barclays Group retail | 0.3 | 7.5 | 51.3 | 2.5 | | | 1,687 | | 81 | |
Barclays UK | 0.1 | 1.6 | 9.6 | 0.5 | | | 33 | | 11 | |
Barclays International | 0.1 | 3.1 | 27.7 | 0.8 | | | 113 | | 11 | |
Head Office | - | - | 94.6 | 1.2 | | | - | | - | |
Total Barclays Group wholesale1 | 0.1 | 2.7 | 21.3 | 0.8 | | | 146 | | 11 | |
Total loans and advances at amortised cost | 0.2 | 6.2 | 40.7 | 1.8 | | | 1,833 | | 53 | |
Off-balance sheet loan commitments and financial guarantee contracts2 | - | 0.9 | 5.9 | 0.1 | | | 71 | | | |
Other financial assets subject to impairment3 | | | | | | | 8 | | | |
Total4 | 0.1 | 4.4 | 37.1 | 1.0 | | | 1,912 | | | |
1 | Includes Wealth and Private Banking exposures measured on an individual customer exposure basis, and excludes Business Banking exposures that are managed on a collective basis. The net impact is a difference in total exposure of £6,434m of balances reported as wholesale loans on page 29 in the Loans and advances at amortised cost by product disclosure. |
2 | Excludes loan commitments and financial guarantees of £17.7bn carried at fair value. |
3 | Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £149.3bn and impairment allowance of £24m. This comprises £12m ECL on £148.5bn stage 1 assets, £2m on £0.8bn stage 2 fair value through other comprehensive income assets, cash collateral and settlement balances and £10m on £10m stage 3 other assets. |
4 | The loan loss rate is 55bps after applying the total impairment charge of £1,912m. |
Loans and advances at amortised cost by product
The table below presents a breakdown of loans and advances at amortised cost and the impairment allowance with stage allocation by asset classification.
| Stage 2 | | | ||||
As at 31.12.20 | Stage 1 | Not past due | <=30 days past due | >30 days past due | Total | Stage 3 | Total |
Gross exposure | £m | £m | £m | £m | £m | £m | £m |
Home loans | 138,639 | 16,651 | 1,785 | 876 | 19,312 | 2,234 | 160,185 |
Credit cards, unsecured loans and other retail lending | 33,021 | 9,470 | 544 | 306 | 10,320 | 3,172 | 46,513 |
Wholesale loans | 119,304 | 19,501 | 1,097 | 776 | 21,374 | 3,591 | 144,269 |
Total | 290,964 | 45,622 | 3,426 | 1,958 | 51,006 | 8,997 | 350,967 |
| | | | | | | |
Impairment allowance | | | | | | | |
Home loans | 33 | 57 | 13 | 14 | 84 | 421 | 538 |
Credit cards, unsecured loans and other retail lending | 680 | 2,382 | 180 | 207 | 2,769 | 2,251 | 5,700 |
Wholesale loans | 320 | 650 | 50 | 11 | 711 | 1,066 | 2,097 |
Total | 1,033 | 3,089 | 243 | 232 | 3,564 | 3,738 | 8,335 |
| | | | | | | |
Net exposure | | | | | | | |
Home loans | 138,606 | 16,594 | 1,772 | 862 | 19,228 | 1,813 | 159,647 |
Credit cards, unsecured loans and other retail lending | 32,341 | 7,088 | 364 | 99 | 7,551 | 921 | 40,813 |
Wholesale loans | 118,984 | 18,851 | 1,047 | 765 | 20,663 | 2,525 | 142,172 |
Total | 289,931 | 42,533 | 3,183 | 1,726 | 47,442 | 5,259 | 342,632 |
| | | | | | | |
Coverage ratio | % | % | % | % | % | % | % |
Home loans | - | 0.3 | 0.7 | 1.6 | 0.4 | 18.8 | 0.3 |
Credit cards, unsecured loans and other retail lending | 2.1 | 25.2 | 33.1 | 67.6 | 26.8 | 71.0 | 12.3 |
Wholesale loans | 0.3 | 3.3 | 4.6 | 1.4 | 3.3 | 29.7 | 1.5 |
Total | 0.4 | 6.8 | 7.1 | 11.8 | 7.0 | 41.5 | 2.4 |
| | | | | | | |
As at 31.12.19 | | | | | | | |
Gross exposure | £m | £m | £m | £m | £m | £m | £m |
Home loans | 135,713 | 14,733 | 1,585 | 725 | 17,043 | 2,155 | 154,911 |
Credit cards, unsecured loans and other retail lending | 46,012 | 9,759 | 496 | 504 | 10,759 | 3,409 | 60,180 |
Wholesale loans | 117,541 | 9,374 | 374 | 684 | 10,432 | 2,359 | 130,332 |
Total | 299,266 | 33,866 | 2,455 | 1,913 | 38,234 | 7,923 | 345,423 |
| | | | | | | |
Impairment allowance | | | | | | | |
Home loans | 22 | 37 | 14 | 13 | 64 | 346 | 432 |
Credit cards, unsecured loans and other retail lending | 542 | 1,597 | 159 | 251 | 2,007 | 2,335 | 4,884 |
Wholesale loans | 143 | 284 | 9 | 9 | 302 | 547 | 992 |
Total | 707 | 1,918 | 182 | 273 | 2,373 | 3,228 | 6,308 |
| | | | | | | |
Net exposure | | | | | | | |
Home loans | 135,691 | 14,696 | 1,571 | 712 | 16,979 | 1,809 | 154,479 |
Credit cards, unsecured loans and other retail lending | 45,470 | 8,162 | 337 | 253 | 8,752 | 1,074 | 55,296 |
Wholesale loans | 117,398 | 9,090 | 365 | 675 | 10,130 | 1,812 | 129,340 |
Total | 298,559 | 31,948 | 2,273 | 1,640 | 35,861 | 4,695 | 339,115 |
| | | | | | | |
Coverage ratio | % | % | % | % | % | % | % |
Home loans | - | 0.3 | 0.9 | 1.8 | 0.4 | 16.1 | 0.3 |
Credit cards, unsecured loans and other retail lending | 1.2 | 16.4 | 32.1 | 49.8 | 18.7 | 68.5 | 8.1 |
Wholesale loans | 0.1 | 3.0 | 2.4 | 1.3 | 2.9 | 23.2 | 0.8 |
Total | 0.2 | 5.7 | 7.4 | 14.3 | 6.2 | 40.7 | 1.8 |
Loans and advances at amortised cost by selected sectors
The table below presents a breakdown of loans and advances at amortised cost and the impairment allowance, with gross exposure and stage allocation for selected industry sectors within the wholesale loans portfolio. The industry sectors have been selected based upon the level of management focus they have received following the onset of the COVID-19 pandemic.
The gross loans and advances to these sectors have increased over the year as a result of additional drawdowns on committed credit lines provided by the bank. Overall limits and exposures have remained broadly stable over the year whilst provisions have increased in light of the heightened stress. The wholesale portfolio also benefits from a hedge protection programme that enables effective risk management against systemic losses.
| Gross exposure | | Impairment allowance | ||||||
| Stage 1 | Stage 2 | Stage 3 | Total | | Stage 1 | Stage 2 | Stage 3 | Total |
As at 31.12.20 | £m | £m | £m | £m | | £m | £m | £m | £m |
Air travel | 367 | 525 | 56 | 948 | | 9 | 27 | 23 | 59 |
Hospitality and leisure | 4,440 | 2,387 | 313 | 7,140 | | 53 | 115 | 61 | 229 |
Oil and gas | 1,754 | 854 | 465 | 3,073 | | 31 | 27 | 140 | 198 |
Retail | 3,907 | 1,153 | 283 | 5,343 | | 78 | 51 | 108 | 237 |
Shipping | 308 | 389 | 12 | 709 | | 2 | 30 | 1 | 33 |
Transportation | 1,148 | 253 | 125 | 1,526 | | 19 | 10 | 57 | 86 |
Total | 11,924 | 5,561 | 1,254 | 18,739 | | 192 | 260 | 390 | 842 |
Total of Wholesale exposures | 10% | 26% | 35% | 13% | | 60% | 37% | 37% | 40% |
| | | | | | | | | |
| Gross exposure | | Impairment allowance | ||||||
| Stage 1 | Stage 2 | Stage 3 | Total | | Stage 1 | Stage 2 | Stage 3 | Total |
As at 31.12.19 | £m | £m | £m | £m | | £m | £m | £m | £m |
Air travel | 194 | 31 | 26 | 251 | | - | - | 24 | 24 |
Hospitality and leisure | 4,321 | 851 | 199 | 5,371 | | 8 | 18 | 29 | 55 |
Oil and gas | 2,539 | 612 | 136 | 3,287 | | 8 | 24 | 47 | 79 |
Retail | 3,395 | 777 | 207 | 4,379 | | 11 | 24 | 85 | 120 |
Shipping | 357 | 52 | 7 | 416 | | 1 | - | 3 | 4 |
Transportation | 873 | 82 | 89 | 1,044 | | 5 | 5 | 54 | 64 |
Total | 11,679 | 2,405 | 664 | 14,748 | | 33 | 71 | 242 | 346 |
Total of Wholesale exposures | 10% | 23% | 28% | 11% | | 23% | 24% | 44% | 35% |
A £0.2bn adjustment has been applied to selected sectors in Stage 1 to increase the ECL coverage on these names in line with the average Stage 2 coverage of the respective sector. This adjustment is materially in response to the increased stress in these sectors not captured through the ECL models. An additional £0.1bn adjustment is held against undrawn exposure which does not appear in the table.
The coverage ratio for selected sectors has increased from 2.3% as at 31 December 2019 to 4.5% as at 31 December 2020.
Movement in gross exposures and impairment allowance including provisions for loan commitments and financial guarantees
The following tables present a reconciliation of the opening to the closing balance of the exposure and impairment allowance. An explanation of the terms 12-month ECL, lifetime ECL and credit-impaired is included in the Barclays PLC Annual Report 2020 on page 296. Transfers between stages in the table have been reflected as if they had taken place at the beginning of the year. The movements are measured over a 12-month period.
Loans and advances at amortised cost | ||||||||
| Stage 1 | Stage 2 | Stage 3 | Total | ||||
| Gross exposure | ECL | Gross exposure | ECL | Gross exposure | ECL | Gross exposure | ECL |
Home loans | £m | £m | £m | £m | £m | £m | £m | £m |
As at 1 January 2020 | 135,713 | 22 | 17,043 | 64 | 2,155 | 346 | 154,911 | 432 |
Transfers from Stage 1 to Stage 2 | (8,724) | (1) | 8,724 | 1 | - | - | - | - |
Transfers from Stage 2 to Stage 1 | 4,618 | 14 | (4,618) | (14) | - | - | - | - |
Transfers to Stage 3 | (308) | - | (420) | (10) | 728 | 10 | - | - |
Transfers from Stage 3 | 47 | 1 | 219 | 2 | (266) | (3) | - | - |
Business activity in the year | 22,548 | 7 | 714 | 2 | 4 | - | 23,266 | 9 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (6,195) | (9) | (841) | 42 | (57) | 105 | (7,093) | 138 |
Final repayments | (9,060) | (1) | (1,509) | (3) | (308) | (15) | (10,877) | (19) |
Disposals3 | - | - | - | - | - | - | - | - |
Write-offs4 | - | - | - | - | (22) | (22) | (22) | (22) |
As at 31 December 20205 | 138,639 | 33 | 19,312 | 84 | 2,234 | 421 | 160,185 | 538 |
| | | | | | | | |
Credit cards, unsecured loans and other retail lending | ||||||||
As at 1 January 2020 | 46,012 | 542 | 10,759 | 2,007 | 3,409 | 2,335 | 60,180 | 4,884 |
Transfers from Stage 1 to Stage 2 | (6,571) | (134) | 6,571 | 134 | - | - | - | - |
Transfers from Stage 2 to Stage 1 | 3,080 | 482 | (3,080) | (482) | - | - | - | - |
Transfers to Stage 3 | (712) | (25) | (1,162) | (398) | 1,874 | 423 | - | - |
Transfers from Stage 3 | 76 | 39 | 67 | 12 | (143) | (51) | - | - |
Business activity in the year | 5,598 | 67 | 324 | 83 | 59 | 28 | 5,981 | 178 |
Changes to models used for calculation1 | - | 13 | - | 296 | - | - | - | 309 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes2 | (9,678) | (229) | (2,706) | 1,174 | (10) | 1,353 | (12,394) | 2,298 |
Final repayments | (3,291) | (67) | (270) | (37) | (204) | (84) | (3,765) | (188) |
Disposals3 | (1,493) | (8) | (183) | (20) | (204) | (144) | (1,880) | (172) |
Write-offs4 | - | - | - | - | (1,609) | (1,609) | (1,609) | (1,609) |
As at 31 December 20205 | 33,021 | 680 | 10,320 | 2,769 | 3,172 | 2,251 | 46,513 | 5,700 |
1 | Changes to models used for calculation include a £309m adjustment which largely represents model remediation to correct for over recovery of debt in UK unsecured lending. Barclays continually review the output of models to determine accuracy of the ECL calculation including review of model monitoring, external benchmarking and experience of model operation over an extended period of time. This ensures that the models used continue to reflect the risks inherent across the businesses. |
2 | Transfers and risk parameter changes has seen an ECL increase which is materially driven by stage migration in response to the macroeconomic scenario updates, partially offset by a net release in ECL of £0.6bn due to a reclassification of £2bn gross loans and advances from Stage 2 to Stage 1 in credit cards and unsecured loans. The reclassification followed a review of back-testing of results which indicated that origination probability of default characteristics were unnecessarily moving stage 1 accounts into stage 2. |
3 | The £1.9bn disposals reported within Credit cards, unsecured loans and other retail lending portfolio include £1.7bn sale of motor financing business within the Barclays Partner Finance business and £0.2bn relate to debt sales undertaken during the year. The £2.4bn disposal reported within Wholesale loans include sale of debt securities as part of Group Treasury Operations. |
4 | In 2020, gross write-offs amounted to £1,964m (2019: £1,883m) and post write-off recoveries amounted to £35m (2019: £124m). Net write-offs represent gross write-offs less post write-off recoveries and amounted to £1,929m (2019: £1,759m). |
5 | Other financial assets subject to impairment excluded from the tables above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £180.3bn (December 2019: £149.3bn) and impairment allowance of £175.7m (December 2019: £24m). This comprises £11m ECL (December 2019: £12m) on £175.7bn Stage 1 assets (December 2019: £148.5m), £9m (December 2019: £2m) on £4.4bn Stage 2 fair value through other comprehensive income assets, cash collateral and settlement assets (December 2019: £0.8bn) and £145m (December 2019: £10m) on £154m Stage 3 other assets (December 2019: £10m). |
Loans and advances at amortised cost | ||||||||
| Stage 1 | Stage 2 | Stage 3 | Total | ||||
| Gross exposure | ECL | Gross exposure | ECL | Gross exposure | ECL | Gross exposure | ECL |
Wholesale loans | £m | £m | £m | £m | £m | £m | £m | £m |
As at 1 January 2020 | 117,541 | 143 | 10,432 | 302 | 2,359 | 547 | 130,332 | 992 |
Transfers from Stage 1 to Stage 2 | (12,531) | (35) | 12,531 | 35 | - | - | - | - |
Transfers from Stage 2 to Stage 1 | 4,121 | 40 | (4,121) | (40) | - | - | - | - |
Transfers to Stage 3 | (1,137) | (4) | (875) | (58) | 2,012 | 62 | - | - |
Transfers from Stage 3 | 471 | 22 | 247 | 13 | (718) | (35) | - | - |
Business activity in the year | 27,863 | 46 | 2,336 | 149 | 634 | 85 | 30,833 | 280 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 13,828 | 130 | 3,811 | 339 | (64) | 799 | 17,575 | 1,268 |
Final repayments | (28,458) | (22) | (2,977) | (29) | (299) | (59) | (31,734) | (110) |
Disposals1 | (2,394) | - | (10) | - | - | - | (2,404) | - |
Write-offs2 | - | - | - | - | (333) | (333) | (333) | (333) |
As at 31 December 20203 | 119,304 | 320 | 21,374 | 711 | 3,591 | 1,066 | 144,269 | 2,097 |
| | | | | | | | |
Reconciliation of ECL movement to impairment charge/(release) for the period | £m | |||||||
Home loans | | | | | | | | 128 |
Credit cards, unsecured loans and other retail lending | | 2,597 | ||||||
Wholesale loans | | 1,438 | ||||||
ECL movement excluding assets derecognised due to disposals and write-offs | | 4,163 | ||||||
Recoveries and reimbursements4 | | (399) | ||||||
Exchange and other adjustments5 | | 145 | ||||||
Impairment charge on loan commitments and other financial guarantees | | 776 | ||||||
Impairment charge on other financial assets3 | | 153 | ||||||
As at 31 December 2020 | | | | | | | | 4,838 |
1 | The £1.9bn disposals reported within Credit cards, unsecured loans and other retail lending portfolio include £1.7bn sale of motor financing business within the Barclays Partner Finance business and £0.2bn relate to debt sales undertaken during the year. The £2.4bn disposal reported within Wholesale loans include sale of debt securities as part of Group Treasury Operations. |
2 | In 2020, gross write-offs amounted to £1,964m (2019: £1,883m) and post write-off recoveries amounted to £35m (2019: £124m). Net write-offs represent gross write-offs less post write-off recoveries and amounted to £1,929m (2019: £1,759m). |
3 | Other financial assets subject to impairment excluded from the tables above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £180.3bn (December 2019: £149.3bn) and impairment allowance of £175.7m (December 2019: £24m). This comprises £11m ECL (December 2019: £12m) on £175.7bn Stage 1 assets (December 2019: £148.5m), £9m (December 2019: £2m) on £4.4bn Stage 2 fair value through other comprehensive income assets, cash collateral and settlement assets (December 2019: £0.8bn) and £145m (December 2019: £10m) on £154m Stage 3 other assets (December 2019: £10m). |
4 | Recoveries and reimbursements includes £364m for reimbursements expected to be received under the arrangement where Group has entered into financial guarantee contracts which provide credit protection over certain loans assets with third parties. Cash recoveries of previously written off amounts to £35m. |
5 | Includes foreign exchange and interest and fees in suspense. |
Loan commitments and financial guarantees | ||||||||
| Stage 1 | Stage 2 | Stage 3 | Total | ||||
| Gross exposure | ECL | Gross exposure | ECL | Gross exposure | ECL | Gross exposure | ECL |
Home loans | £m | £m | £m | £m | £m | £m | £m | £m |
As at 1 January 2020 | 9,542 | - | 500 | - | 4 | - | 10,046 | - |
Net transfers between stages | (82) | - | 78 | - | 4 | - | - | - |
Business activity in the year | 7,975 | - | - | - | - | - | 7,975 | - |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (5,332) | - | (27) | - | (2) | - | (5,361) | - |
Limit management and final repayments | (242) | - | (35) | - | (1) | - | (278) | - |
As at 31 December 2020 | 11,861 | - | 516 | - | 5 | - | 12,382 | - |
| | | | | | | | |
Credit cards, unsecured loans and other retail lending | ||||||||
As at 1 January 2020 | 125,759 | 35 | 6,238 | 71 | 250 | 14 | 132,247 | 120 |
Net transfers between stages | (5,477) | 43 | 4,725 | (40) | 752 | (3) | - | - |
Business activity in the year | 5,214 | 2 | 158 | 3 | 2 | 1 | 5,374 | 6 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 1,298 | (22) | 1,636 | 272 | (671) | 15 | 2,263 | 265 |
Limit management and final repayments | (12,423) | (3) | (640) | (1) | (104) | (4) | (13,167) | (8) |
As at 31 December 2020 | 114,371 | 55 | 12,117 | 305 | 229 | 23 | 126,717 | 383 |
| | | | | | | | |
Wholesale loans | | | | | | | | |
As at 1 January 2020 | 185,839 | 62 | 12,447 | 99 | 681 | 41 | 198,967 | 202 |
Net transfers between stages | (28,325) | 67 | 27,319 | (72) | 1,006 | 5 | - | - |
Business activity in the year | 42,917 | 32 | 4,708 | 102 | 774 | 2 | 48,399 | 136 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 13,637 | 47 | (44) | 338 | (69) | (20) | 13,524 | 365 |
Limit management and final repayments | (50,361) | (7) | (4,172) | (14) | (296) | (1) | (54,829) | (22) |
As at 31 December 2020 | 163,707 | 201 | 40,258 | 453 | 2,096 | 27 | 206,061 | 681 |
Management adjustments to models for impairment
Management adjustments to impairment models are applied in order to factor in certain conditions or changes in policy that are not fully incorporated into the impairment models, or to reflect additional facts and circumstances at the period end. Management adjustments are reviewed and incorporated into future model development where applicable.
Total management adjustments to impairment allowance are presented by product below.
Management adjustments to models for impairment1 | ||||
| 2020 | 2019 | ||
| Management adjustments to impairment allowances | Proportion of total impairment allowances | Management adjustments to impairment allowances | Proportion of total impairment allowances2 |
As at 31 December | £m | % | £m | % |
Home loans | 131 | 24.3 | 57 | 13.2 |
Credit cards, unsecured loans and other retail lending | 1,234 | 20.3 | 308 | 6.2 |
Wholesale loans | 23 | 0.8 | (25) | (2.1) |
Total | 1,388 | 14.8 | 340 | 5.1 |
Management adjustments to models for impairment charges1 | ||||
| Impairment allowance pre management adjustments3 | Economic uncertainty adjustments | Other adjustments | Total impairment allowance |
As at 31 December 2020 | £m | £m | £m | £m |
Home loans | 407 | 21 | 110 | 538 |
Credit cards, unsecured loans and other retail lending | 4,849 | 1,625 | (391) | 6,083 |
Wholesale loans | 2,755 | 421 | (398) | 2,778 |
Total | 8,011 | 2,067 | (679) | 9,399 |
1 | Positive values relate to an increase in impairment allowance. |
2 | The 2019 comparative figures have been restated to include impairment allowances on both drawn and undrawn exposures. |
3 | Includes £6.8bn of modelled ECL, £0.9bn of individually assessed impairments and £0.3bn ECL from non-modelled exposures. |
Economic uncertainty adjustments:
The pandemic impacted the global economy throughout 2020 and macroeconomic forecasts indicate longer-term impacts will result in higher unemployment levels and customer and client stress. However, to date, little real credit deterioration has occurred, largely as a result of government and bank support. Observed 30-day arrears rates in consumer loans in particular have remained stable in both US cards (2020: 2.5%; 2019: 2.7%) and UK cards (2020: 1.7%; 2019: 1.7%). A similar phenomenon is observed in wholesale, where the average risk profile of the portfolio has broadly remained stable during the year and has not deteriorated in line with the macroeconomic crisis.
Given this backdrop, management has applied COVID-19 specific adjustments to modelled outputs to ensure the full potential impacts of stress are provided for. These adjustments address the temporary nature of ongoing government support, the uncertainty in relation to the timing of stress and the degree to which economic consensus has not yet captured the range of economic uncertainty.
The COVID-19 adjustments of £2.1bn broadly comprised the following:
· | Use of expert judgement to adjust the probability of default £0.7bn to pre-COVID levels to reflect the impact of temporary support measures on underlying customer behaviour, partially offset by government guarantees £(0.1)bn which are materially against BBLs; |
· | Adjusting macroeconomic variables deemed temporarily influenced by support measures, enabling models to consume the expected stress £1.2bn; |
· | A £0.3bn adjustment has been applied to selected sectors in Stage 1 to increase the ECL coverage on these names in line with the average Stage 2 coverage of the respective sector. This adjustment is materially in response to the increased stress in these sectors not captured through the ECL models. |
Other adjustments
Home loans: The low average LTV nature of the UK Home Loans portfolio means that modelled ECL estimates are low in all but the most severe economic scenarios. An adjustment is held to maintain an appropriate level of ECL.
Credit cards, unsecured loans and other retail lending: Transfers and risk parameters changes include a net release in ECL of £0.6bn due to a reclassification of £2bn gross loans and advances from Stage 2 to Stage 1 in credit cards and unsecured loans. The reclassification followed a review of back-testing of results which indicated that origination probability of default characteristics were unnecessarily moving Stage 1 accounts into Stage 2.
Wholesale loans: Adjustments include a release in the Investment Bank to limit excessive ECL sensitivity to the macroeconomic variable for Federal Tax Receipts and a correction to Corporate and Investment Bank ECL to adjust for model inaccuracies informed by back-testing.
Management adjustments of £340m in 2019 largely comprises a £210m PMA to compensate for over-recovery of debt in UK unsecured lending, and subsequently fixed within the underlying model; and £150m for UK economic uncertainty, now subsumed within managements broader approach to economic uncertainty.
Measurement uncertainty
The measurement of ECL involves complexity and judgement, including estimation of probabilities of default (PD), loss given default (LGD), a range of unbiased future economic scenarios, estimation of expected lives, estimation of exposures at default (EAD) and assessing significant increases in credit risk.
The Group uses a five-scenario model to calculate ECL. An external consensus forecast is assembled from key sources, including HM Treasury (short and medium term forecasts), Bloomberg (based on median of economic forecasts) and the Urban Land Institute (for US House Prices), which forms the Baseline scenario. In addition, two adverse scenarios (Downside 1 and Downside 2) and two favourable scenarios (Upside 1 and Upside 2) are derived, with associated probability weightings. The adverse scenarios are calibrated to a broadly similar severity to Barclays' internal stress tests and stress scenarios provided by regulators whilst also considering IFRS 9 specific sensitivities and non-linearity. Downside 2 is benchmarked to the Bank of England's stress scenarios and to the most severe scenario from Moody's inventory, but is not designed to be the same. The favourable scenarios are calibrated to reflect upside risks to the Baseline scenario to the extent that is broadly consistent with recent favourable benchmark scenarios. All scenarios are regenerated at a minimum semi-annually. The scenarios include eight economic variables, (GDP, unemployment, House Price Index (HPI) and base rates in both the UK and US markets), and expanded variables using statistical models based on historical correlations. The upside and downside shocks are designed to evolve over a five-year stress horizon, with all five scenarios converging to a steady state after approximately eight years.
Scenarios used to calculate the Group's ECL charge were reviewed and updated regularly throughout 2020, following the outbreak of the COVID-19 pandemic in the first quarter. The current Baseline scenario reflects the latest consensus economic forecasts with unemployment continuing to decrease in the US and peaking at Q221 in the UK followed by a steady decline. In the downside scenarios, an economic downturn in early 2021 in the UK and the US begins to recover later in the year, with unemployment increasing to the end of 2021. In the upside scenarios, the strong rebound in UK and US GDP continues into 2021, following the bounce-back in growth in Q320 and, subsequently, the projections stay above the year on year growth rates seen in the Baseline for a prolonged period of time before finally reverting to the long term run rate. This reflects the assumption of approved vaccines being successfully rolled out throughout 2021 and pent up savings being deployed into a more certain consumer environment to drive significant growth. Scenario weights have been updated to reflect the latest economics.
As a result of government and bank support measures, significant credit deterioration has not yet occurred. This delay increases uncertainty on the timing of the stress and the realisation of defaults. Management has applied COVID-19 specific adjustments to modelled outputs to reflect the temporary nature of ongoing government support, the uncertainty in relation to the timing of stress and the degree to which economic consensus has yet captured the range of economic uncertainty, particularly in the UK. As a result, ECL is higher than would be the case if it were based on the forecast economic scenarios alone.
Scenario weights
The methodology for estimating probability weights for each of the scenarios involves a comparison of the distribution of key historical UK and US macroeconomic variables against the forecast paths of the five scenarios. The methodology works such that the Baseline (reflecting current consensus outlook) has the highest weight and the weights of adverse and favourable scenarios depend on the deviation from the Baseline; the further from the Baseline, the smaller the weight. This is reflected in the table below where the probability weights of the scenarios are shown. A single set of five scenarios is used across all portfolios and all five weights are normalised to equate to 100%. The same scenarios and weights that are used in the estimation of expected credit losses are also used for Barclays internal planning purposes. The impacts across the portfolios are different because of the sensitivities of each of the portfolios to specific macroeconomic variables, for example, mortgages are highly sensitive to house prices and base rates, credit cards and unsecured consumer loans are highly sensitive to unemployment.
The range of forecast paths generated in the calculation of the weights at 31 December 2020 is much wider than in previous periods due to the uncertainty caused by COVID-19, thus the Upside and Downside scenarios are closer to the Baseline resulting in a more even distribution of weights than at 31 December 2019.
The economic environment remains uncertain and future impairment charges may be subject to further volatility (including from changes to macroeconomic variable forecasts) depending on the longevity of the COVID-19 pandemic and related containment measures, as well as the longer term effectiveness of central bank, government and other support measures.
The tables below show the key consensus macroeconomic variables used in the baseline scenario (3 year annual paths), the probability weights applied to each scenario and the macroeconomic variables by scenario using 'specific bases' i.e. the most extreme position of each variable in the context of the scenario, for example, the highest unemployment for downside scenarios and the lowest unemployment for upside scenarios. 5-year average tables and movement over time graphs provide additional transparency.
Annual paths show quarterly averages for the year (unemployment and base rate) or change in the year (GDP and HPI). Expected worst point is the most negative quarter in the relevant 3 year period, which is calculated relative to the start point for GDP and HPI.
Baseline average macroeconomic variables used in the calculation of ECL | ||||
| 2021 | 2022 | 2023 | Expected Worst Point |
As at 31.12.20 | % | % | % | % |
UK GDP1 | 6.3 | 3.3 | 2.6 | 1.2 |
UK unemployment2 | 6.7 | 6.4 | 5.8 | 7.4 |
UK HPI3 | 2.4 | 2.3 | 5.0 | 0.6 |
UK bank rate | - | (0.1) | - | (0.1) |
US GDP1 | 3.9 | 3.1 | 2.9 | 1.0 |
US unemployment4 | 6.9 | 5.7 | 5.6 | 7.5 |
US HPI5 | 2.8 | 4.7 | 4.7 | 0.7 |
US federal funds rate | 0.3 | 0.3 | 0.3 | 0.3 |
| | | | |
| 2020 | 2021 | 2022 | Expected Worst Point |
As at 31.12.19 | % | % | % | % |
UK GDP1 | 1.3 | 1.5 | 1.6 | 0.3 |
UK unemployment2 | 4.1 | 4.2 | 4.2 | 4.2 |
UK HPI3 | 1.9 | 3.1 | 3.6 | 0.3 |
UK bank rate | 0.6 | 0.5 | 0.8 | 0.5 |
US GDP1 | 2.1 | 1.9 | 1.9 | 0.5 |
US unemployment4 | 3.6 | 3.9 | 4.0 | 4.0 |
US HPI5 | 3.4 | 2.9 | 2.8 | 1.0 |
US federal funds rate | 1.7 | 1.5 | 1.7 | 1.5 |
1 | Average Real GDP seasonally adjusted change in year; expected worst point is the minimum growth relative to Q420 (2019: Q419) based on a 12 quarter period. |
2 | Average UK unemployment rate 16-year+; expected worst point is the highest rate in the 12 quarter period starting Q121 (2019: Q120). |
3 | Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end; worst point is based on minimum growth relative to Q420 (2019: Q419) based on a 12 quarter period. |
4 | Average US civilian unemployment rate 16-year+; expected worst point is the highest rate in the 12 quarter period starting Q121 (2019: Q120). |
5 | Change in year end US HPI = FHFA house price index, relative to prior year end; worst point is based on minimum growth relative to Q420 (2019: Q419) based on a 12 quarter period. |
Scenario probability weighting | | | | | |
| Upside 2 | Upside 1 | Baseline | Downside 1 | Downside 2 |
| % | % | % | % | % |
As at 31.12.20 | | | | | |
Scenario probability weighting | 20.2 | 24.2 | 24.7 | 15.5 | 15.4 |
As at 31.12.19 | | | | | |
Scenario probability weighting | 10.1 | 23.1 | 40.8 | 22.7 | 3.3 |
Specific bases shows the most extreme position of each variable in the context of the scenario, for example, the highest unemployment for downside scenarios, average unemployment for baseline scenarios and lowest unemployment for upside scenarios. GDP and HPI downside and upside scenario data represents the lowest and highest points relative to the start point in the 20 quarter period.
Macroeconomic variables (specific bases)1 | | | | | |
| Upside 2 | Upside 1 | Baseline | Downside 1 | Downside 2 |
As at 31.12.20 | % | % | % | % | % |
UK GDP2 | 14.2 | 8.8 | 0.7 | (22.1) | (22.1) |
UK unemployment3 | 4.0 | 4.0 | 5.7 | 8.4 | 10.1 |
UK HPI4 | 48.2 | 30.8 | 3.6 | (4.5) | (18.3) |
UK bank rate3 | 0.1 | 0.1 | - | 0.6 | 0.6 |
US GDP2 | 15.7 | 12.8 | 1.6 | (10.6) | (10.6) |
US unemployment3 | 3.8 | 3.8 | 6.4 | 13.0 | 13.7 |
US HPI4 | 42.2 | 30.9 | 3.8 | (3.7) | (15.9) |
US federal funds rate3 | 0.1 | 0.1 | 0.3 | 1.3 | 1.3 |
| | | | | |
As at 31.12.19 | | | | | |
UK GDP2 | 15.4 | 11.7 | 1.5 | 0.2 | (4.6) |
UK unemployment3 | 3.4 | 3.8 | 4.1 | 5.8 | 8.8 |
UK HPI4 | 41.1 | 28.8 | 2.8 | (6.3) | (31.1) |
UK bank rate3 | 0.5 | 0.5 | 0.7 | 2.8 | 4.0 |
US GDP2 | 17.9 | 14.9 | 2.1 | 0.5 | (3.0) |
US unemployment3 | 3.0 | 3.5 | 3.9 | 5.4 | 8.5 |
US HPI4 | 35.8 | 23.7 | 3.2 | 0.3 | (16.7) |
US federal funds rate3 | 1.5 | 1.5 | 1.8 | 3.0 | 3.5 |
Average basis represents the average quarterly value of variables in the 20 quarter period with GDP and HPI based on yearly average and quarterly CAGRs respectively.
Macroeconomic variables (5-year averages)1 | | | | | |
| Upside 2 | Upside 1 | Baseline | Downside 1 | Downside 2 |
As at 31.12.20 | % | % | % | % | % |
UK GDP5 | 2.5 | 1.6 | 0.7 | 0.1 | (0.9) |
UK unemployment6 | 5.0 | 5.3 | 5.7 | 6.5 | 7.2 |
UK HPI7 | 8.2 | 5.5 | 3.6 | (0.2) | (3.6) |
UK bank rate6 | 0.3 | 0.2 | - | - | (0.1) |
US GDP5 | 2.9 | 2.4 | 1.6 | 0.8 | 0.1 |
US unemployment6 | 5.3 | 5.7 | 6.4 | 8.3 | 10.4 |
US HPI7 | 7.3 | 5.5 | 3.8 | 0.8 | (3.0) |
US federal funds rate6 | 0.5 | 0.5 | 0.3 | 0.3 | 0.3 |
| | | | | |
As at 31.12.19 | | | | | |
UK GDP5 | 2.9 | 2.2 | 1.5 | 0.8 | (0.6) |
UK unemployment6 | 3.6 | 3.9 | 4.1 | 5.1 | 7.0 |
UK HPI7 | 7.1 | 5.2 | 2.8 | (1.1) | (6.9) |
UK bank rate6 | 0.6 | 0.6 | 0.7 | 2.1 | 3.1 |
US GDP5 | 3.4 | 2.9 | 2.1 | 1.3 | (0.1) |
US unemployment6 | 3.2 | 3.7 | 3.9 | 4.7 | 6.6 |
US HPI7 | 6.3 | 4.3 | 3.2 | 1.6 | (3.4) |
US federal funds rate6 | 1.7 | 1.7 | 1.8 | 2.8 | 3.2 |
1 | UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HPI = Halifax All Houses, All Buyers Index; US GDP = Real GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA house price index. |
2 | Maximum growth relative to Q419 (2019: Q418), based on 20 quarter period in Upside scenarios; 5-year yearly average CAGR in Baseline; minimum growth relative to Q419 (2019: Q418), based on 20 quarter period in Downside scenarios. |
3 | Lowest quarter in Upside scenarios; 5-year average in Baseline; highest quarter in Downside scenarios. Period based on 20 quarters from Q120 (2019: Q119). |
4 | Maximum growth relative to Q419 (2019: Q418), based on 20 quarter period in Upside scenarios; 5-year quarter end CAGR in Baseline; minimum growth relative to Q419 (2019: Q418), based on 20 quarter period in Downside scenarios. |
5 | 5-year yearly average CAGR, starting 2019 (2019: 2018). |
6 | 5-year average. Period based on 20 quarters from Q120 (2019: Q119). |
7 | 5-year quarter end CAGR, starting Q419 (2019: Q418). |
2019 data presented on a revised, simplified basis for ease of comparison.
Analysis of specific portfolios and asset types
Secured home loans
The UK home loan portfolio primarily comprises first lien mortgages and accounts for 93% (December 2019: 92%) of the Group's total home loans balance.
Home loans principal portfolios | | | Barclays UK | |
| | As at 31.12.20 | As at 31.12.19 | |
Gross loans and advances (£m) | | | 148,343 | 143,259 |
90 day arrears rate, excluding recovery book (%) | | | 0.2 | 0.2 |
Annualised gross charge-off rate - 180 days past due (%) | | | 0.6 | 0.6 |
Recovery book proportion of outstanding balances (%) | | | 0.6 | 0.5 |
Recovery book impairment coverage ratio (%)1 | | | 3.2 | 5.2 |
| | | | |
Average marked to market LTV | | | | |
Balance weighted (%) | | | 50.7 | 51.1 |
Valuation weighted (%)1 | | | 37.6 | 37.9 |
| | | | |
New lending | | | Year ended 31.12.20 | Year ended 31.12.19 |
New home loan completions (£m) | | | 22,776 | 25,530 |
New home loans proportion > 90% LTV (%) | | | 2.6 | 4.2 |
Average LTV on new home loans: balance weighted (%) | | | 67.5 | 67.9 |
Average LTV on new home loans: valuation weighted (%)1 | | | 59.6 | 59.8 |
Home loans principal portfolios - distribution of balances by LTV2 | ||||||||||||
| | | | | | | | | | | | |
| Distribution of balances | Distribution of impairment allowance | Coverage ratio | |||||||||
| Stage 1 | Stage 2 | Stage 3 | Total | Stage 1 | Stage 2 | Stage 3 | Total | Stage 1 | Stage 2 | Stage 3 | Total |
Barclays UK | % | % | % | % | % | % | % | % | % | % | % | % |
As at 31.12.20 | | | | | | | | | | | | |
<=75% | 75.7 | 11.6 | 0.6 | 87.9 | 17.9 | 15.0 | 19.0 | 51.9 | - | 0.1 | 1.8 | - |
>75% and <=90% | 10.8 | 0.8 | - | 11.6 | 9.7 | 14.8 | 7.6 | 32.1 | 0.1 | 1.2 | 16.0 | 0.2 |
>90% and <=100% | 0.4 | - | - | 0.4 | 0.8 | 1.5 | 2.2 | 4.5 | 0.1 | 2.6 | 35.7 | 0.7 |
>100% | 0.1 | - | - | 0.1 | 0.7 | 3.4 | 7.4 | 11.5 | 0.7 | 10.3 | 69.1 | 8.0 |
As at 31.12.19 | | | | | | | | | | | | |
<=75% | 76.0 | 10.7 | 0.7 | 87.4 | 4.2 | 15.4 | 28.5 | 48.1 | - | 0.1 | 2.2 | - |
>75% and <=90% | 10.4 | 0.7 | - | 11.1 | 2.7 | 11.5 | 12.6 | 26.8 | - | 0.9 | 19.7 | 0.1 |
>90% and <=100% | 1.3 | 0.1 | - | 1.4 | 0.8 | 2.5 | 4.9 | 8.2 | - | 1.8 | 54.4 | 0.3 |
>100% | 0.1 | - | - | 0.1 | 0.2 | 4.1 | 12.6 | 16.9 | 0.2 | 8.7 | 107.4 | 9.0 |
1 | 2019 numbers have been restated to factor in Wealth accounts to align with 2020 figures. |
2 | Portfolio marked to market based on the most updated valuation including recovery book balances. Updated valuations reflect the application of the latest HPI available as at 31 December 2020. |
New bookings reduced by 10.8% with a decrease in new flows across both portfolios: 6.1% decrease in owner occupied and 34.8% decrease in the BTL portfolio. This decrease was driven by supply and demand effects of the COVID-19 pandemic. Demand was impacted by a significant shrinking of the market in Q2 although this was partially offset by a resurgent Q3 and Q4. High LTV supply was reduced by credit management actions.
During 2020, a total of 128k payment holidays were provided to customers. At 31 December 2020, the book value of the portfolio where payment holidays remain in place was £2.2bn, representing 1.5% of the portfolio.
Head Office: Italian home loans and advances at amortised cost reduced to £5.7bn (2019: £6.0bn) and continue to run-off since new bookings ceased in 2016. The portfolio is secured on residential property with an average balance weighted mark to market LTV of 62.1% (2019: 64.4%). 90-day arrears remained broadly stable at 1.7% (2019: 1.8%) and gross charge-off rate increased to 1.0% (2019: 0.8%). At 31 December 2020, the book value of the portfolio where payment holidays remain in place was £181.7m, representing 3.2% of the portfolio.
Credit cards, unsecured loans and other retail lending
The principal portfolios listed below accounted for 84% (December 2019: 87%) of the Group's total credit cards, unsecured loans and other retail lending.
Principal portfolios | Gross exposure | 30 day arrears rate, excluding recovery book | 90 day arrears rate, excluding recovery book | Annualised gross write-off rate | Annualised net write-off rate |
As at 31.12.20 | £m | % | % | % | % |
Barclays UK | | | | | |
UK cards | 11,911 | 1.7 | 0.8 | 2.9 | 2.9 |
UK personal loans | 4,591 | 2.3 | 1.2 | 3.4 | 3.1 |
Barclays Partner Finance1 | 2,469 | 0.5 | 0.3 | 1.1 | 1.1 |
Barclays International | | | | | |
US cards | 16,845 | 2.5 | 1.4 | 5.6 | 5.6 |
Germany consumer lending | 3,458 | 1.9 | 0.8 | 1.2 | 1.1 |
| | | | | |
As at 31.12.19 | | | | | |
Barclays UK | | | | | |
UK cards | 16,457 | 1.7 | 0.8 | 1.6 | 1.6 |
UK personal loans | 6,139 | 2.1 | 1.0 | 3.2 | 2.9 |
Barclays International | | | | | |
US cards | 22,041 | 2.7 | 1.4 | 4.5 | 4.4 |
Barclays Partner Finance1 | 4,134 | 0.9 | 0.3 | 1.7 | 1.7 |
Germany consumer lending2 | 3,683 | 1.8 | 0.7 | 1.1 | 1.0 |
1 | On 1 April 2020, the Barclays Partner Finance business moved from Barclays International to Barclays UK. The 2019 comparative figures have not been restated. |
2 | 2019 Germany consumer lending numbers have been restated to include the Fundy unsecured portfolio and other adjustments to write off rates. |
UK cards: 30 and 90 day arrears rates have remained stable at 1.7% and 0.8% respectively, despite balances reducing by c.£4.5bn. Delinquency rates initially increased as some customers missed payments prior to payment holidays being initiated. Subsequently payment holidays and government support schemes were introduced, which coupled with significantly lower spend and balance growth activities have resulted in suppressed flows into delinquency cycles. Upon exit from payment holidays the majority of customers were able to resume making payments. During 2020, a total of 178k payment holidays were provided to customers. At 31 December 2020, the book value of the portfolio where payment holidays remain in place was £93m, representing 0.8% of the portfolio.
UK personal loans: 30 and 90 day arrears rates both increased by 0.2% to 2.3% and 1.2% respectively driven by a 25% reduction in overall balances, coupled with a higher flow in to delinquency of customers previously granted a payment holiday. During 2020, a total of 84k payment holidays were provided to customers. At 31 December 2020, the book value of the portfolio where payment holidays remain in place was £85.4m, representing 1.9% of the portfolio.
Barclays Partner Finance: 30 day arrears rate has reduced by 0.5% (2019: 0.9%) due to the sale of the motor financing business and the impact of payment holidays however the vast majority of these were exited and customers resumed making payments. A total of 17k payment holidays were provided to customers and 18k payment holidays were provided to motor financing business customers in the year. At 31 December 2020, the book value of the portfolio where payment holidays remain in place was £6.6m, representing 0.3% of the portfolio.
US cards: 30 days arrears rate decreased to 2.5% (2019: 2.7%) due to government support schemes and payment holidays resulting in fewer accounts entering into delinquency. 90 day arrears rate remained stable at 1.4%. Write-off rates were in line with seasonal trends. A total of 251k payment holidays were provided to customers in the year. At 31 December 2020, the book value of the portfolio where payment holidays remain in place was £54.7m, representing 0.3% of the portfolio.
Germany consumer lending: Increases in 30 and 90 days arrears rates were primarily driven by the drop in the overall balances. A total of 9k payment holidays were provided to customers in the year. At 31 December 2020, the book value of the portfolio where payment holidays remain in place was £0.24m, representing 0.01% of the portfolio.
Market Risk
Analysis of management value at risk (VaR)
The table below shows the total management VaR on a diversified basis by risk factor. Total management VaR includes all trading positions in CIB and Treasury and it is calculated with a one-day holding period.
Limits are applied against each risk factor VaR as well as total management VaR, which are then cascaded further by risk managers to each business.
Management VaR (95%) by asset class | | | | | |||
| | | | | | | |
| Year ended 31.12.20 | | Year ended 31.12.19 | ||||
| Average | High1 | Low1 | | Average | High1 | Low1 |
| £m | £m | £m | | £m | £m | £m |
Credit risk | 20 | 38 | 10 | | 12 | 17 | 8 |
Interest rate risk | 10 | 17 | 6 | | 6 | 11 | 3 |
Equity risk | 13 | 35 | 6 | | 10 | 22 | 5 |
Basis risk | 10 | 16 | 7 | | 8 | 11 | 6 |
Spread risk | 5 | 9 | 3 | | 4 | 5 | 3 |
Foreign exchange risk | 5 | 7 | 2 | | 3 | 5 | 2 |
Commodity risk | 1 | 1 | - | | 1 | 2 | - |
Inflation risk | 2 | 3 | 1 | | 2 | 3 | 1 |
Diversification effect | (34) | n/a | n/a | | (23) | n/a | n/a |
Total management VaR | 32 | 57 | 18 | | 23 | 29 | 17 |
1 | Diversification effects recognise that forecast losses from different assets or businesses are unlikely to occur concurrently, hence the expected aggregate loss is lower than the sum of the expected losses from each area. Historical correlations between losses are taken into account in making these assessments. The high and low VaR figures reported for each category did not necessarily occur on the same day as the high and low VaR reported as a whole. Consequently, a diversification effect balance for the high and low VaR figures would not be meaningful and is therefore omitted from the above table. |
Average management VaR increased to £32m in 2020 (2019: £23m), driven by an increase in market volatility in late Q1 and Q2 during the initial phase of the COVID-19 pandemic. Management VaR stabilised and declined in the second half of the year.
Treasury and Capital Risk
The Group has a comprehensive Key Risk Control Framework for managing its liquidity risk. The Liquidity Framework meets the PRA standards and is designed to maintain liquidity resources that are sufficient in amount and quality, and a funding profile that is appropriate to meet the Group's Liquidity Risk Appetite. The Liquidity Framework is delivered via a combination of policy formation, review and governance, analysis, stress testing, limit setting and monitoring.
Liquidity risk stress testing
The liquidity risk stress assessment measures the potential contractual and contingent stress outflows under a range of scenarios, which are then used to determine the size of the liquidity pool that is immediately available to meet anticipated outflows if a stress occurs. The short-term scenarios include a 30 day Barclays-specific stress event, a 90-day market-wide stress event and a 30-day combined scenario consisting of both a Barclays specific and market-wide stress event. The Group also runs a long-term liquidity stress test, which measures the anticipated outflows over a 12-month market-wide scenario.
The CRR (as amended by CRR II) LCR requirement takes into account the relative stability of different sources of funding and potential incremental funding requirements in a stress. The LCR is designed to promote short-term resilience of a bank's liquidity risk profile by holding sufficient high quality liquid assets to survive an acute stress scenario lasting for 30 days.
As at 31 December 2020, the Group held eligible liquid assets in excess of 100% of net stress outflows to its internal and external regulatory requirements.
Liquidity coverage ratio | | |
| As at 31.12.20 | As at 31.12.19 |
| £bn | £bn |
Eligible liquidity buffer | 258 | 206 |
Net stress outflows | (159) | (128) |
Surplus | 99 | 78 |
| | |
Liquidity coverage ratio | 162% | 160% |
The Group plans to maintain its surplus to the internal and regulatory stress requirements at an efficient level, while considering risks to market funding conditions and its liquidity position. The continuous reassessment of these risks may lead to execution of appropriate actions to resize the liquidity pool.
Composition of the Group liquidity pool | |||||
| As at 31.12.20 | As at 31.12.19 | |||
| Liquidity pool | Liquidity pool of which CRR LCR eligible3 | Liquidity pool | ||
| Cash | Level 1 | Level 2A | ||
| £bn | £bn | £bn | £bn | £bn |
Cash and deposits with central banks1 | 197 | 192 | - | - | 153 |
| | | | | |
Government bonds2 | | | | | |
AAA to AA- | 31 | - | 29 | 1 | 31 |
A+ to A- | 13 | - | 6 | 7 | 2 |
BBB+ to BBB- | 1 | - | 1 | - | 3 |
Total government bonds | 45 | - | 36 | 8 | 36 |
| | | | | |
Other | | | | | |
Government guaranteed issuers, PSEs and GSEs | 10 | - | 8 | 1 | 9 |
International organisations and MDBs | 6 | - | 5 | - | 7 |
Covered bonds | 8 | - | 6 | 2 | 6 |
Total other | 24 | - | 19 | 3 | 22 |
| | | | | |
Total as at 31 December 2020 | 266 | 192 | 55 | 11 | 211 |
Total as at 31 December 2019 | 211 | 150 | 50 | 3 | |
1 | Includes cash held at central banks and surplus cash at central banks related to payment schemes. Over 98% (December 2019: over 98%) was placed with the Bank of England, US Federal Reserve, European Central Bank, Bank of Japan and Swiss National Bank. |
2 | Of which over 78% (December 2019: over 79%) comprised UK, US, French, German, Japanese, Swiss and Dutch securities. |
3 | The LCR eligible liquidity pool is adjusted for trapped liquidity and other regulatory deductions. It also incorporates other CRR (as amended by CRR II) qualifying assets that are not eligible under Barclays' internal risk appetite. |
The Group liquidity pool increased to £266bn as at December 2020 (December 2019: £211bn) driven by a 16% growth in deposits, which was largely a consequence of government and central bank policy response to the COVID-19 pandemic. The reduction in Q420 reflects actions taken to manage down surplus liquidity proactively as the prevailing uncertainty from earlier in the year abated. During 2020, the month-end liquidity pool ranged from £218bn to £332bn (2019: £211bn to £225bn), and the month-end average was £287bn (2019: £235bn). The liquidity pool is held unencumbered and is not used to support payment or clearing requirements. Such requirements are treated as part of our regular business funding. The liquidity pool is intended to offset stress outflows, and comprises the above cash and unencumbered assets.
As at December 2020, 64% (December 2019: 67%) of the liquidity pool was located in Barclays Bank PLC, 23% (December 2019: 20%) in Barclays Bank UK PLC and 7% (December 2019: 6%) in Barclays Bank Ireland PLC. The residual portion of the liquidity pool is held outside of these entities, predominantly in US subsidiaries, to meet entity-specific stress outflows and local regulatory requirements. To the extent the use of this residual portion of the liquidity pool is restricted due to local regulatory requirements, it is assumed to be unavailable to the rest of the Group in calculating the LCR.
The composition of the pool is subject to limits set by the Board and the independent liquidity risk, credit risk and market risk functions. In addition, the investment of the liquidity pool is monitored for concentration by issuer, currency and asset type. Given returns generated by these highly liquid assets, the risk and reward profile is continuously managed.
Deposit funding | | | | | |
| As at 31.12.20 | | As at 31.12.19 | ||
| Loans and advances at amortised cost | Deposits at amortised cost | Loan: deposit ratio1 | | Loan: deposit ratio1 |
Funding of loans and advances | £bn | £bn | % | | % |
Barclays UK | 214 | 240 | 89% | | 96% |
Barclays International | 123 | 241 | 51% | | 63% |
Head Office | 6 | | | | |
Barclays Group | 343 | 481 | 71% | | 82% |
1 | The loan: deposit ratio is calculated as loans and advances at amortised cost divided by deposits at amortised cost. |
Composition of wholesale funding
Wholesale funding outstanding (excluding repurchase agreements) was £145.0bn (December 2019: £147.1bn). In 2020, the Group issued £7.9bn of MREL eligible instruments from Barclays PLC (the Parent company) in a range of tenors and currencies.
Our operating companies also access wholesale funding markets to maintain their stable and diversified funding bases. Barclays Bank PLC continued to issue in the shorter-term and medium-term notes markets including a $1.75bn two-year senior bond issuance in May and a $1.5bn 7.625% Contingent Capital Notes repurchase in December. Barclays Bank UK PLC continued to issue in the shorter-term markets and maintains an active secured funding programme.
Wholesale funding of £42.7bn (December 2019: £40.6bn) matures in less than one year, representing 29% (December 2019: 28%) of total wholesale funding outstanding. This includes £20.3bn (December 2019: £16.3bn) related to term funding2. Although not a requirement, the liquidity pool exceeded wholesale funding maturing in less than one year by £223bn (December 2019: £170bn).
Maturity profile of wholesale funding1,2 | | | | | | | | ||||
| <1 | 1-3 | 3-6 | 6-12 | <1 | 1-2 | 2-3 | 3-4 | 4-5 | >5 | |
| month | months | months | months | year | years | years | years | years | years | Total |
| £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
Barclays PLC (the Parent company) | | | | | | | | | | | |
Senior unsecured (public benchmark) | 1.1 | 1.1 | - | 1.2 | 3.4 | 1.4 | 7.7 | 5.6 | 5.1 | 13.5 | 36.7 |
Senior unsecured (privately placed) | 0.1 | - | - | 0.1 | 0.2 | - | 0.2 | 0.2 | - | 0.7 | 1.3 |
Subordinated liabilities | - | - | - | - | - | - | - | 0.9 | - | 6.8 | 7.7 |
Barclays Bank PLC (including subsidiaries) | | | | | | | | | | | |
Certificates of deposit and commercial paper | - | 5.4 | 3.1 | 5.6 | 14.1 | 0.5 | 0.1 | - | - | - | 14.7 |
Asset backed commercial paper | 1.4 | 5.0 | 0.7 | - | 7.1 | - | - | - | - | - | 7.1 |
Senior unsecured (public benchmark) | - | 0.5 | 0.1 | 0.1 | 0.7 | 1.3 | 0.1 | 1.1 | - | 0.9 | 4.1 |
Senior unsecured (privately placed)3 | 0.8 | 2.3 | 2.2 | 4.2 | 9.5 | 7.1 | 6.4 | 3.9 | 4.9 | 21.7 | 53.5 |
Asset backed securities | - | - | - | 0.5 | 0.5 | 0.8 | 0.4 | 0.5 | 0.2 | 1.4 | 3.8 |
Subordinated liabilities | 1.4 | 0.2 | 3.2 | 0.3 | 5.1 | 2.2 | - | 0.1 | - | 1.2 | 8.6 |
Barclays Bank UK PLC (including subsidiaries) | | | | | | | | | | | |
Certificates of deposit and commercial paper | - | 0.9 | 0.2 | 0.1 | 1.2 | - | - | - | - | - | 1.2 |
Senior unsecured (Public benchmark) | - | - | - | - | - | - | - | - | - | 0.1 | 0.1 |
Covered bonds | 0.9 | - | - | - | 0.9 | 2.3 | 1.8 | - | - | 1.2 | 6.2 |
Total as at 31 December 2020 | 5.7 | 15.4 | 9.5 | 12.1 | 42.7 | 15.6 | 16.7 | 12.3 | 10.2 | 47.5 | 145.0 |
Of which secured | 2.3 | 5.0 | 0.7 | 0.5 | 8.5 | 3.1 | 2.2 | 0.5 | 0.2 | 2.6 | 17.1 |
Of which unsecured | 3.4 | 10.4 | 8.8 | 11.6 | 34.2 | 12.5 | 14.5 | 11.8 | 10.0 | 44.9 | 127.9 |
| | | | | | | | | | | |
Total as at 31 December 2019 | 4.5 | 11.6 | 9.4 | 15.1 | 40.6 | 19.8 | 12.1 | 15.1 | 11.6 | 47.9 | 147.1 |
Of which secured | 1.6 | 5.3 | 2.3 | 0.5 | 9.7 | 0.9 | 2.5 | 2.4 | 0.9 | 3.2 | 19.6 |
Of which unsecured | 2.9 | 6.3 | 7.1 | 14.6 | 30.9 | 18.9 | 9.6 | 12.7 | 10.7 | 44.7 | 127.5 |
1 | The composition of wholesale funds comprises the balance sheet reported financial liabilities at fair value, debt securities in issue and subordinated liabilities. It does not include participation in the central bank facilities reported within repurchase agreements and other similar secured borrowing. |
2 | Term funding comprises public benchmark and privately placed senior unsecured notes, covered bonds, asset-backed securities and subordinated debt where the original maturity of the instrument is more than 1 year. |
3 | Includes structured notes of £45.4bn, of which £8.7bn matures within one year. |
Capital
Minimum requirements
The Group's Overall Capital Requirement for CET1 is 11.2% comprising a 4.5% Pillar 1 minimum, a 2.5% Capital Conservation Buffer (CCB), a 1.5% Global Systemically Important Institution (G-SII) buffer, a 2.7% Pillar 2A requirement and a 0.0% Countercyclical Capital Buffer (CCyB).
The Group's CCyB is based on the buffer rate applicable for each jurisdiction in which the Group has exposures. On 11 March 2020, the Financial Policy Committee (FPC) set the CCyB rate for UK exposures at 0% with immediate effect. The buffer rates set by other national authorities for non-UK exposures are not currently material. Overall, this results in a 0.0% CCyB for the Group.
The Group's Pillar 2A requirement as per the PRA's Individual Capital Requirement is 4.8% of which at least 56.25% needs to be met with CET1 capital, equating to approximately 2.7% of RWAs. The Pillar 2A requirement is subject to at least annual review and has been set as a nominal capital amount. This is based on a point in time assessment and the requirement (when expressed as a proportion of RWAs) will change depending on the total RWAs at each reporting period.
Significant regulatory updates in the period
Under the withdrawal agreement between the UK and the EU, the 11-month transition period expired at 11pm on 31 December 2020. Any references to CRR as amended by CRR II mean, unless otherwise specified, CRR as amended by CRR II, as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018 and subject to the temporary transitional powers (TTP) available to UK regulators to delay or phase-in on-shoring changes to UK regulatory requirements arising at the end of the transition period until 31 March 2022, as at the applicable reporting date. Throughout the TTP period, the Bank of England (BoE) and PRA are expected to review the UK legislation framework and any disclosures made by the Group will be subject to any resulting guidance.
The following regulatory updates formed part of CRR as amended by CRR II prior to 31 December 2020 and subsequently form part of UK law as defined above.
On 22 April 2020, the regulatory technical standards on prudent valuation were amended to include an increase to diversification factors applied to certain additional valuation adjustments. The amendments temporarily reduced the additional value adjustment deduction (PVA) and were applied until 31 December 2020 inclusive.
On 27 June 2020, CRR as amended by CRR II, was further amended to accelerate specific CRR II measures and implement a new IFRS 9 transitional relief calculation. Previously due to be implemented in June 2021, the accelerated measures primarily relate to non-deduction of prudently valued software assets from CET1 capital, the CRR leverage calculation to include additional settlement netting and limited changes to the calculation of RWAs. For UK leverage calculations, the PRA early adopted the CRR II settlement netting measure in April 2020.
The IFRS 9 transitional arrangements have been extended by two years and a new modified calculation has been introduced. 100% relief will be applied to increases in Stage 1 and Stage 2 provisions from 1 January 2020 throughout 2020 and 2021; 75% in 2022; 50% in 2023; 25% in 2024 with no relief applied from 2025. The phasing out of transitional relief on the "day 1" impact of IFRS 9 as well as increases in Stage 1 and Stage 2 provisions between 1 January 2018 and 31 December 2019 under the modified calculation remain unchanged and continue to be subject to 70% transitional relief throughout 2020; 50% for 2021; 25% for 2022 and with no relief applied from 2023.
On 23 December 2020, a new regulatory technical standard on the prudential treatment of qualifying software assets was adopted into EU law replacing the CET1 capital deduction with prudential amortisation up to a 3-year period. Intangible assets that are no longer deducted are subject to 100% risk weight instead.
Following its stated intention to consult, on 12 February 2021 the PRA launched a consultation on certain items within the Basel standards that remain to be implemented in the UK as well as setting out proposed new PRA CRR rules. The proposals include reverting to the previous treatment of 100% CET1 capital deduction for qualifying software assets by the end of 2021, meaning the benefit in the CET1 ratio is likely to be reversed in future periods.
Capital ratios1,2,3 | As at | As at | As at |
31.12.20 | 30.09.20 | 31.12.19 | |
CET1 | 15.1% | 14.6% | 13.8% |
Tier 1 (T1) | 19.0% | 18.7% | 17.7% |
Total regulatory capital | 22.1% | 22.5% | 21.6% |
| | | |
Capital resources | £m | £m | £m |
Total equity excluding non-controlling interests per the balance sheet | 65,797 | 67,816 | 64,429 |
Less: other equity instruments (recognised as AT1 capital) | (11,172) | (12,012) | (10,871) |
Adjustment to retained earnings for foreseeable dividends and other equity coupons | (204) | (65) | (1,096) |
| | | |
Other regulatory adjustments and deductions | | | |
Additional value adjustments (PVA) | (1,146) | (1,241) | (1,746) |
Goodwill and intangible assets | (6,914) | (8,154) | (8,109) |
Deferred tax assets that rely on future profitability excluding temporary differences | (595) | (422) | (479) |
Fair value reserves related to gains or losses on cash flow hedges | (1,575) | (1,745) | (1,002) |
Gains or losses on liabilities at fair value resulting from own credit | 870 | 717 | 260 |
Defined benefit pension fund assets | (1,326) | (1,785) | (1,594) |
Direct and indirect holdings by an institution of own CET1 instruments | (50) | (50) | (50) |
Adjustment under IFRS 9 transitional arrangements | 2,556 | 2,512 | 1,126 |
Other regulatory adjustments | 55 | (62) | (55) |
CET1 capital | 46,296 | 45,509 | 40,813 |
| | | |
AT1 capital | | | |
Capital instruments and related share premium accounts | 11,172 | 12,012 | 10,871 |
Qualifying AT1 capital (including minority interests) issued by subsidiaries | 646 | 622 | 687 |
Other regulatory adjustments and deductions | (80) | (80) | (130) |
AT1 capital | 11,738 | 12,554 | 11,428 |
| | | |
T1 capital | 58,034 | 58,063 | 52,241 |
| | | |
T2 capital | | | |
Capital instruments and related share premium accounts | 7,836 | 9,451 | 7,650 |
Qualifying T2 capital (including minority interests) issued by subsidiaries | 1,893 | 2,516 | 3,984 |
Credit risk adjustments (excess of impairment over expected losses) | 57 | 36 | 16 |
Other regulatory adjustments and deductions | (160) | (160) | (250) |
Total regulatory capital | 67,660 | 69,906 | 63,641 |
| | | |
Total RWAs | 306,203 | 310,727 | 295,131 |
1 | CET1, T1 and T2 capital, and RWAs are calculated applying the transitional arrangements of the CRR as amended by CRR II. This includes IFRS 9 transitional arrangements and the grandfathering of CRR and CRR II non-compliant capital instruments. |
2 | The fully loaded CET1 ratio, as is relevant for assessing against the conversion trigger in Barclays PLC AT1 securities, was 14.3%, with £43.7bn of CET1 capital and £305.3bn of RWAs calculated without applying the transitional arrangements of the CRR as amended by CRR II. |
3 | The Group's CET1 ratio, as is relevant for assessing against the conversion trigger in Barclays Bank PLC 7.625% Contingent Capital Notes, was 15.1%. For this calculation CET1 capital and RWAs are calculated applying the transitional arrangements under the CRR as amended by CRR II, including the IFRS 9 transitional arrangements. The benefit of the Financial Services Authority (FSA) October 2012 interpretation of the transitional provisions, relating to the implementation of CRD IV, expired in December 2017. |
Movement in CET1 capital | Three months | Year |
ended | ended | |
31.12.20 | 31.12.20 | |
£m | £m | |
Opening CET1 capital | 45,509 | 40,813 |
| | |
Profit for the period attributable to equity holders | 446 | 2,383 |
Own credit relating to derivative liabilities | 10 | 29 |
Dividends and other equity coupons paid and foreseen | (365) | 35 |
Increase in retained regulatory capital generated from earnings | 91 | 2,447 |
| | |
Net impact of share schemes | 95 | 115 |
Fair value through other comprehensive income reserve | 397 | 192 |
Currency translation reserve | (977) | (473) |
Other reserves | (42) | (48) |
Decrease in other qualifying reserves | (527) | (214) |
| | |
Pension remeasurements within reserves | (433) | (111) |
Defined benefit pension fund asset deduction | 459 | 268 |
Net impact of pensions | 26 | 157 |
| | |
Additional value adjustments (PVA) | 95 | 600 |
Goodwill and intangible assets | 1,240 | 1,195 |
Deferred tax assets that rely on future profitability excluding those arising from temporary differences | (173) | (116) |
Adjustment under IFRS 9 transitional arrangements | 44 | 1,430 |
Other regulatory adjustments | (9) | (16) |
Increase in regulatory capital due to adjustments and deductions | 1,197 | 3,093 |
| | |
Closing CET1 capital | 46,296 | 46,296 |
| | |
CET1 capital increased £5.5bn to £46.3bn (December 2019: £40.8bn).
£2.4bn of capital generated from profits, and a £1.0bn increase due to the cancellation of the full year 2019 dividend were partially offset by £0.9bn of AT1 coupons paid and £0.2bn dividends foreseen for the announced 2020 full year dividend. Other significant movements in the period were:
· | A £0.5bn decrease in the currency translation reserve mainly driven by the depreciation of period end USD against GBP |
· | A £0.6bn increase due to a reduction in PVA which includes the temporary increase to diversification factors applied to certain additional valuation adjustments |
· | A £1.2bn increase due to a reduction in the goodwill and intangible assets deduction driven by a new regulatory technical standard replacing the deduction with prudential amortisation up to a 3-year period on qualifying software assets |
· | A £1.4bn increase in the IFRS 9 transitional relief after tax, following new impairment charges and the implementation of new regulatory measures which allow for 100% relief on increases in stage 1 and stage 2 impairment throughout 2020 and 2021 |
RWAs by risk type and business | |||||||||||||
| Credit risk | | Counterparty credit risk | | Market risk | | Operational risk | Total RWAs | |||||
| Std | IRB | | Std | IRB | Settlement risk | CVA | | Std | IMA | | | |
As at 31.12.20 | £m | £m | | £m | £m | £m | £m | | £m | £m | | £m | £m |
Barclays UK | 7,360 | 54,340 | | 394 | - | - | 136 | | 72 | - | | 11,359 | 73,661 |
Corporate and Investment Bank | 24,660 | 73,792 | | 12,047 | 20,280 | 246 | 2,351 | | 13,123 | 22,363 | | 23,343 | 192,205 |
Consumer, Cards and Payments | 19,754 | 3,041 | | 177 | 45 | - | 31 | | - | 71 | | 6,996 | 30,115 |
Barclays International | 44,414 | 76,833 | | 12,224 | 20,325 | 246 | 2,382 | | 13,123 | 22,434 | | 30,339 | 222,320 |
Head Office | 4,153 | 6,869 | | - | - | - | - | | - | - | | (800) | 10,222 |
Barclays Group | 55,927 | 138,042 | | 12,618 | 20,325 | 246 | 2,518 | | 13,195 | 22,434 | | 40,898 | 306,203 |
| | | | | | | | | | | | | |
As at 30.09.20 | | | | | | | | | | | | | |
Barclays UK | 7,350 | 56,373 | | 369 | - | - | 100 | | 125 | - | | 11,851 | 76,168 |
Corporate and Investment Bank | 24,800 | 76,464 | | 11,628 | 20,645 | 106 | 2,545 | | 13,043 | 22,709 | | 21,388 | 193,328 |
Consumer, Cards and Payments | 20,597 | 2,921 | | 168 | 47 | - | 35 | | - | 75 | | 7,538 | 31,381 |
Barclays International | 45,397 | 79,385 | | 11,796 | 20,692 | 106 | 2,580 | | 13,043 | 22,784 | | 28,926 | 224,709 |
Head Office | 3,701 | 6,022 | | - | - | - | - | | - | - | | 127 | 9,850 |
Barclays Group | 56,448 | 141,780 | | 12,165 | 20,692 | 106 | 2,680 | | 13,168 | 22,784 | | 40,904 | 310,727 |
| | | | | | | | | | | | | |
As at 31.12.19 | | | | | | | | ||||||
Barclays UK | 5,189 | 57,455 | | 235 | - | - | 23 | | 178 | - | | 11,821 | 74,901 |
Corporate and Investment Bank | 25,749 | 62,177 | | 12,051 | 16,875 | 276 | 2,470 | | 12,854 | 17,626 | | 21,475 | 171,553 |
Consumer, Cards and Payments | 27,209 | 2,706 | | 92 | 37 | - | 11 | | - | 103 | | 7,532 | 37,690 |
Barclays International | 52,958 | 64,883 | | 12,143 | 16,912 | 276 | 2,481 | | 12,854 | 17,729 | | 29,007 | 209,243 |
Head Office | 5,104 | 5,754 | | - | - | - | - | | - | - | | 129 | 10,987 |
Barclays Group | 63,251 | 128,092 | | 12,378 | 16,912 | 276 | 2,504 | | 13,032 | 17,729 | | 40,957 | 295,131 |
Movement analysis of RWAs | |||||
| Credit risk | Counterparty credit risk | Market risk | Operational risk | Total RWAs |
| £m | £m | £m | £m | £m |
Opening RWAs (as at 31.12.19) | 191,343 | 32,070 | 30,761 | 40,957 | 295,131 |
Book size | (6,573) | 2,232 | 9,188 | (59) | 4,788 |
Acquisitions and disposals | (165) | - | - | - | (165) |
Book quality | 9,081 | 1,365 | - | - | 10,446 |
Model updates | 2,796 | 150 | - | - | 2,946 |
Methodology and policy | (851) | (110) | (4,320) | - | (5,281) |
Foreign exchange movements1 | (1,662) | - | - | - | (1,662) |
Total RWA movements | 2,626 | 3,637 | 4,868 | (59) | 11,072 |
Closing RWAs (as at 31.12.20) | 193,969 | 35,707 | 35,629 | 40,898 | 306,203 |
1 | Foreign exchange movements do not include foreign exchange for counterparty credit risk or market risk. |
Overall RWAs increased £11.1bn to £306.2bn (December 2019: £295.1bn). Significant movements in the period were:
Credit risk RWAs increased £2.6bn:
· | A £6.6bn decrease in book size primarily due to lower consumer lending partially offset by growth in mortgages within BUK |
· | A £9.1bn increase in book quality due to a reduction in credit quality primarily within CIB |
· | A £2.8bn increase in model updates primarily due to modelled risk weight recalibrations |
· | A £0.9bn decrease in methodology and policy primarily due the application of revised SME discount factors under CRR II, partially offset by an increase due to the risk weighting of qualifying software assets that are no longer deducted from CET1 capital |
· | A £1.7bn decrease due to the depreciation of period end USD against GBP |
Counterparty credit risk RWAs increased £3.6bn:
· | A £2.2bn increase in book size primarily due to an increase in trading activities across SFTs and derivatives |
· | A £1.4bn increase in book quality primarily due to a reduction in credit quality within CIB |
Market risk RWAs increased £4.9bn:
· | A £9.2bn increase in book size primarily due to an increase in trading activities and higher market volatility |
· | A £4.3bn decrease in methodology and policy primarily due to the removal of a Risk Not In VaR (RNIV) and a reduction in pre COVID-19 VaR backtesting exceptions |
Leverage ratio and exposures
The Group is subject to a leverage ratio requirement of 3.8% as at 31 December 2020. This comprises the 3.25% minimum requirement, a G-SII additional leverage ratio buffer (G-SII ALRB) of 0.53% and a countercyclical leverage ratio buffer of 0.0%. Although the leverage ratio is expressed in terms of T1 capital, 75% of the minimum requirement, equating to 2.4375%, needs to be met with CET1 capital. In addition, the G-SII ALRB must be covered solely with CET1 capital. The CET1 capital held against the 0.53% G-SII ALRB was £6.0bn.
The Group is required to disclose an average UK leverage ratio which is based on capital on the last day of each month in the quarter and an exposure measure for each day in the quarter. The Group is also required to disclose a UK leverage ratio based on capital and exposure on the last day of the quarter. Both approaches exclude qualifying claims on central banks from the leverage exposures and include the PRA's early adoption of CRR II settlement netting. The FPC intends to review the UK leverage framework in 2021.
Leverage ratios1,2 | As at 31.12.20 | As at 30.09.20 | As at 31.12.19 |
£m | £m | £m | |
Average UK leverage ratio | 5.0% | 5.1% | 4.5% |
Average T1 capital3 | 57,069 | 56,690 | 51,823 |
Average UK leverage exposure | 1,146,919 | 1,111,052 | 1,142,819 |
| | | |
UK leverage ratio | 5.3% | 5.2% | 5.1% |
| | | |
CET1 capital | 46,296 | 45,509 | 40,813 |
AT1 capital | 11,092 | 11,932 | 10,741 |
T1 capital3 | 57,388 | 57,441 | 51,554 |
| | | |
UK leverage exposure | 1,090,907 | 1,095,097 | 1,007,721 |
| | | |
UK leverage exposure | | | |
Accounting assets | | | |
Derivative financial instruments | 302,446 | 296,551 | 229,236 |
Derivative cash collateral | 64,798 | 67,034 | 56,589 |
Securities financing transactions (SFTs) | 164,034 | 178,736 | 111,307 |
Loans and advances and other assets | 818,236 | 879,348 | 743,097 |
Total IFRS assets | 1,349,514 | 1,421,669 | 1,140,229 |
| | | |
Regulatory consolidation adjustments | (1,144) | (1,943) | (1,170) |
| | | |
Derivatives adjustments | | | |
Derivatives netting | (272,275) | (269,441) | (207,756) |
Adjustments to cash collateral | (57,414) | (58,298) | (48,464) |
Net written credit protection | 14,986 | 15,890 | 13,784 |
Potential future exposure (PFE) on derivatives | 117,010 | 122,426 | 119,118 |
Total derivatives adjustments | (197,693) | (189,423) | (123,318) |
| | | |
SFTs adjustments | 21,114 | 20,274 | 18,339 |
| | | |
Regulatory deductions and other adjustments | (17,469) | (18,011) | (11,984) |
| | | |
Weighted off-balance sheet commitments | 113,704 | 110,749 | 105,289 |
| | | |
Qualifying central bank claims | (155,890) | (205,451) | (119,664) |
| | | |
Settlement netting | (21,229) | (42,767) | - |
| | | |
UK leverage exposure | 1,090,907 | 1,095,097 | 1,007,721 |
1 | Fully loaded average UK leverage ratio was 4.8%, with £54.6bn of T1 capital and £1,144bn of leverage exposure. Fully loaded UK leverage ratio was 5.0%, with £54.8bn of T1 capital and £1,088bn of leverage exposure. Fully loaded UK leverage ratios are calculated without applying the transitional arrangements of the CRR as amended by CRR II. |
2 | Capital and leverage measures are calculated applying the transitional arrangements of the CRR as amended by CRR II. |
3 | T1 capital is calculated in line with the PRA Handbook. |
The average UK leverage ratio increased to 5.0% (December 2019: 4.5%) primarily driven by the increase in T1 capital. The average leverage exposure increased to £1,147bn (December 2019: £1,143bn) primarily driven by an increase in SFTs and TPAs largely driven by an increase in secured lending and client activity within CIB, partially offset by the PRA's early adoption of CRR II settlement netting.
The UK leverage ratio increased to 5.3% (December 2019: 5.1%) primarily driven by an increase of £5.8bn in Tier 1 capital partially offset by an increase in the UK leverage exposure of £83.2bn.
The UK leverage exposure increase of £83.2bn was primarily driven by:
· | A £52.7bn increase in SFTs and £75.1bn of loans advances and other; partially offset by |
· | A £36.2bn decrease due to the exemption of qualifying central bank claims; and |
· | A £21.2bn decrease due to the PRA's adoption of CRR II settlement netting |
The Group also discloses a CRR leverage ratio1 within its additional regulatory disclosures prepared in accordance with EBA guidelines on disclosure under Part Eight of the CRR (see Barclays PLC Pillar 3 Report 2020, due to be published on 18 February 2021 and which will be available at home.barclays/investor-relations/reports-and-events/latest-financial-results).
1 | CRR leverage ratio as amended by CRR II. |
MREL
The Group is required to meet the higher of: (i) the requirements set by the BoE based on RWAs and the higher of average and UK leverage exposures; and (ii) the requirements in CRR as amended by CRR II based on RWAs and CRR leverage exposures. The MREL requirements are subject to phased implementation and will be fully implemented by 1 January 2022.
On 19 January 2021 the BoE published indicative MREL requirements that show the Group's highest requirement in 2022 will be 7.70% of CRR leverage exposure, based on 30 September 2020 exposures. The BoE is currently reviewing the MREL calibration and intends to make any policy changes by the end of 2021. Separately, the FPC intends to review the UK leverage framework in 2021 and this, along with any MREL policy changes, may result in a different MREL requirement from 1 January 2022 than that which is currently proposed. CET1 capital cannot be counted towards both MREL and the capital buffers, meaning that the buffers will effectively be applied above MREL requirements.
Own funds and eligible liabilities ratios1,2 | As a percentage of RWAs | | As a percentage of CRR leverage exposure | ||||
As at 31.12.20 | As at 30.09.20 | As at 31.12.19 | | As at 31.12.20 | As at 30.09.20 | As at 31.12.19 | |
Total Barclays PLC (the Parent company) own funds and eligible liabilities | 32.7% | 32.8% | 31.2% | | 8.0% | 7.8% | 8.2% |
Total own funds and eligible liabilities, including eligible Barclays Bank PLC instruments3 | 33.6% | 33.8% | 32.8% | | 8.2% | 8.0% | 8.6% |
| | | | | | | |
| | | | | | | |
Own funds and eligible liabilities1,2 | | | | | As at 31.12.20 | As at 30.09.20 | As at 31.12.19 |
| | | | | £m | £m | £m |
CET1 capital | | 46,296 | 45,509 | 40,813 | |||
AT1 capital instruments and related share premium accounts4 | | 11,092 | 11,932 | 10,741 | |||
T2 capital instruments and related share premium accounts4 | | 7,733 | 9,327 | 7,416 | |||
Eligible liabilities | | 35,086 | 35,209 | 33,025 | |||
Total Barclays PLC (the Parent company) own funds and eligible liabilities | | 100,207 | 101,977 | 91,995 | |||
Qualifying AT1 capital (including minority interests) issued by subsidiaries | | 646 | 622 | 687 | |||
Qualifying T2 capital (including minority interests) issued by subsidiaries | | 1,893 | 2,516 | 3,984 | |||
Total own funds and eligible liabilities, including eligible Barclays Bank PLC instruments3 | | 102,746 | 105,115 | 96,666 | |||
| | | | | | | |
Total RWAs | | 306,203 | 310,727 | 295,131 | |||
Total CRR leverage exposure5 | | 1,254,157 | 1,306,828 | 1,126,259 |
1 | CET1, T1 and T2 capital, and RWAs are calculated applying the transitional arrangements of the CRR as amended by CRR II. This includes IFRS 9 transitional arrangements and the grandfathering of CRR and CRR II non-compliant capital instruments. |
2 | The BoE has set external MREL based on the higher of RWAs and CRR or UK leverage exposures which could result in the binding measure changing in future periods. The 31 December 2020 Barclays PLC (the Parent company) own funds and eligible liabilities ratio as a percentage of the UK leverage exposure was 9.2% and as a percentage of the average UK leverage exposure was 8.7%. |
3 | Own funds instruments issued by subsidiaries will not be counted towards MREL from 1 January 2022. |
4 | Includes other AT1 capital regulatory adjustments and deductions of £80m (December 2019: £130m), and other T2 credit risk adjustments and deductions of £103m (December 2019: £234m). |
5 | Fully loaded CRR leverage exposure is calculated without applying the transitional arrangements of the CRR as amended by CRR II. |
Statement of Directors' Responsibilities
Each of the Directors (the names of whom are set out below) confirm that:
· | to the best of their knowledge, the condensed consolidated financial statements (set out on pages 54 to 58), which have been prepared in accordance with international accounting standards in conformity with the requirements of the Companies Act 2006 and international financial reporting standards adopted pursuant to Regulation (EC) No. 1606/2002 as it applies in the European Union, give a true and fair view of the assets, liabilities, financial position and profit or loss of the Company and the undertakings included in the consolidation taken as a whole. The condensed consolidated financial statements should be read in conjunction with the annual financial statements as included in the Annual Report for the year ended 31 December 2020; and |
· | to the best of their knowledge, the management information (set out on pages 1 to 52) includes a fair review of the development and performance of the business and the position of the Company and the undertakings included in the consolidation taken as a whole, together with a description of the principal risks and uncertainties that they face. This management information should be read in conjunction with the principal risks and uncertainties included in the Annual Report for the year ended 31 December 2020. |
Signed on behalf of the Board by
James E Staley | Tushar Morzaria |
Group Chief Executive | Group Finance Director |
Barclays PLC Board of Directors:
Chairman | Executive Directors | Non-executive Directors |
Nigel Higgins | James E Staley | Mike Ashley |
| Tushar Morzaria | Tim Breedon CBE |
| | Sir Ian Cheshire |
| | Mohamed A. El-Erian |
| | Dawn Fitzpatrick |
| | Mary Francis CBE |
| | Crawford Gillies |
| | Brian Gilvary |
| | Diane Schueneman |
Condensed Consolidated Financial Statements
Condensed consolidated income statement | |||
| | Year ended | Year ended |
| | 31.12.20 | 31.12.19 |
| Notes1 | £m | £m |
Interest and similar income | | 11,892 | 15,456 |
Interest and similar expense | | (3,770) | (6,049) |
Net interest income | | 8,122 | 9,407 |
Fee and commission income | | 8,641 | 9,122 |
Fee and commission expense | | (2,070) | (2,362) |
Net fee and commission income | | 6,571 | 6,760 |
Net trading income | | 7,029 | 4,235 |
Net investment income | | 13 | 1,131 |
Other income | | 31 | 99 |
Total income | | 21,766 | 21,632 |
Credit impairment charges | | (4,838) | (1,912) |
Net operating income | | 16,928 | 19,720 |
| | | |
Staff costs | | (8,097) | (8,315) |
Infrastructure, administration and general expenses | | (5,636) | (5,270) |
Litigation and conduct | | (153) | (1,849) |
Operating expenses | | (13,886) | (15,434) |
| | | |
Share of post-tax results of associates and joint ventures | | 6 | 61 |
Profit on disposal of subsidiaries, associates and joint ventures | | 17 | 10 |
Profit before tax | | 3,065 | 4,357 |
Tax charge | 1 | (604) | (1,003) |
Profit after tax | | 2,461 | 3,354 |
| | | |
Attributable to: | | | |
Equity holders of the parent | | 1,526 | 2,461 |
Other equity instrument holders | | 857 | 813 |
Total equity holders of the parent | | 2,383 | 3,274 |
Non-controlling interests | 2 | 78 | 80 |
Profit after tax | | 2,461 | 3,354 |
| | | |
Earnings per share | | p | p |
Basic earnings per ordinary share | 3 | 8.8 | 14.3 |
Diluted earnings per ordinary share | 3 | 8.6 | 14.1 |
1 | For notes to the Financial Statements see pages 59 to 64. |
Condensed consolidated statement of comprehensive income | |||
| | | |
| | Year ended | Year ended |
| | 31.12.20 | 31.12.19 |
| Notes1 | £m | £m |
Profit after tax | | 2,461 | 3,354 |
| | | |
Other comprehensive income/(loss) that may be recycled to profit or loss:2 | | | |
Currency translation reserve | 11 | (473) | (544) |
Fair value through other comprehensive income reserve relating to debt securities | 11 | 454 | 166 |
Cash flow hedging reserve | 11 | 573 | 342 |
Other | 11 | 5 | 16 |
Other comprehensive income/(loss) that may be recycled to profit or loss | | 559 | (20) |
| | | |
Other comprehensive income/(loss) not recycled to profit or loss:2 | | | |
Retirement benefit remeasurements | 8 | (111) | (194) |
Fair value through other comprehensive income reserve relating to equity instruments | 11 | (262) | (95) |
Own credit | 11 | (581) | (252) |
Other comprehensive income/(loss) not recycled to profit or loss | | (954) | (541) |
| | | |
Other comprehensive income/(loss) for the period | | (395) | (561) |
| | | |
Total comprehensive income for the period | | 2,066 | 2,793 |
| | | |
Attributable to: | | | |
Equity holders of the parent | | 1,988 | 2,713 |
Non-controlling interests | | 78 | 80 |
Total comprehensive income for the period | | 2,066 | 2,793 |
1 | For notes to the Financial Statements see pages 59 to 64. |
2 | Reported net of tax. |
Condensed consolidated balance sheet | |||
| | As at | As at |
| | 31.12.20 | 31.12.19 |
Assets | Notes1 | £m | £m |
Cash and balances at central banks | | 191,127 | 150,258 |
Cash collateral and settlement balances | | 101,367 | 83,256 |
Loans and advances at amortised cost | | 342,632 | 339,115 |
Reverse repurchase agreements and other similar secured lending | | 9,031 | 3,379 |
Trading portfolio assets | | 127,950 | 114,195 |
Financial assets at fair value through the income statement | | 175,151 | 133,086 |
Derivative financial instruments | | 302,446 | 229,236 |
Financial assets at fair value through other comprehensive income | | 78,688 | 65,750 |
Investments in associates and joint ventures | | 781 | 721 |
Goodwill and intangible assets | | 7,948 | 8,119 |
Property, plant and equipment | | 4,036 | 4,215 |
Current tax assets | | 477 | 412 |
Deferred tax assets | 1 | 3,444 | 3,290 |
Retirement benefit assets | 8 | 1,814 | 2,108 |
Other assets | | 2,622 | 3,089 |
Total assets | | 1,349,514 | 1,140,229 |
| | | |
Liabilities | | | |
Deposits at amortised cost | | 481,036 | 415,787 |
Cash collateral and settlement balances | | 85,423 | 67,341 |
Repurchase agreements and other similar secured borrowing | | 14,174 | 14,517 |
Debt securities in issue | | 75,796 | 76,369 |
Subordinated liabilities | 6 | 16,341 | 18,156 |
Trading portfolio liabilities | | 47,405 | 36,916 |
Financial liabilities designated at fair value | | 249,765 | 204,326 |
Derivative financial instruments | | 300,775 | 229,204 |
Current tax liabilities | | 645 | 313 |
Deferred tax liabilities | 1 | 15 | 23 |
Retirement benefit liabilities | 8 | 291 | 348 |
Other liabilities | | 8,662 | 8,505 |
Provisions | 7 | 2,304 | 2,764 |
Total liabilities | | 1,282,632 | 1,074,569 |
| | | |
Equity | | | |
Called up share capital and share premium | 9 | 4,637 | 4,594 |
Other reserves | 11 | 4,461 | 4,760 |
Retained earnings | | 45,527 | 44,204 |
Shareholders' equity attributable to ordinary shareholders of the parent | | 54,625 | 53,558 |
Other equity instruments | 10 | 11,172 | 10,871 |
Total equity excluding non-controlling interests | | 65,797 | 64,429 |
Non-controlling interests | 2 | 1,085 | 1,231 |
Total equity | | 66,882 | 65,660 |
| | | |
Total liabilities and equity | | 1,349,514 | 1,140,229 |
1 | For notes to the Financial Statements see pages 59 to 64. |
Condensed consolidated statement of changes in equity | |||||||
| Called up share capital and share premium1 | Other equity instruments1 | Other reserves1 | Retained earnings | Total | Non-controlling interests2 | Total equity |
Year ended 31.12.20 | £m | £m | £m | £m | £m | £m | £m |
Balance as at 1 January 2020 | 4,594 | 10,871 | 4,760 | 44,204 | 64,429 | 1,231 | 65,660 |
Profit after tax | - | 857 | - | 1,526 | 2,383 | 78 | 2,461 |
Retirement benefit remeasurements | - | - | - | (111) | (111) | - | (111) |
Other comprehensive profit after tax for the year | - | - | (289) | 5 | (284) | - | (284) |
Total comprehensive income for the period | - | 857 | (289) | 1,420 | 1,988 | 78 | 2,066 |
Equity settled share schemes and hedges thereof | 43 | - | - | 303 | 346 | - | 346 |
Issue and exchange of other equity instruments | - | 311 | - | (55) | 256 | (158) | 98 |
Other equity instruments coupons paid | - | (857) | - | - | (857) | - | (857) |
Vesting of shares under employee share schemes | - | - | (10) | (347) | (357) | - | (357) |
Dividends paid | - | - | - | - | - | (79) | (79) |
Other movements | - | (10) | - | 2 | (8) | 13 | 5 |
Balance as at 31 December 2020 | 4,637 | 11,172 | 4,461 | 45,527 | 65,797 | 1,085 | 66,882 |
| | | | | | | |
Year ended 31.12.19 | | | | | | | |
Balance as at 1 January 2019 | 4,311 | 9,632 | 5,153 | 43,460 | 62,556 | 1,223 | 63,779 |
Profit after tax | - | 813 | - | 2,461 | 3,274 | 80 | 3,354 |
Other comprehensive profit after tax for the year | - | - | (383) | (178) | (561) | - | (561) |
Total comprehensive income for the period | - | 813 | (383) | 2,283 | 2,713 | 80 | 2,793 |
Issue of new ordinary shares | 182 | - | - | - | 182 | - | 182 |
Equity settled share schemes | 101 | - | - | 478 | 579 | - | 579 |
Issue and exchange of other equity instruments | - | 1,238 | - | (406) | 832 | - | 832 |
Other equity instruments coupons paid | - | (813) | - | - | (813) | - | (813) |
Vesting of shares under employee share schemes | - | - | (10) | (404) | (414) | - | (414) |
Dividends paid | - | - | - | (1,201) | (1,201) | (80) | (1,281) |
Other movements | - | 1 | - | (6) | (5) | 8 | 3 |
Balance as at 31 December 2019 | 4,594 | 10,871 | 4,760 | 44,204 | 64,429 | 1,231 | 65,660 |
1 | Details of share capital, other equity instruments and other reserves are shown on pages 63 to 64. |
2 | Details of non-controlling interests are shown on page 59. |
Condensed consolidated cash flow statement | | |
| Year ended | Year ended |
| 31.12.20 | 31.12.19 |
| £m | £m |
Profit before tax | 3,065 | 4,357 |
Adjustment for non-cash items | 5,007 | 5,495 |
Net increase in loans and advances at amortised cost1 | (4,365) | (2,255) |
Net increase in deposits at amortised cost | 65,249 | 20,949 |
Net decrease in debt securities in issue | (6,309) | (9,911) |
Changes in other operating assets and liabilities2 | (4,459) | (18,909) |
Corporate income tax paid | (683) | (228) |
Net cash from operating activities1 | 57,505 | (502) |
Net cash from investing activities1 | (18,376) | (23,965) |
Net cash from financing activities | 2,732 | 690 |
Effect of exchange rates on cash and cash equivalents | 1,668 | (3,347) |
Net increase/(decrease) in cash and cash equivalents2 | 43,529 | (27,124) |
Cash and cash equivalents at beginning of the period2 | 166,613 | 193,737 |
Cash and cash equivalents at end of the period2 | 210,142 | 166,613 |
1 | Movements in cash and cash equivalents relating to debt securities at amortised cost were previously shown within loans and advances to banks and customers in operating activities. These debt securities holdings are part of the Group's investing activity and have been presented within investing activities in 2020. Comparatives have been re-presented. The effect of this change was to reclassify £11,139m decrease in cash and cash equivalents from operating activities to investing activities in 2019. |
2 | Cash collateral and settlement balances with banks with original maturity less than three months were previously included in cash and cash equivalents. They are no longer included, with the exception of balances that the Group holds at central banks related to payment schemes. Comparatives have been re-presented. The effect of this change decreased cash and cash equivalents by £16,774m as at 31 December 2019. |
Financial Statement Notes
1. Tax
The tax charge for 2020 was £604m (2019: £1,003m), representing an effective tax rate of 19.7% (2019: 23.0%).
Included in the tax charge is a credit of £233m (2019: £222m) in respect of payments made on AT1 instruments that are classified as equity for accounting purposes.
| As at | As at |
| 31.12.20 | 31.12.19 |
Deferred tax assets and liabilities | £m | £m |
USA | 2,049 | 2,052 |
UK | 886 | 818 |
Other territories | 509 | 420 |
Deferred tax assets | 3,444 | 3,290 |
Deferred tax liabilities | (15) | (23) |
| | |
Analysis of deferred tax assets | | |
Temporary differences | 2,709 | 2,767 |
Tax losses | 735 | 523 |
Deferred tax assets | 3,444 | 3,290 |
2. Non-controlling interests
| Profit attributable to non-controlling interests | | Equity attributable to non-controlling interests | ||
| Year ended | Year ended | | As at | As at |
| 31.12.20 | 31.12.19 | | 31.12.20 | 31.12.19 |
| £m | £m | | £m | £m |
Barclays Bank PLC issued: | | | | | |
- Preference shares | 42 | 41 | | 529 | 529 |
- Upper T2 instruments | 37 | 39 | | 533 | 691 |
Other non-controlling interests | (1) | - | | 23 | 11 |
Total | 78 | 80 | | 1,085 | 1,231 |
3. Earnings per share
| Year ended | Year ended |
| 31.12.20 | 31.12.19 |
| £m | £m |
Profit attributable to ordinary equity holders of the parent | 1,526 | 2,461 |
| | |
| m | m |
Basic weighted average number of shares in issue | 17,300 | 17,200 |
Number of potential ordinary shares | 368 | 282 |
Diluted weighted average number of shares | 17,668 | 17,482 |
| | |
| p | p |
Basic earnings per ordinary share | 8.8 | 14.3 |
Diluted earnings per ordinary share | 8.6 | 14.1 |
4. Dividends on ordinary shares
In response to a request from the PRA, and to preserve additional capital for use in serving Barclays customers and clients through the extraordinary challenges presented by the COVID-19 pandemic, the Board agreed to cancel the 6.0p per ordinary share full year 2019 dividend.
The Directors have approved a total dividend in respect of 2020 of 1.0p per ordinary share of 25p each. The full year dividend for 2020 of 1.0p per ordinary share will be paid on 1 April 2021 to shareholders on the Share Register on 26 February 2021. On 31 December 2020, there were 17,359m ordinary shares in issue. The financial statements for the year ended 31 December 2020 do not reflect this dividend, which will be accounted for in shareholders' equity as an appropriation of retained profits in the year ending 31 December 2021. Dividends are funded out of distributable reserves.
| Year ended 31.12.20 | Year ended 31.12.19 | ||
| Per share | Total | Per share | Total |
Dividends paid during the year | p | £m | p | £m |
Full year dividend paid during year | - | - | 4.0 | 684 |
Half year dividend paid during year | - | - | 3.0 | 517 |
Total dividend | - | - | 7.0 | 1,201 |
5. Fair value of financial instruments
The following table shows the Group's assets and liabilities that are held at fair value disaggregated by valuation technique (fair value hierarchy) and balance sheet classification:
| Valuation technique using | | | ||
| Quoted market prices | Observable inputs | Significant unobservable inputs | | |
| (Level 1) | (Level 2) | (Level 3) | | Total |
As at 31.12.20 | £m | £m | £m | | £m |
Trading portfolio assets | 60,671 | 65,416 | 1,863 | | 127,950 |
Financial assets at fair value through the income statement | 4,503 | 162,142 | 8,506 | | 175,151 |
Derivative financial instruments | 9,155 | 288,822 | 4,469 | | 302,446 |
Financial assets at fair value through other comprehensive income | 19,792 | 58,743 | 153 | | 78,688 |
Investment property | - | - | 10 | | 10 |
Total assets | 94,121 | 575,123 | 15,001 | | 684,245 |
| | | | | |
Trading portfolio liabilities | (24,391) | (22,986) | (28) | | (47,405) |
Financial liabilities designated at fair value | (159) | (249,251) | (355) | | (249,765) |
Derivative financial instruments | (8,762) | (285,774) | (6,239) | | (300,775) |
Total liabilities | (33,312) | (558,011) | (6,622) | | (597,945) |
| | | | | |
As at 31.12.19 | | | | | |
Trading portfolio assets | 60,352 | 51,579 | 2,264 | | 114,195 |
Financial assets at fair value through the income statement | 10,445 | 114,141 | 8,500 | | 133,086 |
Derivative financial instruments | 5,439 | 220,642 | 3,155 | | 229,236 |
Financial assets at fair value through other comprehensive income | 18,755 | 46,566 | 429 | | 65,750 |
Investment property | - | - | 13 | | 13 |
Total assets | 94,991 | 432,928 | 14,361 | | 542,280 |
| | | | | |
Trading portfolio liabilities | (20,977) | (15,939) | - | | (36,916) |
Financial liabilities designated at fair value | (82) | (203,882) | (362) | | (204,326) |
Derivative financial instruments | (5,305) | (219,910) | (3,989) | | (229,204) |
Total liabilities | (26,364) | (439,731) | (4,351) | | (470,446) |
6. Subordinated liabilities | ||
| Year ended | Year ended |
| 31.12.20 | 31.12.19 |
| £m | £m |
Opening balance as at 1 January | 18,156 | 20,559 |
Issuances | 1,438 | 1,352 |
Redemptions | (3,464) | (3,248) |
Other | 211 | (507) |
Closing balance | 16,341 | 18,156 |
Issuances of £1,438m comprise £782m USD 3.564% Fixed Rate Resetting Subordinated Callable Notes and £500m 3.75% Fixed Rate Resetting Subordinated Callable Notes, both issued externally by Barclays PLC and £156m USD Floating Rate Notes issued externally by a Barclays subsidiary.
Redemptions of £3,464m comprise a £1,126m partial redemption of USD 7.625% Contingent Capital Notes issued externally by Barclays Bank PLC and full redemptions of £1,124m EUR 2.625% Fixed Rate Subordinated Callable Notes issued externally by Barclays PLC, £842m USD 5.14% Lower Tier 2 Notes issued externally by Barclays Bank PLC and £342m USD Floating Rate Notes and £30m USD Fixed Rate Notes, both issued externally by Barclays subsidiaries.
Other movements predominantly include foreign exchange movements and fair value hedge adjustments.
7. Provisions | | |
| As at | As at |
| 31.12.20 | 31.12.19 |
| £m | £m |
PPI redress | 129 | 1,155 |
Other customer redress | 368 | 420 |
Legal, competition and regulatory matters | 268 | 376 |
Redundancy and restructuring | 158 | 143 |
Undrawn contractually committed facilities and guarantees | 1,064 | 322 |
Onerous contracts | 28 | 42 |
Sundry provisions | 289 | 306 |
Total | 2,304 | 2,764 |
PPI redress
As at 31 December 2020 Barclays had recognised cumulative provisions totalling £10.9bn including a £55m release in Q4 2020 on resolution of the majority of the items received in Q3 2019 (December 2019: £11bn), against the cost of PPI redress and associated processing costs. Utilisation of the cumulative provisions to date is £10.8bn (December 2019: £9.8bn), leaving a residual provision of £0.1bn (December 2019: £1.2bn) to be utilised in 2021. This represents Barclays best estimate as at 31 December 2020 based on information available.
8. Retirement benefits
As at 31 December 2020, the Group's IAS 19 pension surplus across all schemes was £1.5bn (December 2019: £1.8bn). The UK Retirement Fund (UKRF), which is the Group's main scheme, had an IAS 19 pension surplus of £1.8bn (December 2019: £2.1bn). The movement for the UKRF was driven by a net decrease in the discount rate and changes to pension increase assumptions, offset partially by higher than assumed asset returns.
UKRF funding valuations
The latest annual update as at 30 September 2020 showed the funding deficit had improved to £0.9bn from the £2.3bn shown at the 30 September 2019 triennial valuation. The improvement was mainly due to £1.0bn of deficit reduction contributions paid over the year. The deficit recovery plan agreed at the last triennial valuation requires deficit reduction contributions from Barclays Bank PLC of £700m in 2021, £294m in 2022 and £286m in 2023. The deficit reduction contributions are in addition to the regular contributions to meet the Group's share of the cost of benefits accruing over each year.
The next triennial actuarial valuation of the UKRF is due to be completed in 2023 with an effective date of 30 September 2022.
On 12 June 2020, Barclays Bank PLC paid the £500m deficit reduction contribution agreed for 2020 and at the same time the UKRF subscribed for non-transferrable listed senior fixed rate notes for £750m, backed by UK gilts (the Senior Notes). These Senior Notes entitle the UKRF to semi-annual coupon payments for five years, and full repayment in cash in three equal tranches in 2023, 2024, and at final maturity in 2025. As a result of the investment in Senior Notes, the regulatory capital impact of the £500m deficit reduction contribution paid on 12 June 2020 takes effect in 2023, 2024 and 2025 on maturity of the notes. The £250m additional investment by the UKRF in the Senior Notes has a positive capital impact in 2020 which is reduced equally in 2023, 2024 and 2025 on the maturity of the notes.
On 11 December 2020, the UKRF entered into a £5bn longevity swap to hedge around a quarter of current pensioner liabilities against unexpected increases in life expectancy. The swap forms part of the UKRF's investment portfolio and provides income in the event that pensions are paid out for longer than expected. The UKRF Trustee established a Guernsey based captive insurer (Barclays UKRF No.1 IC Limited) to act as an insurance intermediary between the UKRF and swap provider. The swap is not included directly within the balance sheet of Barclays PLC as it is an asset of the UKRF. At 31 December 2020, the swap is valued at nil fair value as it is considered to remain at fair market value for both parties over the very limited period from 11 December 2020 to 31 December 2020.
9. Called up share capital
Called up share capital comprised 17,359m (December 2019: 17,322m) ordinary shares of 25p each. The increase was mainly due to the issuance of shares under employee share schemes.
| Ordinary share capital | Share premium | Total share capital and share premium |
Year ended 31.12.20 | £m | £m | £m |
Opening balance as at 1 January | 4,331 | 263 | 4,594 |
Movement | 9 | 34 | 43 |
Closing balance | 4,340 | 297 | 4,637 |
10. Other equity instruments | ||
| Year ended | Year ended |
| 31.12.20 | 31.12.19 |
| £m | £m |
Opening balance as at 1 January | 10,871 | 9,632 |
Issuances | 1,142 | 3,500 |
Redemptions | (831) | (2,262) |
Other | (10) | 1 |
Closing balance | 11,172 | 10,871 |
Other equity instruments of £11,172m (December 2019: £10,871m) consists of AT1 securities issued by Barclays PLC.
The AT1 securities are perpetual securities with no fixed maturity and are structured to qualify as AT1 instruments under prevailing capital rules applicable as at the relevant issue date. AT1 securities are undated and are redeemable, at the option of Barclays PLC, in whole on (i) the initial call date, or on any fifth anniversary after the initial call date or (ii) any day falling in a named period ending on the initial reset date, or on any fifth anniversary after the initial reset date. In addition, the AT1 securities are redeemable, at the option of Barclays PLC, in whole in the event of certain changes in the tax or regulatory treatment of the securities. Any redemptions require the prior consent of the PRA.
All Barclays PLC AT1 securities will be converted into ordinary shares of Barclays PLC, at a pre-determined price, should the fully loaded CET1 ratio of the Group fall below 7%.
11. Other reserves | | |
| As at | As at |
| 31.12.20 | 31.12.19 |
| £m | £m |
Currency translation reserve | 2,871 | 3,344 |
Fair value through other comprehensive income reserve | 5 | (187) |
Cash flow hedging reserve | 1,575 | 1,002 |
Own credit reserve | (954) | (373) |
Other reserves and treasury shares | 964 | 974 |
Total | 4,461 | 4,760 |
Currency translation reserve
The currency translation reserve represents the cumulative gains and losses on the retranslation of the Group's net investment in foreign operations, net of the effects of hedging.
As at 31 December 2020, there was a credit balance of £2,871m (December 2019: £3,344m credit) in the currency translation reserve. The £473m debit movement principally reflects the weakening of period end USD exchange rate against GBP.
Fair value through other comprehensive income reserve
The fair value through other comprehensive income reserve represents the unrealised change in the fair value through other comprehensive income investments since initial recognition.
As at 31 December 2020, there was a credit balance of £5m (December 2019: £187m debit) in the fair value through other comprehensive income reserve. The gain of £192m is principally driven by a gain of £902m from the increase in fair value of bonds due to decreasing bond yields. This is partially offset by £295m of net gains transferred to the income statement, loss of £262m due to a decrease in the Absa Group Limited share price and a tax charge of £155m.
Cash flow hedging reserve
The cash flow hedging reserve represents the cumulative gains and losses on effective cash flow hedging instruments that will be recycled to the income statement when the hedged transactions affect profit or loss.
As at 31 December 2020, there was a credit balance of £1,575m (December 2019: £1,002m credit) in the cash flow hedging reserve. The increase of £573m principally reflects a £1,314m increase in the fair value of interest rate swaps held for hedging purposes as major interest rate forward curves decreased. This is partially offset by £510m of gains transferred to the income statement and a tax charge of £216m.
Own credit reserve
The own credit reserve reflects the cumulative own credit gains and losses on financial liabilities at fair value. Amounts in the own credit reserve are not recycled to profit or loss in future periods.
As at 31 December 2020, there was a debit balance of £954m (December 2019: £373m debit) in the own credit reserve. The movement of £581m principally reflects a loss from the tightening of Barclays' funding spreads. This is partially offset by other activity and a tax credit of £229m.
Other reserves and treasury shares
Other reserves relate to redeemed ordinary and preference shares issued by the Group. Treasury shares relate to Barclays PLC shares held principally in relation to the Group's various share schemes.
As at 31 December 2020, there was a credit balance of £964m (December 2019: £974m credit) in other reserves and treasury shares. The decrease of £10m is due to an increase in treasury shares held in relation to employee share schemes.
Appendix: Non-IFRS Performance Measures
The Group's management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses' performance between financial periods, and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by management.
However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well.
Non-IFRS performance measures glossary
Measure | Definition |
Loan: deposit ratio | Loans and advances at amortised cost divided by deposits at amortised cost. The components of the calculation have been included on page 43. |
Period end allocated tangible equity | Allocated tangible equity is calculated as 13.0% (2019: 13.0%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office allocated tangible equity represents the difference between the Group's tangible shareholders' equity and the amounts allocated to businesses. |
Average tangible shareholders' equity | Calculated as the average of the previous month's period end tangible equity and the current month's period end tangible equity. The average tangible shareholders' equity for the period is the average of the monthly averages within that period. |
Average allocated tangible equity | Calculated as the average of the previous month's period end allocated tangible equity and the current month's period end allocated tangible equity. The average allocated tangible equity for the period is the average of the monthly averages within that period. |
Return on average tangible shareholders' equity | Statutory profit after tax attributable to ordinary equity holders of the parent, as a proportion of average shareholders' equity excluding non-controlling interests and other equity instruments adjusted for the deduction of intangible assets and goodwill. The components of the calculation have been included on page 66. |
Return on average allocated tangible equity | Statutory profit after tax attributable to ordinary equity holders of the parent, as a proportion of average allocated tangible equity. The components of the calculation have been included on page 66. |
Cost: income ratio | Total operating expenses divided by total income. |
Loan loss rate | Quoted in basis points and represents total impairment charges divided by gross loans and advances held at amortised cost at the balance sheet date. The components of the calculation have been included on page 27. |
Net interest margin | Net interest income divided by the sum of average customer assets. The components of the calculation have been included on page 23. |
Tangible net asset value per share | Calculated by dividing shareholders' equity, excluding non-controlling interests and other equity instruments, less goodwill and intangible assets, by the number of issued ordinary shares. The components of the calculation have been included on page 74. |
Performance measures excluding litigation and conduct | Calculated by excluding litigation and conduct charges from performance measures. The components of the calculations have been included on pages 67 to 74. |
Pre-provision profits | Calculated by excluding credit impairment charges from profit before tax. The components of the calculation have been included on pages 67 to 69. |
Pre-provision profits excluding litigation and conduct | Calculated by excluding credit impairment charges, and litigation and conduct charges from profit before tax. The components of the calculation have been included on pages 67 to 69. |
Returns
Return on average tangible equity is calculated as profit after tax attributable to ordinary equity holders of the parent as a proportion of average tangible equity, excluding non-controlling and other equity interests for businesses. Allocated tangible equity has been calculated as 13.0% (2019: 13.0%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office average allocated tangible equity represents the difference between the Group's average tangible shareholders' equity and the amounts allocated to businesses.
| Profit/(loss) attributable to ordinary equity holders of the parent | | Average tangible equity | | Return on average tangible equity |
For the year ended 31.12.20 | £m | | £bn | | % |
Barclays UK | 325 | | 10.1 | | 3.2 |
Corporate and Investment Bank | 2,554 | | 27.0 | | 9.5 |
Consumer, Cards and Payments | (334) | | 4.5 | | (7.5) |
Barclays International | 2,220 | | 31.5 | | 7.1 |
Head Office | (1,019) | | 6.7 | | n/m |
Barclays Group | 1,526 | | 48.3 | | 3.2 |
| | | | | |
For the year ended 31.12.19 | | | | | |
Barclays UK | 281 | | 10.3 | | 2.7 |
Corporate and Investment Bank | 1,980 | | 25.9 | | 7.6 |
Consumer, Cards and Payments | 836 | | 5.3 | | 15.8 |
Barclays International | 2,816 | | 31.2 | | 9.0 |
Head Office | (636) | | 5.1 | | n/m |
Barclays Group | 2,461 | | 46.6 | | 5.3 |
Performance measures excluding litigation and conduct | ||||||
| | | | | | |
| Year ended 31.12.20 | |||||
| Barclays UK | Corporate and Investment Bank | Consumer, Cards and Payments | Barclays International | Head Office | Barclays Group |
Cost: income ratio | £m | £m | £m | £m | £m | £m |
Total operating expenses | (4,352) | (6,919) | (2,134) | (9,053) | (481) | (13,886) |
Impact of litigation and conduct | 32 | 4 | 44 | 48 | 73 | 153 |
Operating expenses | (4,320) | (6,915) | (2,090) | (9,005) | (408) | (13,733) |
| | | | | | |
Total income | 6,347 | 12,476 | 3,445 | 15,921 | (502) | 21,766 |
| | | | | | |
Cost: income ratio excluding litigation and conduct | 68% | 55% | 61% | 57% | n/m | 63% |
| | | | | | |
Profit before tax | | | | | | |
Profit/(loss) before tax | 546 | 4,004 | (388) | 3,616 | (1,097) | 3,065 |
Impact of litigation and conduct | 32 | 4 | 44 | 48 | 73 | 153 |
Profit/(loss) before tax excluding litigation and conduct | 578 | 4,008 | (344) | 3,664 | (1,024) | 3,218 |
| | | | | | |
Profit attributable to ordinary equity holders of the parent | | | | | | |
Attributable profit/(loss) | 325 | 2,554 | (334) | 2,220 | (1,019) | 1,526 |
Post-tax impact of litigation and conduct | 18 | 2 | 36 | 38 | 56 | 112 |
Profit/(loss) attributable to ordinary equity holders of the parent excluding litigation and conduct | 343 | 2,556 | (298) | 2,258 | (963) | 1,638 |
| | | | | | |
Return on average tangible shareholders' equity | £bn | £bn | £bn | £bn | £bn | £bn |
Average shareholders' equity | 13.7 | 27.0 | 5.1 | 32.1 | 10.6 | 56.4 |
Average goodwill and intangibles | (3.6) | - | (0.6) | (0.6) | (3.9) | (8.1) |
Average tangible shareholders' equity | 10.1 | 27.0 | 4.5 | 31.5 | 6.7 | 48.3 |
| | | | | | |
Return on average tangible shareholders' equity excluding litigation and conduct | 3.4% | 9.5% | (6.7%) | 7.2% | n/m | 3.4% |
| | | | | | |
Basic earnings per ordinary share | | | | | | |
Basic weighted average number of shares (m) | | | | | | 17,300 |
| | | | | | |
Basic earnings per ordinary share excluding litigation and conduct | | | | | | 9.5p |
| | | | | | |
Pre-provision profits | ||||||
| | | | | | |
Profit before tax excluding credit impairment charges and litigation and conduct | | | | | | £m |
Profit before tax | | | | | | 3,065 |
Impact of credit impairment charges | | | | | | 4,838 |
Profit before tax excluding credit impairment charges | | | | | | 7,903 |
Impact of litigation and conduct | | | | | | 153 |
Profit before tax excluding credit impairment charges and litigation and conduct | | | | | | 8,056 |
Year ended 31.12.19 | ||||||
| Barclays UK | Corporate and Investment Bank | Consumer, Cards and Payments | Barclays International | Head Office | Barclays Group |
Cost: income ratio | £m | £m | £m | £m | £m | £m |
Total operating expenses | (5,619) | (7,147) | (2,306) | (9,453) | (362) | (15,434) |
Impact of litigation and conduct | 1,582 | 109 | 7 | 116 | 151 | 1,849 |
Operating expenses | (4,037) | (7,038) | (2,299) | (9,337) | (211) | (13,585) |
| | | | | | |
Total income | 7,353 | 10,231 | 4,444 | 14,675 | (396) | 21,632 |
| | | | | | |
Cost: income ratio excluding litigation and conduct | 55% | 69% | 52% | 64% | n/m | 63% |
| | | | | | |
Profit before tax | | | | | | |
Profit/(loss) before tax | 1,022 | 2,955 | 1,163 | 4,118 | (783) | 4,357 |
Impact of litigation and conduct | 1,582 | 109 | 7 | 116 | 151 | 1,849 |
Profit/(loss) before tax excluding litigation and conduct | 2,604 | 3,064 | 1,170 | 4,234 | (632) | 6,206 |
| | | | | | |
Profit attributable to ordinary equity holders of the parent | | | | | | |
Attributable profit/(loss) | 281 | 1,980 | 836 | 2,816 | (636) | 2,461 |
Post-tax impact of litigation and conduct | 1,532 | 84 | 6 | 90 | 111 | 1,733 |
Profit/(loss) attributable to ordinary equity holders of the parent excluding litigation and conduct | 1,813 | 2,064 | 842 | 2,906 | (525) | 4,194 |
| | | | | | |
Return on average tangible shareholders' equity | £bn | £bn | £bn | £bn | £bn | £bn |
Average shareholders' equity | 13.9 | 25.9 | 6.3 | 32.2 | 8.5 | 54.6 |
Average goodwill and intangibles | (3.6) | - | (1.0) | (1.0) | (3.4) | (8.0) |
Average tangible shareholders' equity | 10.3 | 25.9 | 5.3 | 31.2 | 5.1 | 46.6 |
| | | | | | |
Return on average tangible shareholders' equity excluding litigation and conduct | 17.5% | 8.0% | 15.9% | 9.3% | n/m | 9.0% |
| | | | | | |
Basic earnings per ordinary share | | | | | | |
Basic weighted average number of shares (m) | | | | | | 17,200 |
| | | | | | |
Basic earnings per ordinary share excluding litigation and conduct | | | | | | 24.4p |
| | | | | | |
Pre-provision profits | ||||||
| | | | | | |
Profit before tax excluding credit impairment charges and litigation and conduct | | | | | | £m |
Profit before tax | | | | | | 4,357 |
Impact of credit impairment charges | | | | | | 1,912 |
Profit before tax excluding credit impairment charges | | | | | | 6,269 |
Impact of litigation and conduct | | | | | | 1,849 |
Profit before tax excluding credit impairment charges and litigation and conduct | | | | | | 8,118 |
Barclays Group | | | | | | | | | |
| Q420 | Q320 | Q220 | Q120 | | Q419 | Q319 | Q219 | Q119 |
Cost: income ratio | £m | £m | £m | £m | | £m | £m | £m | £m |
Total operating expenses | (3,826) | (3,467) | (3,330) | (3,263) | | (3,701) | (4,861) | (3,554) | (3,318) |
Impact of litigation and conduct | 47 | 76 | 20 | 10 | | 167 | 1,568 | 53 | 61 |
Operating expenses | (3,779) | (3,391) | (3,310) | (3,253) | | (3,534) | (3,293) | (3,501) | (3,257) |
| | | | | | | | | |
Total income | 4,941 | 5,204 | 5,338 | 6,283 | | 5,301 | 5,541 | 5,538 | 5,252 |
| | | | | | | | | |
Cost: income ratio excluding litigation and conduct | 76% | 65% | 62% | 52% | | 67% | 59% | 63% | 62% |
| | | | | | | | | |
Profit before tax | | | | | | | | | |
Profit before tax | 646 | 1,147 | 359 | 913 | | 1,097 | 246 | 1,531 | 1,483 |
Impact of litigation and conduct | 47 | 76 | 20 | 10 | | 167 | 1,568 | 53 | 61 |
Profit before tax excluding litigation and conduct | 693 | 1,223 | 379 | 923 | | 1,264 | 1,814 | 1,584 | 1,544 |
| | | | | | | | | |
Profit attributable to ordinary equity holders of the parent | | | | | | | | | |
Attributable profit/(loss) | 220 | 611 | 90 | 605 | | 681 | (292) | 1,034 | 1,038 |
Post-tax impact of litigation and conduct | 40 | 57 | 16 | (1) | | 122 | 1,525 | 40 | 46 |
Profit attributable to ordinary equity holders of the parent excluding litigation and conduct | 260 | 668 | 106 | 604 | | 803 | 1,233 | 1,074 | 1,084 |
| | | | | | | | | |
Return on average tangible shareholders' equity | £bn | £bn | £bn | £bn | | £bn | £bn | £bn | £bn |
Average shareholders' equity | 55.7 | 56.4 | 58.4 | 55.2 | | 54.5 | 56.4 | 54.0 | 53.2 |
Average goodwill and intangibles | (8.1) | (8.1) | (8.2) | (8.2) | | (8.1) | (8.0) | (7.8) | (8.0) |
Average tangible shareholders' equity | 47.6 | 48.3 | 50.2 | 47.0 | | 46.4 | 48.4 | 46.2 | 45.2 |
| | | | | | | | | |
Return on average tangible shareholders' equity excluding litigation and conduct | 2.2% | 5.5% | 0.8% | 5.1% | | 6.9% | 10.2% | 9.3% | 9.6% |
| | | | | | | | | |
Basic earnings per ordinary share | | | | | | | | | |
Basic weighted average number of shares (m) | 17,300 | 17,298 | 17,294 | 17,278 | | 17,200 | 17,192 | 17,178 | 17,111 |
| | | | | | | | | |
Basic earnings per ordinary share excluding litigation and conduct | 1.5p | 3.9p | 0.6p | 3.5p | | 4.7p | 7.2p | 6.3p | 6.3p |
| | | | | | | | | |
Pre-provision profits | | | | | | | | | |
| | | | | | | | | |
Profit before tax excluding credit impairment charges and litigation and conduct | Q420 | Q320 | Q220 | Q120 | | Q419 | Q319 | Q219 | Q119 |
£m | £m | £m | £m | | £m | £m | £m | £m | |
Profit before tax | 646 | 1,147 | 359 | 913 | | 1,097 | 246 | 1,531 | 1,483 |
Impact of credit impairment charges | 492 | 608 | 1,623 | 2,115 | | 523 | 461 | 480 | 448 |
Profit before tax excluding credit impairment charges | 1,138 | 1,755 | 1,982 | 3,028 | | 1,620 | 707 | 2,011 | 1,931 |
Impact of litigation and conduct | 47 | 76 | 20 | 10 | | 167 | 1,568 | 53 | 61 |
Profit before tax excluding credit impairment charges and litigation and conduct | 1,185 | 1,831 | 2,002 | 3,038 | | 1,787 | 2,275 | 2,064 | 1,992 |
Barclays UK | | | | | | | | | |
| Q420 | Q320 | Q220 | Q120 | | Q419 | Q319 | Q219 | Q119 |
Cost: income ratio | £m | £m | £m | £m | | £m | £m | £m | £m |
Total operating expenses | (1,180) | (1,120) | (1,024) | (1,028) | | (1,122) | (2,432) | (1,063) | (1,002) |
Impact of litigation and conduct | (4) | 25 | 6 | 5 | | 58 | 1,480 | 41 | 3 |
Operating expenses | (1,184) | (1,095) | (1,018) | (1,023) | | (1,064) | (952) | (1,022) | (999) |
| | | | | | | | | |
Total income | 1,626 | 1,550 | 1,467 | 1,704 | | 1,959 | 1,846 | 1,771 | 1,777 |
| | | | | | | | | |
Cost: income ratio excluding litigation and conduct | 73% | 71% | 69% | 60% | | 54% | 52% | 58% | 56% |
| | | | | | | | | |
Profit before tax | | | | | | | | | |
Profit/(loss) before tax | 282 | 196 | (127) | 195 | | 647 | (687) | 477 | 585 |
Impact of litigation and conduct | (4) | 25 | 6 | 5 | | 58 | 1,480 | 41 | 3 |
Profit/(loss) before tax excluding litigation and conduct | 278 | 221 | (121) | 200 | | 705 | 793 | 518 | 588 |
| | | | | | | | | |
Profit attributable to ordinary equity holders of the parent | | | | | | | | | |
Attributable profit/(loss) | 160 | 113 | (123) | 175 | | 438 | (907) | 328 | 422 |
Post-tax impact of litigation and conduct | (7) | 17 | 5 | 3 | | 43 | 1,457 | 30 | 2 |
Profit/(loss) attributable to ordinary equity holders of the parent excluding litigation and conduct | 153 | 130 | (118) | 178 | | 481 | 550 | 358 | 424 |
| | | | | | | | | |
Return on average allocated tangible equity | £bn | £bn | £bn | £bn | | £bn | £bn | £bn | £bn |
Average allocated equity | 13.4 | 13.7 | 13.9 | 13.7 | | 13.8 | 13.9 | 13.8 | 13.9 |
Average goodwill and intangibles | (3.6) | (3.6) | (3.6) | (3.6) | | (3.5) | (3.5) | (3.5) | (3.5) |
Average allocated tangible equity | 9.8 | 10.1 | 10.3 | 10.1 | | 10.3 | 10.4 | 10.3 | 10.4 |
| | | | | | | | | |
Return on average allocated tangible equity excluding litigation and conduct | 6.2% | 5.2% | (4.6%) | 7.0% | | 18.7% | 21.2% | 13.9% | 16.4% |
Barclays International | | | | | | | | | |
| Q420 | Q320 | Q220 | Q120 | | Q419 | Q319 | Q219 | Q119 |
Cost: income ratio | £m | £m | £m | £m | | £m | £m | £m | £m |
Total operating expenses | (2,382) | (2,255) | (2,197) | (2,219) | | (2,500) | (2,282) | (2,446) | (2,225) |
Impact of litigation and conduct | 9 | 28 | 11 | - | | 86 | - | 11 | 19 |
Operating expenses | (2,373) | (2,227) | (2,186) | (2,219) | | (2,414) | (2,282) | (2,435) | (2,206) |
| | | | | | | | | |
Total income | 3,486 | 3,781 | 4,010 | 4,644 | | 3,452 | 3,750 | 3,903 | 3,570 |
| | | | | | | | | |
Cost: income ratio excluding litigation and conduct | 68% | 59% | 55% | 48% | | 70% | 61% | 62% | 62% |
| | | | | | | | | |
Profit before tax | | | | | | | | | |
Profit before tax | 822 | 1,165 | 807 | 822 | | 640 | 1,137 | 1,223 | 1,118 |
Impact of litigation and conduct | 9 | 28 | 11 | - | | 86 | - | 11 | 19 |
Profit before tax excluding litigation and conduct | 831 | 1,193 | 818 | 822 | | 726 | 1,137 | 1,234 | 1,137 |
| | | | | | | | | |
Profit attributable to ordinary equity holders of the parent | | | | | | | | | |
Attributable profit | 441 | 782 | 468 | 529 | | 397 | 799 | 832 | 788 |
Post-tax impact of litigation and conduct | 9 | 21 | 8 | - | | 64 | 2 | 8 | 16 |
Profit attributable to ordinary equity holders of the parent excluding litigation and conduct | 450 | 803 | 476 | 529 | | 461 | 801 | 840 | 804 |
| | | | | | | | | |
Return on average allocated tangible equity | £bn | £bn | £bn | £bn | | £bn | £bn | £bn | £bn |
Average allocated equity | 31.1 | 31.2 | 34.2 | 31.9 | | 31.9 | 33.3 | 32.1 | 31.6 |
Average goodwill and intangibles | (0.6) | (0.6) | (0.7) | (0.7) | | (1.0) | (1.1) | (1.0) | (1.1) |
Average allocated tangible equity | 30.5 | 30.6 | 33.5 | 31.2 | | 30.9 | 32.2 | 31.1 | 30.5 |
| | | | | | | | | |
Return on average allocated tangible equity excluding litigation and conduct | 5.9% | 10.5% | 5.7% | 6.8% | | 6.0% | 10.0% | 10.8% | 10.6% |
Corporate and Investment Bank | |||||||||
| Q420 | Q320 | Q220 | Q120 | | Q419 | Q319 | Q219 | Q119 |
Cost: income ratio | £m | £m | £m | £m | | £m | £m | £m | £m |
Total operating expenses | (1,827) | (1,719) | (1,683) | (1,690) | | (1,926) | (1,716) | (1,867) | (1,638) |
Impact of litigation and conduct | (2) | 3 | 3 | - | | 79 | 4 | 7 | 19 |
Operating expenses | (1,829) | (1,716) | (1,680) | (1,690) | | (1,847) | (1,712) | (1,860) | (1,619) |
| | | | | | | | | |
Total income | 2,638 | 2,905 | 3,316 | 3,617 | | 2,314 | 2,617 | 2,795 | 2,505 |
| | | | | | | | | |
Cost: income ratio excluding litigation and conduct | 69% | 59% | 51% | 47% | | 80% | 65% | 67% | 65% |
| | | | | | | | | |
Profit before tax | | | | | | | | | |
Profit before tax | 761 | 1,000 | 1,040 | 1,203 | | 359 | 882 | 887 | 827 |
Impact of litigation and conduct | (2) | 3 | 3 | - | | 79 | 4 | 7 | 19 |
Profit before tax excluding litigation and conduct | 759 | 1,003 | 1,043 | 1,203 | | 438 | 886 | 894 | 846 |
| | | | | | | | | |
Profit attributable to ordinary equity holders of the parent | | | | | | | | | |
Attributable profit | 413 | 627 | 694 | 820 | | 193 | 609 | 596 | 582 |
Post-tax impact of litigation and conduct | (2) | 2 | 2 | - | | 58 | 5 | 5 | 16 |
Profit attributable to ordinary equity holders of the parent excluding litigation and conduct | 411 | 629 | 696 | 820 | | 251 | 614 | 601 | 598 |
| | | | | | | | | |
Return on average allocated tangible equity | £bn | £bn | £bn | £bn | | £bn | £bn | £bn | £bn |
Average allocated equity | 26.3 | 26.4 | 29.1 | 26.2 | | 25.9 | 26.9 | 25.8 | 25.2 |
Average goodwill and intangibles | - | - | (0.1) | - | | (0.1) | - | - | (0.1) |
Average allocated tangible equity | 26.3 | 26.4 | 29.0 | 26.2 | | 25.8 | 26.9 | 25.8 | 25.1 |
| | | | | | | | | |
Return on average allocated tangible equity excluding litigation and conduct | 6.2% | 9.5% | 9.6% | 12.5% | | 3.9% | 9.2% | 9.3% | 9.5% |
Consumer, Cards and Payments | |||||||||
| Q420 | Q320 | Q220 | Q120 | | Q419 | Q319 | Q219 | Q119 |
Cost: income ratio | £m | £m | £m | £m | | £m | £m | £m | £m |
Total operating expenses | (555) | (536) | (514) | (529) | | (574) | (566) | (579) | (587) |
Impact of litigation and conduct | 11 | 25 | 8 | - | | 7 | (4) | 4 | - |
Operating expenses | (544) | (511) | (506) | (529) | | (567) | (570) | (575) | (587) |
| | | | | | | | | |
Total income | 848 | 876 | 694 | 1,027 | | 1,138 | 1,133 | 1,108 | 1,065 |
| | | | | | | | | |
Cost: income ratio excluding litigation and conduct | 64% | 58% | 73% | 52% | | 50% | 50% | 52% | 55% |
| | | | | | | | | |
Profit before tax | | | | | | | | | |
Profit/(loss) before tax | 61 | 165 | (233) | (381) | | 281 | 255 | 336 | 291 |
Impact of litigation and conduct | 11 | 25 | 8 | - | | 7 | (4) | 4 | - |
Profit/(loss) before tax excluding litigation and conduct | 72 | 190 | (225) | (381) | | 288 | 251 | 340 | 291 |
| | | | | | | | | |
Profit attributable to ordinary equity holders of the parent | | | | | | | | | |
Attributable profit/(loss) | 28 | 155 | (226) | (291) | | 204 | 190 | 236 | 206 |
Post-tax impact of litigation and conduct | 11 | 19 | 6 | - | | 6 | (3) | 3 | - |
Profit/(loss) attributable to ordinary equity holders of the parent excluding litigation and conduct | 39 | 174 | (220) | (291) | | 210 | 187 | 239 | 206 |
| | | | | | | | | |
Return on average allocated tangible equity | £bn | £bn | £bn | £bn | | £bn | £bn | £bn | £bn |
Average allocated equity | 4.8 | 4.8 | 5.1 | 5.7 | | 6.0 | 6.4 | 6.3 | 6.4 |
Average goodwill and intangibles | (0.6) | (0.6) | (0.6) | (0.7) | | (0.9) | (1.1) | (1.0) | (1.0) |
Average allocated tangible equity | 4.2 | 4.2 | 4.5 | 5.0 | | 5.1 | 5.3 | 5.3 | 5.4 |
| | | | | | | | | |
Return on average allocated tangible equity excluding litigation and conduct | 3.8% | 16.5% | (19.6%) | (23.5%) | | 16.3% | 14.0% | 18.0% | 15.4% |
Head Office | | | | | | | | | |
| Q420 | Q320 | Q220 | Q120 | | Q419 | Q319 | Q219 | Q119 |
Profit before tax | £m | £m | £m | £m | | £m | £m | £m | £m |
Loss before tax | (458) | (214) | (321) | (104) | | (190) | (204) | (169) | (220) |
Impact of litigation and conduct | 42 | 23 | 3 | 5 | | 23 | 88 | 1 | 39 |
Loss before tax excluding litigation and conduct | (416) | (191) | (318) | (99) | | (167) | (116) | (168) | (181) |
| | | | | | | | | |
Profit attributable to ordinary equity holders of the parent | | | | | | | | | |
Attributable loss | (381) | (284) | (255) | (99) | | (154) | (184) | (126) | (172) |
Post-tax impact of litigation and conduct | 38 | 19 | 3 | (4) | | 15 | 66 | 2 | 28 |
Attributable loss excluding litigation and conduct | (343) | (265) | (252) | (103) | | (139) | (118) | (124) | (144) |
Tangible net asset value per share | As at | As at |
| 31.12.20 | 31.12.19 |
| £m | £m |
Total equity excluding non-controlling interests | 65,797 | 64,429 |
Other equity instruments | (11,172) | (10,871) |
Goodwill and intangibles | (7,948) | (8,119) |
Tangible shareholders' equity attributable to ordinary shareholders of the parent | 46,677 | 45,439 |
| | |
| m | m |
Shares in issue | 17,359 | 17,322 |
| | |
| p | p |
Tangible net asset value per share | 269 | 262 |
Shareholder Information
| | | |
Results timetable1 | | Date | |
Ex-dividend date | | 25 February 2021 | |
Dividend record date | | 26 February 2021 | |
Cut off time of 5:00pm (UK time) for the receipt of DRIP Application Form Mandate Forms or Revocation | 12 March 2021 | | |
Dividend payment date | | 1 April 2021 | |
Q1 2021 Results Announcement | | 30 April 2021 | |
| | | |
| | | |
Barclays has decided to cease to offer the scrip dividend programme and will no longer offer a scrip alternative for dividends. For those | |||
shareholders who wish to elect to use their cash dividends to purchase additional ordinary shares in the market, rather than receive a cash | |||
payment, Barclays has arranged for its registrar, Equiniti, to provide and administer a dividend re-investment plan (DRIP). Further details | |||
regarding the DRIP can be found at www.barclays.com and www.shareview.co.uk/info/drip | |||
| | | |
For qualifying US and Canadian resident ADR holders, the 2020 full year dividend of 1.0p per ordinary share becomes 4.0p per ADS | |||
(representing four shares). The ex-dividend, dividend record and dividend payment dates for ADR holders are shown above. | |||
| | | |
| | | |
| Year ended | Year ended | |
Exchange rates2 | 31.12.20 | 31.12.19 | % Change3 |
Period end - USD/GBP | 1.37 | 1.33 | 3% |
Average - USD/GBP | 1.28 | 1.28 | - |
3 month average - USD/GBP | 1.32 | 1.29 | 2% |
Period end - EUR/GBP | 1.12 | 1.18 | (5%) |
Average - EUR/GBP | 1.13 | 1.14 | (1%) |
3 month average - EUR/GBP | 1.11 | 1.16 | (4%) |
| | | |
Share price data | | | |
Barclays PLC (p) | 146.68 | 179.64 | |
Barclays PLC number of shares (m) | 17,359 | 17,322 | |
| | | |
| | | |
For further information please contact | | | |
| | | |
Investor relations | Media relations | ||
Chris Manners +44 (0) 20 7773 2136 | Tom Hoskin +44 (0) 20 7116 4755 | ||
| | | |
| | | |
More information on Barclays can be found on our website: home.barclays. | | | |
| | | |
Registered office | | | |
1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839. | |||
| | | |
Registrar | | | |
Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA, United Kingdom. | |||
Tel: 0371 384 20554 from the UK or +44 121 415 7004 from overseas. | |||
| | | |
American Depositary Receipts (ADRs) | | | |
Shareowner Services | |||
StockTransfer@equiniti.com | |||
Tel: +1 800 990 1135 (toll free in US and Canada), +1 651 453 2128 (outside the US and Canada) | |||
Shareowner Services, PO Box 64504, St Paul, MN 55164-0504, USA. | |||
| | | |
Delivery of ADR certificates and overnight mail | | | |
Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120, USA. | |||
| |||
Qualifying US and Canadian resident ADR holders should contact Shareowner Services for further details regarding the DRIP |
1 | Note that these dates are provisional and subject to change. |
2 | The average rates shown above are derived from daily spot rates during the year. |
3 | The change is the impact to GBP reported information. |
4 | Lines open 8.30am to 5.30pm (UK time), Monday to Friday, excluding UK public holidays in England and Wales. |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.